Annual Report of Academic Activities July 1, 2017—June 30, 2018

UNIVERSITY OF CALIFORNIA, DAVIS

Department of Psychiatry and Behavioral Sciences

2

INTRODUCTION

Attached you will find the Department of Psychiatry and Behavioral Sciences Eighteenth

Annual Report of Academic Activities. This report reflects the publications,

presentations, research grants and community service of faculty members during the

period July 1, 2017, through June 30, 2018. During this year faculty published peer-

viewed articles and books, book chapters and other non-peer reviewed publications.

Only articles, book chapters, or books that were actually published during this time

frame are included. Faculty within the department have been quite productive in terms of

the number and quality of publications and their participation in national, regional and

local scientific meetings and educational programs. In addition, faculty were involved in

a number of community activities benefiting both the UC Davis and the greater

Sacramento County communities.

Ladson Hinton, M.D.

Joe P. Tupin Professor and Interim Chair

3

Introduction 2

Index 3

Abbeduto, Leonard, PhD 5

Amaral, David G, PhD 9

Barnhorst, Amy, MD 13

Bauman, Melissa D, PhD 15

Bhe, Emilie, MD 17

Carter, Cameron S, MD 18

Chadha, Puja L, MD 22

Crawley, Jacqueline N, PhD 23

Cross, Richard A, MD 27

DeMartini, Jeremy, MD 28

Dewa, Carolyn Sachiko, MPH, PhD 29

Dufek, Sarah Anne, PhD, BCBA-D 32

Fairman, Nathan, MD, MPH 33

Fassbender, Catherine, PhD 34

Giroux, Caroline, MD 35

Hersevoort, Shawn, MD 37

Hessl, David, PhD 38

Hilty, Donald M, MD, MBA 40

Hinton, W Ladson, MD 43

Horst, Robert, MD 45

How, Poh Choo, MD, PhD 46

Kahn, Debra, MD 47

Kenkel, Laura, MD 48

Koike, Alan, MD, MSHS 49

Lesh, Tyler, PhD 50

Lim, Russell, MD, MEd 52

Maddock, Richard, MD 53

McBride, Anne, MD 54

McDermott, Barbara E, PhD 55

Miller, Meghan, PhD 56

Murray, Karl D, PhD 57

Niendam, Tara A, PhD 58

Noctor, Stephen, PhD 62

Nord, Alex S, PhD 64

Nordahl, Christine Wu, PhD 67

Ozonoff, Sally, PhD 69

Pakyurek, Murat, MD 72

Ragland, J Daniel, PhD 73

Rao, Swati, MD 76

Robitz, Rachel, MD 78

Rogers, Sally, PhD 79

Roof, Jason G, MD 83

Scher, Lorin M, MD 84

Schumann, Cynthia, PhD 86

INDEX

4

Schweitzer, Julie, PhD 88

Sciolla, Andrés F, MD 91

Scott, Charles L, MD 93

Servis, Mark E, MD 96

Shen, Hong, MD 98

Shim, Ruth S, MD, MPH 99

Silverman, Jill L, PhD 103

Simon, Tony J, PhD 107

Solomon, Elizabeth, PsyD 108

Solomon, Marjorie, PhD, MBA 109

Stahmer, Aubyn C, PhD, BCBA-D 113

Suo, Shannon, MD 118

Tully, Laura Magdalen, PhD 120

Wadell, Paula, MD 122

Wheeler, Carlina Ramirez, PhD 123

Xia, Guohua, MD, PhD 124

Xiong, Glen L, MD 126

Yellowlees, Peter, MBBS, MD 128

Youngdale, Erik, MD 133

5

Leonard Abbeduto, PhD Journal Articles 2017 Lorang E, Sterling A, and the Expressive Language Consortium (Abbeduto L;

Member). The impact of autism spectrum disorder symptoms on gesture use in fragile X syndrome and Down syndrome. Autism & Developmental Language Impairments, 2, 1-14. https://doi.org/10.1177/2396941517745673.

2017 Ashby SA, Channell MM, Abbeduto L. Inferential language use by youth with Down

syndrome during narration. Research in Developmental Disabilities, 71, 98-108. doi: 10.1016/j.ridd.2017.10.002. Epub 2017 Oct 13. PMID: 29032290.

2017 Bullard L, McDuffie A, Abbeduto L. Distance delivery of a parent-implemented

language intervention for young boys with fragile X syndrome. Autism & Developmental Language Impairments, 2, 1-22. https://doi.org/10.1177/2396941517728690.

2018 Adolf SM, Klusek J, Hoffman A, Chitwood K, Brazendale A, Riley K, Abbeduto L,

Roberts JE. Reading in children with fragile X syndrome: Phonological awareness and feasibility of intervention. American Journal on Intellectual and Developmental Disabilities, 123, 193-211. doi: 10.1352/1944-7558-123.3.193. PMID: 29671637.

2018 Channell MM, Conners FA, Loveall S, Abbeduto L. Narrative language sampling in

typical development: Implications for clinical trials. American Journal of Speech-Language Pathology, 27, 123-135. doi: 10.1044/2017_AJSLP-17-0046. PMID: 29222570.

2018 Conners FA, Tungate AS, Abbeduto L, Merrill EC, Faught GG. Growth and decline in

language and phonological memory over two years among adolescents with Down syndrome. American Journal on Intellectual and Developmental Disabilities, 123, 103-118. doi: 10.1352/1944-7558-123.2.103. PMID: 29480772.

2018 Del Hoyo Soriano L, Thurman AJ, Harvey DJ, Brown WT, Abbeduto L. Genetic and

maternal predictors of cognitive and behavioral trajectories in females with fragile X syndrome. Journal of Neurodevelopmental Disorders, 10:22. doi: 10.1186/s11689-018-9240-2. PMID: 29925305.

2018 Nelson S, McDuffie A, Banasik A, Tempero Feigles R, Thurman AJ, Abbeduto L.

Inferential language use by school-aged boys with fragile X syndrome: Effects of a parent-implemented spoken language intervention. Journal of Communication Disorders, 72, 64-76. doi: 10.1016/j.jcomdis.2018.02.007. Epub 2018 Feb 15. PMID: 29494850.

6

2018 McDuffie A, Banasik A, Bullard L, Nelson S, Tempero Feigles R, Hagerman RJ, Abbeduto L. Distance delivery of a spoken language intervention for school-aged and adolescent boys with fragile X syndrome. Developmental Neurorehabilitation, 21, 48-63. doi: 10.1080/17518423.2017.1369189. Epub 2017 Sep 28. PMID: 28956679.

2018 Matherly SM, Klusek J, Thurman AJ, McDuffie A, Abbeduto L, Roberts JE. Cortisol

profiles differentiated in adolescents and young adult males with fragile X syndrome versus autism spectrum disorder. Developmental Psychobiology, 60, 78-89. doi: 10.1002/dev.21578. Epub 2017 Nov 24. PMID: 29171019.

2018 The SPARK Consortium (Abbeduto L; Member). SPARK (Simons Foundation

Powering Autism Research for Knowledge): a US cohort of 50,000 families to accelerate autism research. Neuron, 97, 488-493. doi: 10.1016/j.neuron.2018.01.015. PMID: 29420931.

Book Chapters 2018 Abbeduto L, Greiss-Hess L, Wilbarger J, McDuffie A. Language, communication and

occupational therapy interventions for autism spectrum disorder. In E Hollander, D Fein, RJ Hagerman (Eds.), Autism spectrum disorders. Pp. 277-305. Washington, DC: American Psychiatric Association.

Abstracts and Presentations 2017 Abbeduto L. Enlisting Parents as Therapists: Distance-Delivered, Parent-

Implemented Language Interventions for Individuals with Developmental and Intellectual Disabilities. Presentation, UC Davis MIND Institute Summer Institute on Neurodevelopmental Disorders, Davis, CA. July.

2017 Abbeduto L, McDuffie A, Banasik A, Bullard L, Nelson S, Tempero Feigles R,

Hagerman RJ. Distance delivery of a spoken language intervention for school-aged and adolescent boys with fragile X syndrome. Poster presentation at the 18th International Fragile X and Related Neurodevelopmental Disorders Workshop, Quebec, Canada. October.

2018 Abbeduto L. Technology as a Tool for Bringing Services and Research to Individuals

with Developmental Disabilities, Families, and Communities. Keynote lecture, Vanderbilt Kennedy Center 10th Annual Science Day, Vanderbilt University, Nashville, TN. January.

2018 Abbeduto L, Thurman AJ, Berry-Kravis E, Sterling A, Sherman S, Edgin J, McDuffie

A. Expressive Language Sampling as an Outcome Measure for Clinical Trials for Fragile X Syndrome and Down Syndrome. Poster presented at the Gatlinburg Conference on Research and Theory in Intellectual and Developmental Disorders, San Diego, CA. April.

7

2018 Nelson S, Bullard L, McDuffie A, Abbeduto L. Maternal Psychological Profiles and Child Language Outcomes in a Parent-Implemented Spoken Language Intervention for Fragile X Syndrome. Paper presented at the 51st Annual Gatlinburg Conference on Research and Theory in Intellectual and Developmental Disorders, San Diego, CA. April.

2018 Klusek J, Moser C, Schmidt J, Abbeduto L, Roberts JE. A novel eye tracking

paradigm for indexing core social phenotypes of fragile X syndrome. Poster presented at the Gatlinburg Conference on Research and Theory in Intellectual and Developmental Disorders, San Diego, CA. April.

2018 Del Hoyo L, Thurman AJ, Harvey D, Brown WT, Abbeduto LJ. Trajectories of Fluid

and Crystallized Intelligence and the Influence of Biological and Maternal Factors in Adolescent Females with Fragile X Syndrome. Poster presented at the 51st annual Gatlinburg Conference, San Diego, CA. April.

2018 Abbeduto L. Using Technology to Bring Treatments to Families Affected by Autism

and Related Neurodevelopmental Disorders in their Communities. Public lecture, All About Language: Science, Theory, and Practice Conference. St. Petersburg State University, St. Petersburg, Russia. May-June.

2018 Wormwood KL, Dupree EJ, Woods AG, Abbeduto L, Darie CC. Mass Spectrometry-

Based Salivary Proteomics Investigation of Fragile X Syndrome (FXS). Poster presented at the annual meeting of the ASMS Mass Spectrometry Society. June.

2018 Abbeduto L. Characterizing the Language Abilities of Individuals with Intellectual

Disabilities in Treatment Studies. Invited Keynote at the biennial Conference on Laboratory Phonology, Variation, Development, and Impairment: Between Phonetics and Phonology, Lisbon, Portugal. June.

Research Funding PI/PD, Expressive Language Sampling as an Outcome Measure. National Institute of Child Health and Human Development, R01 HD074346, 3/1/13-2/28/2019, approx. $3,000,000 (total costs). PI/PD, Expressive Language Sampling as an Outcome Measure. National Institute of Child Health and Human Development, R01 HD074346-03S1, 12/1/15-2/28/2019, approx. $1,000,000 (total costs). Note that this is a competitive supplement to R01. PI/PD, MIND Institute Intellectual and Developmental Disabilities Research Center, National Institute of Child Health and Human Development, U54 HD079125, 9/24/13-6/30/19, $7,300,000 (approx. total costs). PI/PD (MPI), UC Davis MIND Institute Clinical Site for National Autism Cohort, Simons Foundation Autism Research Initiative, 4/1/16-3/31/19, $450,000 (total costs).

8

PI/PD (MPI), Effects of AFQ056 on Language Learning in Young Children with Fragile X Syndrome (FXS), U01 NS096767, 09/30/2016 – 06/30/2020, $11,500,000 (total costs). PI/PD, Gatlinburg Conference on ID/DD. National Institute of Child Health and Human Development, R13 HD084155, 1/15/16-12/31/2020, $95,000 (total costs). Co-I (J. Edgin, PI). Memory Measures for Clinical Trials in Down syndrome and Fragile X syndrome, R01HD088409, 09/22/2016 – 06/30/2021, $3,000,000 (total costs). Co-I (PI: van Santen). Automated Measurement of Language Outcomes for Neurodevelopmental Disorders. R01DC012033, 4/11/2017 – 3/31/22. Approx. $3,000,000 (total costs). Community Service Vice President, American Association on Intellectual and Developmental Disabilities Director, UC Davis MIND Institute Member, Executive Committee, Gatlinburg Conference on Research and Theory in Intellectual and Developmental Disabilities

9

David G. Amaral, PhD Journal Articles 2017 Shen MD, Kim SH, McKinstry RC, Gu H, Hazlett HC, Nordahl CW, Emerson RE,

Shaw D, Elison JT, Swanson MR, Fonov VS, Gerig G, Dager SR, Botteron KN, Paterson S, Schultz RT, Evans AC, Estes AM, Zwaigenbaum L, Styner MA, Amaral DG, Piven J, Chappell C, Dager S, Shaw D, McKinstry R, Constantino J, Pruett J, Schultz R, Elison J, Collins DL, Pike GB, Kostopoulos P, Das S, Gu H, Increased Extra-axial Cerebrospinal Fluid in High-Risk Infants who Later Develop Autism. Biological Psychiatry. PMID:28392081 PMCID: 5531051. August.

2017 Chareyron LJ, Lavenex PB, Amaral DG, Lavenex P. Functional organization of the

medial temporal lobe memory system following neonatal hippocampal lesion in rhesus monkeys. Brain Structure & Function. PMID: 28488186 PMCID: 6018021. December.

2018 Solomon M, Iosif A, Reinhardt VP, Libero LE, Nordahl CW, Ozonoff S, Rogers SJ,

Amaral DG. What will my child’s future hold? Phenotypes of Intellectual Development in 2-8 year olds with autism spectrum disorder. International Society for Autism Research. PMID: 29076255 PMCID: 5961488. January.

2018 Feliciano P, et al. SPARK: A US Cohort of 50,000 Families to Accelerate Autism

Research. Neuron Neuroview. Volume 97, Issue 3. pp. 488-493. February. 2018 Avino TA, Barger N, Vargas MV, Carlson EL, Amaral DG, Bauman MD, Schumann

CM. Neuron numbers increase in the human amygdala from birth to adulthood, but not in autism. Proceedings from the National Academy of Sciences. PMID: 29559529 PMCID: 5889677. April.

2018 Libero LE, Schaer M, Li DD, Amaral DG, Nordahl CW. A Longitudinal Study of Local

Gyrification Index in Young Boys With Autism Spectrum Disorder. Cerebral Cortex PMID: 29850803. May.

Book Chapter 2018 Amaral DG, Anderson MP, Ansorge O, Chance S, Hare C, Hof PR, Miller M,

Nagakura I, Picket J, Schumann C, Tamminga C. Autism BrainNet: A network of postmortem brain banks established to facilitate autism research. Handbook of Clinical Neurology, Volume 150 (3rd Series) Chapter 3, pp. 31-39 PMID: 29496150. February.

Abstracts and Presentations 2017 In Pursuit of Neurophenotypes of Autism Spectrum Disorder. Presentation at Africa

Regional IMFAR and the 19th Congress of SA-ACAPAP, Spier Wine Estate, Stellenbosch, South Africa. September.

10

2017 Early Brain Development in Autism. Presentation at the International Autism Conference, Gakushikaikan Hotel, Tokyo Japan. October.

2017 Autism Center of Excellence Overview. Presentation at the Research Seminar Series, UC Davis MIND Institute, Sacramento, CA. October.

2017 Searching for subtypes of autism. Keynote speaker at the Autism Tree Project

Foundation 3rd Annual Neuroscience Conference, San Diego CA. October. 2017 Structural and functional imaging brain tissue banks. Presentation at ASD Later in

Life: A Think Tank Roundtable on the effects of aging in autism spectrum disorder. Vancouver, British Columbia, Canada. October.

2018 An update on the HM Project. Presentation at the 2018 Howard Eichenbaum

Symposium. Boston, MA. March. 2018 The ups and downs of autism spectrum disorder: Tracking the trajectories of autism in

the Autism Phenome Project. Presentation at the University of Southern California, Los Angeles, CA. March.

2018 The ups and downs of autism spectrum disorder: Tracking the trajectories of autism in

the Autism Phenome Project. Presentation at San Diego State University, San Diego, CA. April.

2018 Prospective Validation of Molecular Subtype Diagnostics for Autism Spectrum

Disorders and Neurodevelopmental Disorders. International Society for Autism Research (INSAR) Rotterdam, Netherlands. May.

2018 Multi-Class Pattern Classification Discriminates Young Males and Females with

Autism Spectrum Disorder Based on Cortical Morphology. International Society for Autism Research (INSAR) Rotterdam, Netherlands. May.

2018 Increased Rates of Comorbid Psychopathology in Preschool Aged Females with

Autism Spectrum Disorder. International Society for Autism Research (INSAR) Rotterdam, Netherlands. May.

2018 Sex Differences in Interhemispheric Resting State Functional Connectivity in Autism

Spectrum Disorder in Early Childhood. International Society for Autism Research (INSAR) Rotterdam, Netherlands. May.

2018 Differences in the Anxiety Profiles of Middle Childhood Boys and Girls with ASD.

International Society for Autism Research (INSAR) Rotterdam, Netherlands. May. 2018 Examining Reciprocal and Predictive Relations Among Social, Language and Emotion

Regulation Skills across Early Childhood in a Longitudinal Sample of Children with ASD. International Society for Autism Research (INSAR) Rotterdam, Netherlands. May.

11

2018 Center for the Development of Phenotype based Treatments of Autism Spectrum Disorder. Presentation at the 2018 ACE Investigators Meeting, Bethesda MD. June.

Research Funding 1R01MH103371-03 (Amaral DG: PI); 4/01/15-01/31/20; $663,473. NIH; Neurophenotypic Trajectories and Behavioral Outcomes in Autism Spectrum Disorder. The goal of the proposed research is to determine whether identified neural phenotypes persist into middle childhood and are associated with the quality and severity of core and co-morbid behavioral impairments related to ASD. 1 P50HD093079-01 (Amaral DG: PI, Director); 09/07/17-07/31/22; $2,326,506 NICHD; Center for the Development of Phenotype Based Treatments of ASD. This Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder aims to discover effective treatments for subgroups of children with ASD. The Center starts from the premise that one treatment will not fit all children with ASD. If clinically meaningful subgroups can be identified on the basis of behavioral, biological or genetic features, treatments targeted to the characteristics of the subgroup will undoubtedly be more effective. The Center’s relevance to public health is evident as the behavioral and biological diagnostic information gathered will inform the most effective treatment decisions and greatest reduction of disability for individuals with ASD. T32 MH073124 (Rogers: PI; Amaral DG: Co-Director); 8/01/09-7/31/20; $333,830 NIMH; Interdisciplinary Training for Autism Researchers. This program is designed to provide postdoctoral training in the behavioral and biological aspects of clinical developmental neuroscience, with a focus on autism. P50 MH106438-04 (Amaral DG: PI Project 3); 04/01/15-03/31/20; $356,451 NIH; Multimodal Neuroimaging of Altered Brain Development in MIA Models and SZ. This is Project 3 of the Conte Center application Neuroimmune Mechanisms of Psychiatric Disorders. The goal of this proposed research is to provide information on alterations in brain development caused by MIA (maternal immune system activation) that may precede psychosis and to establish a common developmental neuropathology across mice, monkeys and humans to lead to clinically useful biomarkers for detecting individuals at high risk for Schizophrenia and promote earlier prevention and more effective treatment. P50 MH106438-04 (Carter: Admin Core; Amaral DG: Co-I); 4/01/18-03/31/19; $221,369 NIH; Neuroimmune Mechanisms of Psychiatric Disorders. The overall objective of the Administrative Core is to oversee and coordinate the scientific and administrative operations of the center's activities and foster interactions and synergism among the Conte Center's four research projects and the Nonhuman Primate Core. R01MH103284 (Solomon: PI; Amaral DG: Co-I); 9/14-8/31/19; $322,386 NIH; Predictors of Cognitive Development in Autism Spectrum Disorder. The goal of this study is to evaluate early neural predictors for middle childhood cognitive outcomes in a longitudinal study of children with ASD.

12

P51 OD011107 (Carter: PI; Amaral DG: Core Scientist of the Brain, Mind and Behavior Research unit); 5/01/15-4/30/23; $499,982 NIH/OD; California National Primate Research Center. The CNPRC is an established national resource that has as a primary mission to improve human health and quality of life through support of exceptional nonhuman primate research programs that advance our knowledge of the causes, preventions, treatments, and cures of debilitating diseases. Community Service Chair, Ontario Genomics Research Oversight Committee Director, Autism BrainNet (Simons Foundation Autism Research Initiative, SFARI) Grant Reviewer, New Jersey Governor’s Council for Medical Research and Treatment of Autism Grant Reviewer, Pennsylvania Department of Health Member, Interagency Autism Coordinating Committee (IACC); National Institute of Health Member, Nominations and Elections Committee, International Society for Autism Research (INSAR) Editor in Chief, Autism Research Member, Editorial Board, Behavioral and Brain Functions Member, Editorial Board, Brain Structure and Function Member, Editorial Board, Hippocampus Member, Editorial Board, Molecular Autism Member, Editorial Board, Translational Neuroscience

13

Amy Barnhorst, MD Journal Articles 2018 Barnhorst A, Wintemute GJ, Betz ME. How Should Make Decisions About Mandatory

Reporting When a Patient Might Become Violent? AMA Journal of Ethics 20(1), 29-35. January.

Presentations 2017 Presenter, Suicide: What Mental Health Professionals Can (and Can’t) Do, Minnesota

Gun Violence Prevention Forum, Minneapolis, MN. September. 2017 Presenter, What the Mental Health System Can (and Can’t) Do About Firearm

Violence, UC Davis Organized Medicine Student Interest Group, Sacramento, CA. December.

2018 Panelist, Mental Illness, Mass Shootings, and the Politics of American Firearms,

Steinberg Institute, Sacramento, CA. March. 2018 Presenter, Gun Violence Prevention, Doctors for America Expert Call, Sacramento,

CA. March. 2018 Expert Testimony for Alaska Senate on Senate Bill HB 75. March. 2018 Presenter, What You Can Do: What Every Clinician Should Know About Firearms, UC

Davis School of Medicine, Sacramento, CA. March. 2018 Presenter, Firearms and Mental Illness, Gun Violence Forum, UC Davis School of

Medicine. April. 2018 Expert Testimony for California Senate on SB 1200. April. 2018 Presenter, Mass Shootings and the Mental Health System, UC Office of the President

Stop Stigma Campaign, Sacramento, CA. April. 2018 Panelist, Guns and America after Parkland, UC Davis Campus Conversation, Davis,

CA. April. 2018 Presenter, Addressing the Problem of School Violence in California, UC Center

Sacramento, CA. June. Community Service Faculty Advisor, Wilderness Medicine Student Interest Group, UC Davis School of Medicine Member, California Medical Society Member, Consortium for Risk-Based Firearm Policy

14

Member, Emergency Department / Psychiatry Committee, UC Davis Member, Firearm Violence Committee, California Medical Society Member, Mental Health External Relations Committee Member, Sierra Sacramento Valley Medical Society Medical Clearance Subgroup Member, Sierra Sacramento Valley Medical Society Mental Health Task Force Volunteer Preceptor, Clinica Tepati Student-run Clinic Peer Reviewer, Psychiatry Research Peer Reviewer, Psychologic Services

15

Melissa D. Bauman, PhD Journal Article 2018 Bauman MD, Schumann CM. Advances in nonhuman primate models of autism:

Integrating neuroscience and behavior. Experimental Neurology, Jan;299(Pt A):252-265.

2018 Weir RK, Bauman MD, Jacobs B, Schumann CS. Increased dendritic spine density in

the amygdala of young autism spectrum disorder cases. Journal of Comparative Neurology, Feb 1;526(2):262-274.

2018 Avino TA, Barger N, Vargas MV, Amaral DG, Bauman MD, Schumann CS. Trajectory

of human amygdala neuronal development from youth to adulthood is disrupted in autism spectrum disorder. Proc Natl Acad Sci U S A. Apr 3;115(14):3710-3715.

2018 Berg E, Copping N, Pride M, Bauman MD, Berman RF, Lein P, Harony-Nicolas H,

Buxbaum J, Lerch J, Ellegood J, Wohr M, Jillverman J. Developmental social communication deficits in the Shank3 rat model of Phelan-McDermid Syndrome and Autism Spectrum Disorder. Autism Res. Apr;11(4):587-601.

Abstracts and Presentations 2017 Autism-relevant behavioral outcomes in an antigen-driven rat model of maternal

autoantibody related autism (abstract), Society for Neuroscience; Washington DC. November.

2017 PolyI:C response is dependent on length: Implications for preclinical maternal immune activation models (abstract), American College of Neuropsychopharmacology; Palm Springs, CA. December.

2017 MRS studies of brain glutathione and NAA in a non-human primate model of maternal

immune activation (abstract), American College of Neuropsychopharmacology; Palm Springs, CA. December.

2017 Diffusion measures of extracellular free water in a non-human primate model of

maternal immune activation – Exploring neuroimmune mechanisms of psychiatric disorders (abstract), American College of Neuropsychopharmacology; Palm Springs, CA. December.

Research Funding R21HD080498 NCE (Bauman MD: PI). 2/1/15-1/31/17. Pre-clinical evaluation of oxytocin for ASD treatment discovery. $244,898 Annual Direct and Indirect. IDDRC Pilot Research Award, 1/30/17-12/31/18, (Bauman MD: PI). Sustained Maternal Immune Response: Impact on Social and Cognitive Development”, $75,000 (Total Direct).

16

P50 MH106438 (Carter C: PI, Bauman MD: Novel Model Systems Core Director). 4/1/15-3/30/20. Neuroimmune Mechanisms of Neuropsychiatric Disorders. $587,362 Core Annual Direct and Indirect. Community Service Associate Editor, Developmental Psychobiology Chair, Women in Medicine and Health Sciences (WIMHS) Vice Chancellor Advisory Committee, UC Davis Health System Member, Bridge Funding Request Reviewer, UC Davis Health Member, CSTSC Pilot Translational and Clinical Studies Program Review Committee, UC Davis Member, CTSC Training Programs 14th Annual Scholar Symposium Moderator Member, Diversity Advisory Committee, Department of Psychiatry, UC Davis Member, Executive Committee, MIND Institute Member, Feminist Research Institute Seed Grant Reviewer, UC Davis Member, Health Mentoring Academy Advisory Board, UC Davis Member, Intellectual Development Disabilities Research Center (IDDRC) Executive Committee, MIND Institute Member, IDDRC Pilot Grant Reviewer, UC Davis Member, Neuroscience Doctoral Program Admissions Committee, UC Davis Member, Police Accountability Board, UC Davis Member, Research Advisory Committee, Department of Psychiatry, UC Davis Member, Toolkit Contributor “Equity in Promotion”, Group on Women in Medicine and Science, AAMC Member, Women in Medicine and Health Sciences Faculty Mentee Review Committee, UC Davis Member, Workgroup on Academic Family Leave Policy Member, Workgroup on Sexual Harassment in Academic Medicine Reviewer, The American Journal of Psychiatry Reviewer, Biological Psychiatry Reviewer, Brain, Behavior and Immunology Reviewer, Molecular Psychiatry Reviewer, Neuropsychopharmacology Reviewer, Translational Psychiatry

17

Emilie Bhe, MD Community Service Member, Adult Psychiatry Recruitment Selection Committee Member, Educational Policy Committee Member, EMR Inpatient and Specialty Physician User Group Committee Member, 5150 Training Designee Member, Leaders in Medical Student Education Committee Member, Medical Staff Wellbeing Committee

18

Cameron S. Carter, MD Journal Articles 2017 Smuncy J, Lesh TA, Newton T, Ragland JD, Carter CS. Levels of Cognitive Control:

A Functional Magnetic Resonance Imaging-Based Test of an RDoC Domain Across Bipolar Disorder and Schizophrenia. Neuropsychopharmacology. Sept 26. doi: 10.1038/npp.2017.233. PMID: 28948978.

2017 Carter CS. Clusters, Dimensions, and Hierarchies: Finding a Path Forward for the

Neuroscience of Mental Disorders? Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jan;3(1):2-3. doi: 10.1016/j.bpsc.2017.11.006. Epub 2017 Nov 24. PMID: 29397075.

2017 Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD,

Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, Potter WZ, Carlson M, Wall MM, Choo TH, Grinband J, Lieberman JA. Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Random Clinical Trial. JAMA Psychiatry. 2018 Jan 1;75(1):11-19. doi: 10.1001/jamapsychiatry.2017.3572. PMID 29167877.

2017 Ramsay IS, Ma S, Fisher M, Loewy RL, Ragland JD, Niendam T, Carter CS,

Vinogradov S. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr Res Cogn. 2017 Nov 8;11:1-5. doi: 10.1016/j.scog.2017.10.001. eCollection 2018 Mar. PMID 29159134.

2018 Boudewyn MA, Carter CS. I must have missed that: Alpha-band oscillations track

attention to spoken language. Neuropsychologia. 2018 May 26;117:148-155. doi: 10.1016/j.neuropsychologia.2018.05.024. [Epub ahead of print]. PMID: 29842859.

2018 Lesh TA, Careaga M, Rose DR, McAllister AK, Van de Water J, Carter CS,

Ashwood P. Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. J Neuroinflammation. 2018 May 26;15(1):165. doi: 10.1186/s12974-018-1197-2. PMID: 29803226

2018 Smuncy J, Lesh TA, Iosif AM, Niendam TA, Tully LM, Carter CS. Longitudinal

stability of cognitive control in early psychosis: Nondegenerative deficits across diagnoses. J Abnorm Psychol. 2018 May 21. doi: 10.1037/abn0000356. [Epub ahead of print].

2018 Hogeveen J, Krug MK, Elliott MV, Carter CS, Solomon M. Proactive control as a

double-edged sword in autism spectrum disorder. J Abnorm Psychol. 2018 May;127(4):429-435. doi: 10.1037/abn0000345. PMID:29745707

19

2018 Scangos KW, Carter CS, Gurkoff G, Zhang L, Shahlaie K. A pilot study of subthalamic theta frequency deep brain stimulation for cognitive dysfunction in Parkinson’s disease. Brain Stimulation 2018 Mar - Apr;11(2):456-458. doi: 10.1016/j.brs.2017.11.014.

2018 Minzenberg MJ, Yoon JH, Soosman SK, Carter CS. Altered brainstem responses to

modafinil in schizophrenia: implications for adjunctive treatment of cognition. Transl Psychiatry. 2018 Mar 6;8(1):58. doi: 10.1038/s41398-018-0104-z. PMID: 29507283.

Presentations 2017 Neurodevelopment and Psychosis, Talco University, Santiago Chile. December 18. 2018 Schizophrenia as a Neurodevelopmental Disorder, Research Seminar Series, UC

Davis MIND Institute. March 2. 2018 Mental Health Across the Lifespan, Chancellor’s Big Ideas Fundraising Event,

Houston, Texas. March 22. 2018 Cognition and Neurodevelopment in Psychotic Disorders, Visiting Professor

“Psychology Day,” Vanderbilt University Department of Psychology. April 24. Research Funding R01MH084826; (Carter); 09/30/08-10/31/18 5% 0.6 calendar NIH/NIMH; 2/5-Cognitive Neuroscience Task Reliability & Clinical Applications Consortium. One of five coordinated sites, this project is an extension of the CNTRICS initiative that will begin the translation process for paradigms designed to assess four constructs identified as being ripe for translation. R01MH105411; (Ragland/Ranganath); 01/01/14-12/30/18 10% 1.2 calendar NIH/NIMH; Neural Mechanisms of Memory Dysfunction in Schizophrenia. This grant uses a multimodal functional imaging approach (EEG, fMRI and MRS) to examine the relationship between the function of prefrontal and hippocampal circuitry supporting item-specific and relational memory in the brain to schizophrenia diagnosis, daily function and symptoms in schizophrenia. R01MH059883; (Carter); 06/1/13-03/31/19 5% 0.6 calendar NIH/NIMH; Pathophysiology of Cognitive Disability in Schizophrenia. We will test the hypothesis that cognitive deficits in schizophrenia reflect impairments in aspects of cognitive control supported by the DLPFC anterior cingulate cortex, while cognitive deficits in relatives reflect impaired DLPFC function but intact ACC function.

20

R01MH104235; (Carter); 09/01/14-07/31/19 10% 1.8 calendar NIH/NIMH; Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement. Through the use of technology-enhanced screening and engagement, the proposed project seeks to reduce the duration of untreated psychosis at a community level by addressing two bottlenecks: 1) delays in accurate identification and 2) delays in engagement in FEP care. The results of this project will provide new evidence-based practices for reducing DUP and improving outcomes in recent onset psychosis. R01MH104235-S1; (Carter); 09/01/14-07/31/19 5% 0.6 calendar NIH/NIMH; Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement. Through the use of technology-enhanced screening and engagement, the proposed project seeks to reduce the duration of untreated psychosis at a community level by addressing two bottlenecks: 1) delays in accurate identification and 2) delays in engagement in FEP care. The results of this project will provide new evidence-based practices for reducing DUP and improving outcomes in recent onset psychosis. P50MH106438; (Carter); 04/01/15-03/31/20 25% 3 calendar NIH/NIMH; UC Davis Conte Center Neuroimmune Mechanisms of Psychiatric Disorders. The goal of the Conte Center is to test the hypothesis that maternal immune activation contributes to schizophrenia by altering immune molecules in the brains of offspring, which, in turn, alters cortical connectivity, function, and behavior during development. P50MH106438-S1; (Carter); 04/01/15-03/31/20 0% 0 calendar NIH/NIMH; UC Davis Conte Center Neuroimmune Mechanisms of Psychiatric Disorders. The goal of the Conte Center is to test the hypothesis that maternal immune activation contributes to schizophrenia by altering immune molecules in the brains of offspring, which, in turn, alters cortical connectivity, function, and behavior during development. 1U01MH105258; (Carter); 08/01/15-8/30/20 3% .36 calendar NIH/NIMH; Building the Evidence Base for Adaptive Treatment Sequences in Clinical High Risk. This project seeks to test a clinical SMART trial intervention for adolescents and young adults experiencing the Clinical High Risk Syndrome (CHR). UC Davis will conduct a pilot study of the feasibility of the STEP study intervention in the US healthcare system and conduct focus groups with relevant stakeholders. R01MH106518; (Solomon); 01/01/16-12/31/21 2% .24 calendar NIH/NIMH; Neurodevelopment of cognitive control in autism: adolescence to young adulthood. This study examines the adolescent to young adulthood development of cognitive control and its relationship to functional outcomes using fMRI and behavioral measures. Community Service Interim Vice Chancellor for Research

21

Chair, UC Davis Campus Task Force on Cannabis Research Chair, UC Davis Campus Task Force on Student Mental Health Academic Adviser, Graduate Group in Clinical Research Editor, Biological Psychiatry, Cognitive Neuroscience and Neuroimaging Associate Editor, American Journal of Psychiatry Deputy Editor, Biological Psychiatry Director, UC Davis Behavioral Health Center of Excellence Director, UC Davis Conte Center Director, UC Davis Imaging Research Center Director, Early Diagnosis and Preventive Treatment (EDAPT and SacEDAPT) Clinics Director, Early Psychosis Clinical and Research Programs Member, ACNP Honorific Awards Committee Member, Alzheimer’s Disease Center Advisory Committee, Department of Neurology Member, Editorial Board, Psychiatry Research: Neuroimaging Member, Internal Advisory Committee, BIRCH Scholars Program Member, Internal Advisory Committee, UC Davis Center for Mind and Brain Member, Melbourne Neuropsychiatry Centre Scientific Advisory Committee Member, Mentoring Academy Steering Committee Member, Scientific Council, National Alliance for Research on Schizophrenia and Depression (NARSAD)

22

Puja L. Chadha, MD

Book Chapter 2018 Suo S, Chadha P. “Obsessive-Compulsive and Related Disorders in Older Age”

In, Textbook of Geriatric Psychiatry (Eds. Hategan A, Bourgeois J, Hirsch C, Giroux C), Springer International Publishing.

Presentations 2018 Presenter. National Alliance for Mental Illness. Cultural and Linguistic Competence

Online Curriculum. Webinar Presentation to NAMI Train-the-Trainer/Presenter. Train-the-Trainer Workshop, March.

2018 Presenter. Prioritizing Cultural, Linguistic, and LGBTQ Competence Workshop x2. California Pan-Ethnic Health Network, California Reducing Disparities Project: Advancing Mental Health Equity Statewide Conference, April.

Community Service Member, Vice Chancellor’s LGBTQ+ Advisory Council, UC Davis School of Medicine

23

Jacqueline N. Crawley, PhD

Journal Articles 2017 Gompers AL, Su-Feher L, Ellegood J, Copping NA, Asrafuzzaman Riyadh M,

Stradleigh TW, Pride MC, Schaffler MD, Wade A, Catta-Preta R, Zdilar I, Louis S, Kaushik G, Mannion BJ, Plajzer-Frick I, Afzal V, Visel A, Pennacchio LA, Dickel DE, Lerch JP, Crawley JN, Zarbalis KS, Silverman JL, Nord AS: Germline Chd8 haploinsufficiency alters brain development in mouse, Nature Neuroscience, 20:1062–1073.

2017 Leach PT, Crawley JN: Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2

mouse models of neurodevelopmental disorders with intellectual disabilities. Genes, Brain and Behavior, 17(6):e12452.

2018 Stoppel LJ, Kazdoba TM, Schaffler MD, Preza AR, Heynen A, Crawley JN, Bear

MF. R-baclofen reverses cognitive deficits and improves social interactions. Neuropsychopharmacology, 43:513-524.

2018 Matt L, Kirk LM, Chenaux G, Speca DJ, Puhger KR, Pride MC, Qneibi M, Haham T,

Stern-Bach Y, Silverman JL, Crawley JN, Hell JW, Diaz E: SynDIG4/Prrt1 is required for excitatory synapse development and plasticity underlying cognitive function. Cell Reports, 22(9):2246-2253.

2018 Jones KL, Pride MC, Edmiston E, Yang M, Silverman JL, Crawley JN,

Van de Water J: Autism-specific maternal autoantibodies produce behavioral abnormalities in an endogenous antigen-driven mouse model of autism. Mol Psychiatry, doi: 10.1038/s41380-018-0126-1.

2018 Berry-Kravis E, Lindemann L, Jønch A, Apostol G, Bear M, Carpenter R, Crawley J,

Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf S, Wang P, Von Raison F, Hagerman R, Spooren W, Jacquemont S. Drug development for fragile X syndrome: Lessons learned and implications for treatment of neurodevelopmental disorders, Nature Reviews Drug Discovery 17:280-298.

2018 Gulinello M, Mitchell HA, Chang Q, O'Brien WT, Zhou Z, Abel T, Wang L, Corbin JG,

Veeraragavan S, Samaco RC, Andrews NA, Fagiolini M, Cole TB, Burbacherg TM, Crawley JN. Rigor and reproducibility in rodent behavioral research. Neurobiology of Learning and Memory, S1074-7427(18)30001-7.

Abstracts and Presentations 2017 Biopsychology Seminar, Department of Psychology, University of California Davis,

Davis, CA. “Mouse models of autism for the discovery of effective therapeutics,” October 3.

24

2017 Opening Lecture, The Jackson Laboratory Course in Principles and Techniques in Mouse Behavioral Phenotyping and Pharmacology, “Principles and techniques in mouse behavioral phenotyping and pharmacology,” Bar Harbor, ME, October 22.

2017 Noldus Neuroscience Seminar, Translational approaches to the study of Autism

Spectrum Disorders: methodological and technical trends, innovations and challenges, Washington, DC, “Preclinical discovery of pharmacological therapeutics for autism using mouse models of social deficits and repetitive behaviors,” November 10.

2018 MIND Institute Research Seminar, University of California Davis School of Medicine,

Sacramento, CA, “Translational animal models,” January 5. 2018 Human Genomics Seminar, University of California Davis School of Medicine,

Sacramento, CA, “Behavioral consequences of mutations in risk genes for autism using translational mouse models,” March 7.

2018 University of Ottawa, Ottawa, Ontario, Canada, “Behavioral phenotyping of genetic

mouse models of autism,” March 23. 2018 Institute for Neuroscience Seminar, George Washington University, Washington, DC,

“Discovering pharmacological therapeutics for autism using translational mouse models,” April 12.

2018 Neuroscience Lecture, Santa Clara University, Santa Clara, CA, “Mouse models of

autism to test hypotheses about causes and to discover treatments,” May 1. Research Funding Simons Foundation Clinical Research Associates 497700. Preclinical evaluation of therapeutic efficacy of r-baclofen in reversing behavioral deficits in 16p11.2 deletion mice. (Crawley JN: PI) 01/01/2017 – 09/30/2017. The goal of this project is to evaluate the GABA-B r-baclofen for reversal of cognitive deficits in the Dolmetsch line of 16p11.2 deletion mice. NIH NINDS R01 NS085709. Convergent Synaptic Mechanisms in Neurodevelopmental Disorders. (Crawley JN, Gall C, Lynch G: Co-PIs) 9/1/2013-8/31/2018. The goal of this project is to discover common downstream mechanisms in four mouse models of neurodevelopmental disorders with cognitive impairment. NIH NICHD U54 5U54HD079125. Intellectual and Developmental Disabilities Research Center (Abbeduto L: PI, Crawley JN: Director, Rodent Behavior Core E) 9/24/2013-6/30/2018. The goal of this project is to develop and lead a Rodent Behavioral Core facility for MIND Institute and UC Davis users working on mouse and rat models of neurodevelopmental disorders.

25

NIMH 1 P50 MH106438-01. Conte Center, Neuroimmune Mechanisms of Psychiatric Disorders (Carter C: PI, Crawley JN: Co-Investigator) 4/1/2015 – 3/312020. The goal of this project is to evaluate maternal immune activation on complex phenotypes relevant to schizophrenia, including neuroanatomy, synaptic functions and behaviors in mice. Community Service Chair, Section on Neuroscience, American Association for the Achievement of Science (Fellow) Core E Director, IDDRC Executive Committee, MIND Institute, UC Davis Member, American College of Neuropsychopharmacology Member, Autism Research Training Program Faculty, MIND Institute, UC Davis Member, Behavioral and Neural Genetics Society Member, Editorial Board, Autism Research (2007-present) Member, Editorial Board, Annali dell’Istituto Superiore di Sanità (2011-present) Member, Editorial Board, Behavioural Brain Research (2003-present) Member, Editorial Board, Brain Plasticity (2014-present) Member, Editorial Board, Current Opinion in Behavioral Sciences (2013-present) Member, Editorial Board, Current Psychiatry Reviews (2004-present) Member, Editorial Board, Genes, Brain and Behavior (2001-present) Member, Editorial Board, Neuropeptides (2011-present) Member, Editorial Board, Pharmacology Biochemistry and Behavior (1988-present) Member, Editorial Board, Reviews in the Neurosciences (2005-present) Member, Editorial Board, Trends in Pharmacological Sciences (1990-present) Member, Executive Committee, MIND Institute Member, External Advisory Board, Italian Association for Autism Research Member, External Advisory Committee, Boston Children’s Hospital Intellectual and Developmental Disabilities Center Member, Faculty Membership Committee, MIND Institute, UC Davis Member, Faculty Search Committee: Chair, Department of Psychiatry and Behavioral Sciences, UC Davis Member, Internal Advisory Committee, Mouse Biology Program, UC Davis Member, International Society for Autism Research Member, International Society for Behavioral Neuroscience Member, Learning and Memory Graduate Training Program, Center for Neuroscience, UC Davis Member, Neuroscience Graduate Group Faculty, Center for Neuroscience, UC Davis Member, NIH Developmental Brain Disorders Study Section Member, Review Panel, NARSAD Distinguished Investigator Member, Review Panel, NARSAD Young Investigator Awards Member, Review Panel, NIH Director New Innovator Awards Member, Scientific Council, Brain and Behavior Research Foundation (formerly National Alliance for Research on Schizophrenia and Depression, NARSAD) Member, Society for Neuroscience Reviewer – Journal Manuscripts Autism Research

26

Behavioral Neuroscience Behavioural Brain Research Biological Psychiatry Cell Genes, Brain and Behavior Learning and Memory Molecular Psychiatry Nature Nature Genetics Nature Neuroscience Neuropsychopharmacology Pharmacology Biochemistry and Behavior Psychopharmacology Science Science Translational Medicine Translational Psychiatry Trends in Pharmacological Sciences

27

Richard A. Cross, MD

Community Service Member, ACGME Next Accreditation System Clinical Competency Committee Member, Education Policy Committee

28

Jeremy DeMartini, MD

Journal Articles 2018 Richards K, DeMartini J, Xiong G. “Understanding Sleep Disorders in Older Adults".

Psychiatric Times. Feb; 35(2). http://www.psychiatrictimes.com/sleep-disorders/understanding-sleep-disorders-older-adults.

Book Chapters 2017 DeMartini J, Yu A, Liu A. Chapter 1: General Principles. In Study Guide to

Preventative Medical Care in Psychiatry: A Case Approach. American Psychiatric Publishing. Arlington, VA. Editor McCarron RM.

Community Service Member, Membership Committee, Association of Medicine and Psychiatry

29

Carolyn Sachiko Dewa, MPH, PhD

Journal Articles 2017 Dewa CS, Loong D, Bonato S, Trojanowski L, Rea M. The Relationship between

Resident Burnout and Safety-related and Acceptability-related Quality of Healthcare: A Systematic Review. BMC Medical Education. 17(1):195. doi: 10.1186/s12909-017-1040-y. PMID: 29121895.

2017 Dewa CS. The Costs of Mental Disorders in the Workplace: Can They Be Decreased? Les coûts de la maladie mentale dépression en milieu de travail : peuvent-ils être réduits ? la Revue Santé Mentale au Québec. 42(2): 31-38. PMID: 29267411.

2017 Villotti P, Corbière M, Dewa CS, Fraccaroli F, Taieb HS, Zaniboni S, Lecomte T. A

Serial Mediation Model of Workplace Social Support on Work Productivity: The Role of Self-Stigma and Job Tenure Self-Efficacy in People with Severe Mental Disorders. Disability and Rehabilitation. 12:1-7. PMID: 28899202.

2018 Dewa CS, Loong D, Trojanowski L, Bonato S. The Effectiveness of Enhanced versus

Standard Individual Placement and Support Programs: A Systematic Literature Review. Journal of Mental Health. 27(2):174-83. PMID: 28488948.

2018 Dewa CS, Trojanowski L, Tamminga S, Ringash J, McQuestion M, Hoch JS. Work-

Related Experiences of Head and Neck Cancer Survivors: An Exploratory and Descriptive Qualitative Study. Disability and Rehabilitation. 40(11):1252-58. PMID: 28637151.

2018 Dewa CS, Loong D, Trujillo A, Bonato S. Evidence for the Effectiveness of Police-

Based Pre-Booking Diversion Programs in Decriminalizing Mental Illness: A Systematic Literature Review. PLoS ONE. 13(6):e0199368. doi: 10.1371/journal.pone.0199368. PMID: 29920560.

2018 Nadin S, Katt M, Dewa CS, Cheng C. North B.E.A.T’s Capacity-to-Consent Protocol

for Obtaining Informed Consent for Youth Participation in Evaluation Research: An Alternative to Parental Consent. Canadian Journal of Program Evaluation. 33(1): 135-53.

Abstracts & Poster Presentations 2017 Dewa CS, Hoch JS. Abstract: Making the Case(s) for Health Economics. International

Health Economics Association Revolutions in the Economics of Health Systems Teaching Health Economics Pre-Session. Boston, Massachusetts, July 8-11.

2017 Invited Presenter: Worker Attitudes Towards Mental Illness and Workplace Burden.

University of California, Davis Health Diversity and Inclusion Dialogue Series. Sacramento, California, September 12.

30

2018 Invited Presenter: Effectiveness of Mental Health Gatekeeper Trainings for University

Faculty and Staff. CalMHSA Higher Education Partnership Meeting. Sacramento, CA, January 29.

2018 Dewa CS, Hoch JS, Nieuwenhuijsen K, Sluiter JK. Abstract: Examining the

Relationship Between Depression Symptom Profiles and Work Productivity Loss. 32nd International Congress on Occupational Health. Dublin, Ireland, April 29-May 4.

2018 Nieuwenhuijsen K, Dewa CS. Invited Presenter: Mental Health and Work Disability

Prevention. 32nd International Congress on Occupational Health. Dublin, Ireland, April 29-May 4.

Research Funding $8,200 funded by the University of California Office of the President Health Campus Network Initiative. 11/1/17-12/31/18, (Dewa CS: PI), An Open-Access Resource to Support Mental and Emotional Well-Being. $6,800 funded by the University of California Office of the President Health Campus Network Initiative. 11/1/17-12/31/18, (Dewa CS: PI), Effectiveness of Tools for Managing and Supervising Employees Struggling with Mental Health Challenges. $12.5 million Mental Health Services Act Innovation Grant. 07/01/17-06/30/21, (Dewa, CS: PI on the program evaluation). County of Sacramento’s Department of Behavioral Health Department. Urgent Care Clinic. $2.15 million CAD funded by Canadian Institutes of Health Research (CIHR) Roadmap Accelerator Fund (RAF) in partnership with the National Natural Science Foundation of China (NSFC). 11/3/17-10/31/22, Lam RW, Chen J, Colquhoun H, Culpepper L, (Dewa, CS: Co-Investigator), Greenshaw A, He Y, Kennedy S, Li XM, Liu TL, Michalak E, Morris J, Ng C, Parikh S, Soares C, Upshall P, Wang A, Xu Y. Enhanced Measurement-Based Care Effectiveness for Depression (EMBED): A Canada-China Implementation Project. Community Service Ad Hoc Reviewer, Canadian Journal of Psychiatry Ad Hoc Reviewer, Canadian Medical Association Journal Ad Hoc Reviewer, Journal of Mental Health Policy and Economics Ad Hoc Reviewer, Journal of Occupational and Environmental Medicine Ad Hoc Reviewer, Journal of Occupational Rehabilitation Ad Hoc Reviewer, Occupational Medicine Ad Hoc Reviewer, Psychiatric Services Associate Scientific Editor, Health Promotion and Chronic Disease Prevention in Canada Chair, GGPHS Admissions Committee, Department of Public Health Sciences, University of California, Davis

31

Co-lead, Emotional and Mental Well-being Sub-Committee, Health Campus Network, University of California, Davis Member, Editorial Board, Canadian Journal of Psychiatry Member, Editorial Board, Canadian Journal of Community Mental Health Member, Editorial Board, Journal of Occupational Rehabilitation Member, Editorial Board, Journal of Mental Health Policy and Economics Member, GGPHS Recruitment Committee, Department of Public Health Sciences, University of California, Davis Member, Health Fee Oversight Committee, University of California, Davis Reviewer, Health Services Evaluation and Interventions Research (HS2) Committee, Canadian Institutes of Health Research

32

Sarah Anne Dufek, PhD, BCBA-D Journal Articles 2017 Alexander LM, Escalera J, Andreotti C, Febre K, Mangone A, Vega-Potler N,

Alexander A, Kovacs M, Litke S, O’Hagan B, Anderson J, Bronstein B, Bui A, Bushey M, Butler H, Castagna V, Camacho N, Chan E, Citera D, Clucas J, Cphen S, Dufek S, et al. An open resource for transdiagnostic research in pediatric mental health and learning disorders. Scientific Data, 4, 1-26.

Abstracts and Presentations 2017 Dufek S. Autism Diagnostic Observation Schedule, 2nd Edition Clinical Workshop,

Ottawa Children’s Treatment Centre, Ottawa, Ontario, Canada. 2018 Dufek S. Brief Observation of Social Communication Change (BOSCC) Workshop,

STAR (Service, Training, Advocacy & Research) Center for Autism and Neurodevelopmental Disorders, University of California, San Francisco.

2018 Dufek S. The early bird catches the worm: Autism screening and developmental

assessment, Bridging the Gap Conference, Manila, Philippines. 2018 Dufek S. Interventions for individuals with ASD. Talk presented at Hearts and MIND

seminar at the MIND Institute. Research Support 1R01MH111981 NIH/NIMH (PI: Stahmer A, Dufek S: CPRT trainer and TLI coach-20% time), 02/01/2017-01/31/2021. Effectiveness of a Multi-Level Implementation Strategy for ASD Interventions; (Collaborative R01; Brookman-Frazee; UCSD). This study is testing the effects of the “Translating Evidence-based Interventions for ASD: Multi-Level Implementation Strategy” (TEAMS) model on provider training and child outcomes across two evidence-based interventions for autism spectrum disorder (ASD) and in two service systems (mental health, education). 5R01HD039961-14 NIH/NIMH (PI: Stahmer A; Robins; Dufek S: Recruitment and Assessor-20% time), 10/01/2017-08/31/2022. Autism Center for Excellence Award, Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes. This RCT study aims to demonstrate that standardized high-fidelity, universal early screening lowers the age of diagnosis and treatment onset, leading to improved short- and long-term outcomes. Community Service Abstract reviewer, International Society for Autism Research (INSAR) International Conference Member, International Society for Autism Research Reviewer, Autism

33

Nathan Fairman, MD, MPH Journal Articles 2017 Anderson WG, Puntillo K, Cimino J, Noort J, Pearson D, Boyle D, Grywalski M,

Meyer J, O’Neil-Page E, Cain J, Herman H, Barbour S, Turner K, Moore E, Liao S, Ferrell B, Mitchell W, Edmonds K, Fairman N, Joseph D, MacMillan J, Milic MM, Miller M, Nakagawa L, O’Riordan DL, Pietras C, Thornberry K, Pantilat SZ. Palliative care professional development for critical care nurses: a multicenter program. Am J Crit Care Sep;26(5):361-71.

Book Chapters 2017 Irwin SA, Fairman N, Montross L, Hirst J, Siegel J. Psychiatric, Psychological, and

Spiritual Care. In: Shega J and Paniagua M, Eds. Essential Practices in Hospice and Palliative Medicine. Glenville, IL: American Academy of Hospice and Palliative Medicine.

Abstracts and Presentations 2017 Fairman N. “The California End of Life Option Act: the Experience at UC Davis.”

Annual Advances in Oncology. UC Davis Comprehensive Cancer Center. Sacramento CA, September.

2017 Fairman N. “Palliative Care: Planning for the Road Ahead.” Parkinson Association of

Northern California Annual Education Conference. Sacramento CA, October. 2018 Reed SC, Bell J, Nekhlyudov L, Fairman N, Joseph JG, Miglioretti DL. Fear of cancer

recurrence and associations with mental health status and individual characteristics among cancer survivors: findings from a nationally representative sample. American Society of Clinical Oncology Cancer Survivorship Symposium. Orlando FL, February.

Community Service Chair and Member, End of Life Option Act Committee, UC Davis Medical Center Chair and Member, Supportive Oncology Committee, UC Davis Comprehensive Cancer Center Member, Cancer Committee, UC Davis Comprehensive Cancer Center Member, Clinical Bioethics Consultation Committee Member, Doctoring Programs Steering Committee, UC Davis School of Medicine Member, Palliative Care Committee, UC Davis Medical Center

34

Catherine Fassbender, PhD Journal Articles 2018 Fassbender C. Dimensional and Categorical Approaches to Understanding Attention-

Deficit/Hyperactivity Disorder: New Frontiers in Translational Research. Biological Psychiatry Cognitive Neuroscience and NeuroImaging, 3(8), pp. 652-653.

2018 McCarthy JJ, Vasti EJ, Leamon MH, Graas J, Ward C, Fassbender C. The Use of

Serum Methadone/Metabolite Ratios to Monitor Changing Perinatal Pharmacokinetics, Journal of Addiction Medicine, 12(3), 241-246.

Presentations 2018 Schweitzer JB, Mukherjee P, Fassbender C, Iosif AM, Menor MB, Burns J, Rogawski

AJ, Mlodnicka A, Dixon JF, McClure SM. The impact of framing effects and ADHD on intertemporal choice in adolescence, Society for Neuroscience.

Research Funding R21 DA038005 (Fassbender C: PI) NIH/NIDA, 4/1/2015-3/31/2017, (NCE until 3/31/2019). Cognitive and Reward processes in risk for relapse in poly substance dependence, R01 MH091068 05A1 (Schweitzer J: PI; Fassbender C: Co-Investigator) NIH/NIMH, 8/15/2012-8/31/2021. Developmental Changes in Neural Processes Underlying Attention, Impulsivity and Regulation.

Community Service Administrator, Parenting Resources Facebook Page, UC Davis Medical Center Academic Editor, International Neuropsychiatric Disease Journal Member, Editorial Board, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Member, Evaluation Committee of online Individual Development Plan for UC Davis Health Member, Irish Brain Council Member, MIND Institute Space Committee, UC Davis Member, Neuroimaging Safety Committee, UC Davis Member, Organizing Committee for the Global Conference on Addiction and Behavioral Health (GAB) 2019, August 22-24th, London, UK Peer Reviewer, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Peer Reviewer, Developmental Cognitive Neuroscience Peer Reviewer, European Research Council (ERC), ERC Consolidator Grant Peer Reviewer, Frontiers in Human Neuroscience Peer Reviewer, Journal of Abnormal Psychology Peer Reviewer, Neuropsychology Peer Reviewer, NIH, Brain Disorders and Clinical Neuroscience, ZRG1 BDCN J 02 Grant Peer Reviewer, Psychological Bulletin

35

Caroline Giroux, MD Journal Articles 2017 Giroux C, The Pathologization Conspiracy, Sierra Sacramento Valley Medicine, July-

August, p. 10-13. 2017 Giroux C, A Prior Auth for Parental Oxytocin, Please!, Sierra Sacramento Valley

Medicine, September-October, p. 12-15. 2018 Giroux C, The Goldwater Rule, GUEST EDITORIAL, Sierra Sacramento Valley

Medicine, January-February, p. 6-8. 2018 Giroux C, On Story listening, Sierra Sacramento Valley Medicine, January-February,

p. 28-29. 2018 Giroux C, The Prescription Sins, Sierra Sacramento Valley Medicine, March-April,

p. 10-12. 2018 Giroux C, The Intangible Sought After, Sierra Sacramento Valley Medicine,

May-June, p. 23-25. Book Chapters 2018 Giroux C, Smith WE, Psychotherapy in Late Life. In: Hategan A, Bourgeois JA,

Hirsch C, Giroux C. Textbook of Geriatric Psychiatry: Case Studies. Springer, April. 2018 Giroux C, Smith WE, Personality disorders in Late Life. In: Hategan A, Bourgeois JA,

Hirsch C, Giroux C. Textbook of Geriatric Psychiatry: Case Studies. Springer, April. 2018 Giroux C, Sciolla AF, Trauma- and Stressor-related Disorders in Late Life. In:

Hategan A, Bourgeois JA, Hirsch C, Giroux C. Textbook of Geriatric Psychiatry: Case Studies. Springer, April.

2018 Bourgeois J, Giroux C, Psychosomatic Medicine. In: Hategan A, Bourgeois JA,

Hirsch C, Giroux C. Textbook of Geriatric Psychiatry: Case Studies. Springer, April. 2018 Ferencz JC, Chaimowitz GA, Giroux C. Geriatric Forensic Psychiatry: Risk

Assessment and Management. In: Hategan A, Bourgeois JA, Hirsch C, Giroux C. Textbook of Geriatric Psychiatry: Case Studies. Springer, April.

Presentations 2017 The SAFE project, presentation of a programmatic study on universal trauma

precautions, Harvard Program in Refugee Trauma, Porano, Italy, November 14. 2018 Trauma-Informed Care, presentation for Turning Point, Sacramento, CA, January 26.

36

2018 Invited speaker, Québec detachment for the Royal Canadian Mountain Police

(RCMP): Imbalance, Burnout and Resilience Factors in High-Risk Profession (Déséquilibre, épuisement et facteurs de résilience dans les professions à risque), Québec City, Québec, Canada, April 27.

2018 Invited speaker, Montréal detachment for RCMP, Imbalance, Burnout and

Resilience Factors in High-Risk Profession (Déséquilibre, épuisement et facteurs de résilience dans les professions à risque), Montréal, Québec, Canada, April 30.

2018 Co-presenter, Challenging Conversations: Communicating Effectively with Clients and

Coworkers Utilizing Self-Care, Resilience and Trauma-Informed Approaches, Sacramento Food Bank and Family Services, June 15.

Community Service Chair, Grand Rounds Committee, Psychiatry and Behavioral Sciences, UC Davis Member, Credentials and Privileges Committee Member, Editorial Committee, Sacramento Sierra Valley Medicine Member, Education Policy Committee, Psychiatry and Behavioral Sciences, UC Davis Member, Global Mental Health Interest Group, UC Davis Member, Leaders of Medical Student Education Committee, Psychiatry and Behavioral Sciences, UC Davis School of Medicine Member, Medical Staff Wellbeing Committee, UC Davis Health Member, Psychiatry Clerkship Site Directors Committee, UC Davis School of Medicine Member, Sacramento Psychoanalytical Society Newsletter Editor: The Cutting Edge: Trauma, the New Frontier of Psychiatry, Psychiatry and Behavioral Sciences, UC Davis

37

Shawn Hersevoort, MD Presentations 2017 Essentials of Primary Care Psychiatry CME Conference – CBT Cases, August,

Sacramento. 2018 Essentials of Primary Care Psychiatry CME Conference – Mood Disorders: Diagnosis

and Treatment Considerations, January, Sacramento. 2018 Essentials of Primary Care Psychiatry CME Conference – Small Group Case

Discussions: Co-Morbid Management of Mood Disorders, January, Sacramento. 2018 Treatment of Anxiety Disorders in Primary Care, 16th Annual UC Davis Primary Care

Pharmacotherapy Conference, April, Napa. 2018 Anxiety Case Discussions, 16th Annual UC Davis Primary Care Pharmacotherapy

Conference, April, Napa. Community Service President, Sierra Chapter, Psychiatric Society Secretary, Central California Psychiatric Society Chair/moderator, Vignettes Competition: CCPS Annual Meeting, March 2018, Monterey Co-Chair, Education Committee, California Psychiatric Association Associate Director, Train New Trainers Primary Care Psychiatry Mentor, Train New Trainers Primary Care Psychiatry Key Contact, Political Action Committee, California Psychiatric Association Member, Annual Meeting Planning Committee, Central California Psychiatric Society Member, Integrated Care Committee, California Psychiatric Association Central California Peer Reviewer, Current Psychiatry

38

David Hessl, PhD

Journal Articles

2017 Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R, Drewitt P, Lindemann L, Marcinowski M, Langland R, Horn C, Fontoura P, Santarelli L, Quiroz JA, FragXis Study Group. Effect of the mGluR5-NAM Basimglurant on behavior in adolescents and adults with fragile X syndrome in a randomized, double-blind, placebo-controlled trial: FragXis Phase 2 Results. Neuropsychopharmacology. 43(3): 503-512.

2017 Ligsay A, Van Dijck A, Nguyen DV, Lozano R, Chen Y, Bickel ES, Hessl D, Schneider

A, Angkustsiri K, Tassone F, Ceulemans B, Koy RF, Hagerman RJ (2017). A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. Journal of Neurodevelopmental Disorders. 9(1): 26.

2017 Jiraanont P, Sweha S, Al Olabi RR, Silva M, Tang H ,Durbin-Johnson B, Schneider A,

Espinala M, Hagerman PJ, Rivera SM, Hessl D, Hagerman RJ, Chutabhakdikul N, Tassone F. Clinical and molecular correlates in fragile X premutation females. Neurological Science. 7: 49-56.

2018 Berry-Kravis EM, Lindemann L, Jonch AE, Apostol G, Bear MF, Carpenter RL,

Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman RJ, Spooren W, Jacquemont S. Drug development for neurodevelopmental disorders: Lessons learned from fragile X syndrome. Nature Reviews Drug Discovery. 17: 280-299.

2018 Shickman R, Famula J, Tassone F, Leehey M, Ferrer E, Rivera SM, Hessl D. Age-

and CGG repeat length-related slowing of manual movement in FMR1 carriers: A prodrome of FXTAS? Movement Disorders. 33(4): 628-636.

2018 Benyakorn S, Calub CA, Riley SJ, Schneider A, Iosif AM, Solomon M, Hessl D,

Schweitzer JB. Computerized cognitive training in children with autism and intellectual disabilities: Feasibility and satisfaction study. JMIR Mental Health. 5(2):e40.

2018 Shelton AL, Wang JY, Fourie E, Tassone F, Chen A, Frizzi L, Hagerman RJ,

Ferrer-Caja E, Hessl D, Rivera SM. Middle cerebellar peduncle width: A novel MRI biomarker for FXTAS? Frontiers in Neuroscience. 12: 379.

Abstracts and Presentations 2017 Hessl D, Schweitzer J, Nguyen DV, McLennan Y, Johnston C, Shickman RJ.

Cognitive training for fragile X syndrome: Results of a double blind controlled trial of Cogmed. 18th International Fragile X and Related Neurodevelopmental Disorders Workshop, Saint-Alexis-des-Monts, Quebec, Canada.

39

2017 Hessl D. Invited lecture: Cognition in Down Syndrome and Other Intellectual Disabilities: Assessment Matters. 45th Annual Down Syndrome Congress, Sacramento, CA.

2017 Hessl D. Invited lecture: The NIH Toolbox: Scoring/Using Standardized Tests in

Adults with ID/DD. UC Davis Summer Institute, Davis, CA. Research Funding Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers, NIMH - 2R01MH078041-06, $2,970,846, 2013-2018, Co-Equal Principal Investigator. A Cognitive Test Battery for Intellectual Disabilities, NICHD - R01HD076189, $3,145,326, 2014-2019, Principal Investigator. Community Service Member, Child and Family Care Administrative Advisory Committee, UC Davis Member, Clinical Trials Committee, National Fragile X Foundation Member, Editorial Board, Journal of Neurodevelopmental Disorders Member, Executive Council, National Fragile X Foundation Member, Faculty Welfare Committee, UC Davis Member, Fragile X Clinical and Research Consortium Executive Council Member, Human Development Graduate Group, UC Davis Member, National Fragile X Foundation Clinical and Scientific Advisory Board Member, Neuroscience Graduate Group, UC Davis Member, Research and Clinical Advisory Board, National Fragile X Foundation Participant, NIH Fragile X Working Group, Bethesda

40

Donald M. Hilty, MD, MBA Journal Articles 2017 Hilty DM, Chan S, Hwang T, Wong A, Bauer AM: Advances in mobile mental health:

opportunities and implications for spectrum of e-mental health services. mHealth 21;3:34. doi: 10.21037/mhealth.06.02.

2017 Hilty DM, Maheu M, Drude K, Hertlein K, Wall K, Long R, Luoma T, Ford D:

Telebehavioral health, telemental health, e-therapy and e-health competencies: The need for an interdisciplinary framework. J Technology in Behav Sci. doi.org/10.1007/s41347-017-0036-0.

2017 Myers KM, Nelson EL, Hilty DM, Rabinowitz TR: American Telemedicine Association:

Practice Guideline for Child and Adolescent Telemental Health. Telemed J E Health 23(10):779-804.

2017 Chan S, Godwin H, Gonzalez A, Yellowlees PM, Hilty DM: Review of use and

integration of mobile apps into psychiatric treatments. Curr Psychiatry Rep 19(12):96. doi: 10.1007/s11920-017-0848-9.

2017 Yellowlees PM, Burke Parish M, González A, Chan S, Hilty DM, Iosif AM, McCarron

R, Odor A, Scher L, Sciolla A, Shore J, Xiong G: Asynchronous telepsychiatry: A component of stepped integrated care. Telemed J E-Health. doi: 10.1089/tmj.0103.

2017 Hilty DM: Technology and the brain: What can we learn from our life experience,

patient care, social media and Internet use? Psychol Cogn Sci, http://dx.doi.org/10.17140/PCSOJ-3-128.

2017 Hilty DM, Hwang T, Turvey C: Staying abreast of information in the information age: Digital continuing education and levering technology to stay current for clinical psychiatric practice. Curr Psychiatry Rep 20(3), 15. doi: 10.1007/s11920-018-0878-y.

2017 Reus VI, Fochtmann LJ, Hilty DM, Horvitz-Lennon M, Jibson MD, Lopez OL,

Mahoney J, Pasic J, Tan ZS, Wills CD, Rhoads R, Yager J: The American Psychiatric Association Evidence-Based Clinical Practice Guidelines for the Management of Substance Use Disorders, http://psyciq.apa.org/evidence-based-clinical-practice-guidelines-management-substance-use-disorders/.

2017 Torous J, Chan S, Boland R, Luo J, Hilty DM: Clinical informatics in psychiatric

training. Academic Psychiatry. doi: 10.1007/s40596-017-0811-4. 2017 Hilty DM, Rabinowitz TR, McCarron RM, Katzelnick DJ, Chang T, Bauer A, Fortney J:

An update on telepsychiatry and how it can leverage collaborative, stepped, and integrated services to primary care. Psychosomatics http://www.psychosomaticsjournal.com/article/S0033-3182(17)30267-0/abstract.

41

2018 Maheu M, Drude K, Hertlein K, Lipschutz R, Wall K, Long R, Luoma T, Ford D, Hilty DM: An interdisciplinary framework for telebehavioral health competencies. J Technology in Behav Sci. https://link.springer.com/content/pdf/10.1007%2Fs41347-018-0046-6.pdf or https://doi.org/10.1007/s41347-017-0038-y.

2018 Hilty DM, Zalpuri I, Stubbe D, Snowdy CE, Shoemaker EZ, Joshi SV, Myint MT,

Liu H: Social media/networking as part of e-behavioral health and psychiatric education: competencies, teaching methods, and implications. J Technology in Behav Sci, doi 10.1007/s41347-018-0061-7.

2018 Shore JH, Yellowlees PM, Caudill R, Johnston B, Turvey C, Mishkind M, Krupinski E,

Myers K, Shore P, Kaftarian E, Hilty DM: Best Practices in Videoconferencing-Based Telemental Health April. Telemed J e-Health. doi: 10.1089/tmj.2018.0237.

2018 Evangelatos G, Valasquez A, Hilty DM: Lessons learned on telehealth in inpatient

psychiatric facilities: Quality, continuity and models of care. J Technology in Behav Sci, doi:10.1007/s41347-018-0056-4.

Book Chapters 2018 Hilty DM, Srinivasan S, Rabinowitz T: Geriatric Telepsychiatry: Opportunities, Models

and Outcomes in Textbook of Geriatric Psychiatry. Ed. Hategan A, Bourgeois JA, Hirsch C, Giroux C. New York: Springer Publishing, pp. 710-17.

2018 Hilty DM, Turvey C, Hwang T: Quality Care by Telepsychiatry and Telemental Health:

Patient-Centered Value, Lifelong Learning of Skills, and Applying Guidelines and the Evidence-Base to Practice in Telepsychiatry and e-Health Technologies. Ed. Yellowlees PM, Shore J. Washington, DC: American Psychiatric Publishing Incorporated, pp. 313-52.

Abstracts and Presentations 2017 Duong T, Ureste P, Seritan A, Hilty DM: It's All In My Head: Teaching Geropsychiatry

with Interactive Methods, Workshop, Association for Academic Psychiatry, Denver, CO. September.

2018 Cowley D, Hung E, Ratzliff A, Hilty DM: Creating a Workplace-based Faculty

Development Program, Workshop, American Association of Directors of Psychiatry Residency Training, New Orleans, LA. March.

2018 Turvey C, Yellowlees PM, Johnston B, Caudill R, Krupinski E, Shore J, Hilty DM:

Telepsychiatry Best Practice: Joint American Psychiatric Association and American Telemedicine Association Recommendations for Best Practice, Symposium, American Psychiatric Association, New York, NY. May.

42

2018 Hilty DM, Maheu M, Pantera R, Randhava K: A Concise Review of Virtual Reality, Augmented Reality and Telepresence: Definitions, Approaches and Applications, Workshop, Chicago, IL. May.

2018 Crawford A, Sockalingam S, Serhal E, Hilty DM: Creating a Flexible, Integrated

Approach to Outreach Psychiatry: Models Based on Innovation, Evidence, and Interdisciplinary Collaboration, Workshop, American Psychiatric Association, New York, NY. May.

2018 Shore J, Turvey C, Caudill R, Mishkind M, Hilty DM, Yellowlees PM: Telepsychiatry

Best Practices: Joint American Psychiatric Association and American Telemedicine Association Committee Recommendations, Symposium, American Psychiatric Association, New York, NY. May.

2018 Fiorillo A, Benjamin S, Bhugra D, Hilty DM, Tasman A: Training Psychiatrists of the

New Millenium, Symposium, American Psychiatric Association, New York, NY. May. Community Service Chair, Faculty Development Committee, American Directors in Medical Student Education in Psychiatry Editor, Psychology and Cognitive Sciences Editor, Special Edition, Tele- and e-BH, Social Media/Networking, Apps and Mobile Health, Academic Psychiatry Editor-in-Chief, Journal of Technology in Behavioral Sciences Member, Advisory Group, National Committee for Quality Assurance (NCQA) Telehealth Panel Member, Board of Trustees’ Task Force on Telepsychiatry and Telepsychiatry Committee, American Psychiatric Association Member, Editorial Board, Column Editor, Innovations and Technology in Education, Academic Psychiatry Member, Editorial Board, Families, Systems, & Health Member, Editorial Board, Mobile Health (mHealth), Novena Publishing Member, Governing Board of Health Services, UC Merced Member, Nominations Committee, California Psychiatric Association Member, Psychiatrist-in-Practice Examination, American College of Psychiatry Reviewer, Academic Medicine Reviewer, Academic Psychiatry Reviewer, American Journal of Psychiatry Reviewer, Families, Systems, and Health Reviewer, General Hospital Psychiatry Reviewer, International Review of Psychiatry Reviewer, New England Journal of Medicine Reviewer, Psychiatric Services Reviewer, Psychosomatics Reviewer, Telemedicine Journal and e-Health

43

Ladson Hinton, MD Journal Articles 2017 Hinton L, Sciolla AF, Unützer J, Elizarraras E, Kravitz RL, Apesoa-Varano EC.

Family-centered depression treatment for older men in primary care: a qualitative study of stakeholder perspectives. BMC Family Practice, 29;18(1):88.

2017 Boise L, Hinton L, Rosen HJ, Ruhl M, Will My Soul Go to Heaven If They Take My

Brain? Beliefs and Worries About Brain Donation Among Four Ethnic Groups. The Gerontologist, 57(4):719-734.

2018 Hinton L, Making Sense of Behavioral and Psychological Symptoms of Dementia.

American Journal of Geriatric Psychiatry, 26(5):557-558. 2018 Xiong GL, Godwin H, Ziegahn L, Beckett LA, Filshtein T, Hinton L. The

Communication Gap Between the Medical System and Community Resources for Dementia-Related Behavioral Symptom Management: Family Caregiver Perspectives. Primary Care Companion CNS Disorders, 15;20(2).

2018 Meyer OL, Mungas D, King J, Hinton L, Farias S, Reed B, DeCarli C, Geraghty E,

Beckett L. Neighborhood Socioeconomic Status and Cognitive Trajectories in a Diverse Longitudinal Cohort. Clinical Gerontologist, 41(1):82-93.

2018 Meyer OL, Liu XL, Tancredi D, Ramirez AS, Schulz R, Hinton L. Acculturation level

and caregiver outcomes from a randomized intervention trial to enhance caregivers' health: evidence from REACH II. Aging & Mental Health, 22(6):730-737.

Research Funding Adapting and Testing an Alzheimer’s Caregiver Intervention in Vietnam. National Institution on Aging/Fogarty International Center. R21AG054262, 9/30/2016-4/30/2018. Principal Investigator. Center to Advance Cognitive Health and Healthcare in Older Latinos, National Institute on Aging, P30AG043097, 7/1/2012-6/30/2018, Principal Investigator. Innovations Bridging Clinics and Communities to Advance Late Life Depression Care, Archstone Foundation, 7/1/2014-06/30/2018, Principal Investigator of UC Davis Subcontract. Co-PI (Elena Siegel PhD, PI). Development of an Innovative and Evidence-based Program to Advance Support for Family Caregivers of Persons with Dementia in the Transition from Hospital to Community. Archstone Foundation, 5/1/18-6/30/19, approx. $200,000 (total costs).

44

Community Service Co-Director for Research, Family Caregiving Institute, School of Nursing, UC Davis Member, Search Committee for Chair, Department of Psychiatry, UC Davis Triage Editor, American Journal of Geriatric Psychiatry

45

Robert Horst, MD Grant Funding Grant A18-1917, $5,000. 11/21/2017-11/20/2022. The Klingenstein Third Generation Foundation Fellowship Program in Child and Adolescent Psychiatry, UC Davis Health. Role: Principal Investigator. Community Service Member, American Psychiatric Association Member, American Academy of Child and Adolescent Psychiatry Member, Central California Psychiatric Society Member, Central California Regional Organization of Child and Adolescent Psychiatry Member, Child and Family Mental Health Management Team, Sacramento County Member, Child Training and Education Committee, UC Davis Child Psychiatry Residency Program, UC Davis School of Medicine Member, Juvenile Health and Mental Health – Delinquency Sub-committee, Sacramento County Member, Juvenile Health and Mental Health – Dependency Sub-committee, Sacramento County Member, Sacramento County Child and Family Services Unit Member, Sacramento County Credentialing Committee Member, Sacramento County Management Team Member, Sacramento County Medication Monitoring Committee Member, Sacramento County Pharmaceutical and Therapeutics Committee Member, Sacramento County Quality Improvement Committee Program Director, The Klingenstein Third Generation Foundation Fellowship Program in Child and Adolescent Psychiatry, UC Davis Health System

46

Poh Choo How, MD, PhD Journal Articles 2018 Rao S, How PC, Ton H. Education, Training and Recruitment of a Diverse Workforce

in Psychiatry. Psychiatry Annals. Mar 9;3(48):143-148. Book Chapters 2017 How PC, Lo P, Westervelt M, Ton H. Immigrant and Refugee Mental Health in Volpp

SY, and Tse J, Eds., A Case-Based Approach to Public Psychiatry, (pp.179-186). New York: Oxford University Press. October.

2018 How PC, Lo P, Xiong G. Major or Mild Neurocognitive Disorders with Lewy Bodies in

Hategan A, Bourgeois JA, Hirsch C, and Giroux C, eds. Geriatric Psychiatry A Case-Based Textbook, (pp.429-443). New York. Springer International Publishing. January.

Abstracts and Presentations 2017 How PC. Finding a Creative Balance – Caring for Our Mind, Body, and Spirit. Paul

Hom Student Run Free Clinic Annual Health Fair, Sacramento, CA. October. Community Service Member, Adult Psychiatry Recruitment Selection Committee, Department of Psychiatry and Behavioral Sciences, University of California, Davis, Medical Center Member, Diversity Advisory Committee, Department of Psychiatry and Behavioral Sciences, University of California, Davis, Medical Center Volunteer, Gender Health Center Hormone Clinic, UC Davis Student-Run Free Clinic

47

Debra Kahn, MD Journal Articles 2018 Xiong GL, Iosif A-M, Godwin HT, Khan M, Parish MB, Yellowlees P, Kahn D. A Pilot

Randomized Trial of Asynchronous and Synchronous Telepsychiatry in Skilled Nursing Facilities. JAMDA;19(5): 461-462.

Abstracts and Presentations 2018 Kahn D. Plastic Surgery and Psychiatry, UC Davis Division of Plastic Surgery, Grand

Rounds Presentation

2018 Kahn D. Treatment of psychiatric disorders in Older Adults. Sutter General, Consult Psychiatry Presentation.

Research Funding R01HS025395-01 Agency for Health Care Research and Quality Research, (Xiong G: PI; Kahn D: Clinical Provider), 8/2017-7/2022, $2,000,000. Comparison of Asynchronous Telepsychiatry vs. Synchronous Telepsychiatry in Skilled Nursing Facilities (CATeleST). Community Service MMI Interviewer/Rater, Admissions, UC Davis Medical School Member, Bioethics Committee, UC Davis Medical Center Member, Emergency Department-Psychiatry Patient Flow Committee, UC Davis Medical Center Member, Medical Staff Well-being Committee, UC Davis Medical Center Member, Substance Use Disorder Workgroup Member, Workplace Violence Advisory Group, UC Davis Medical Center

48

Laura Kenkel, MD Community Service Chair, Professionalism Improvement Committee, UC Davis School of Medicine Member, Doctoring Steering Committee, UC Davis School of Medicine Member, Learning Climate Committee, UC Davis School of Medicine Member, Wellness Committee, UC Davis School of Medicine

49

Alan Koike, MD, MSHS Abstracts and Presentations 2017 Panel Discussant for the film First They Killed My Father, University of the Pacific,

Stockton, CA. September. 2018 Moving Beyond Cultural Competency, Kaiser Permanente South Sacramento,

Psychiatry Department Grand Rounds, Sacramento/Elk Grove, CA. April. Community Service Chair, Adult Psychiatry Recruitment Selection Committee, Department of Psychiatry and Behavioral Sciences, University of California, Davis, Medical Center Chair, Educational Policy Committee, Department of Psychiatry and Behavioral Sciences, University of California, Davis, Medical Center Member, Graduate Medical Education Committee, UC Davis School of Medicine Member, Leaders in Medical Student Education Committee, Department of Psychiatry and Behavioral Sciences, UC Davis School of Medicine Member, Quality and Safety Committee, Department of Psychiatry and Behavioral Sciences, UC Davis School of Medicine Member, Student Fourth Year Oversite Committee, UC Davis School of Medicine Member, Student Promotions Committee, UC Davis School of Medicine

50

Tyler Andrew Lesh, PhD Journal Articles 2018 Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD,

Maddock RJ, Lesh TA, Tanase C. Utility of imaging-based biomarkers for glutamate-targeted drug development in psychotic disorders: a randomized clinical trial. JAMA psychiatry, 75(1), 11-19. January.

2018 Smucny J, Lesh TA, Newton K, Niendam TA, Ragland JD, Carter CS. Levels of

cognitive control: a functional magnetic resonance imaging-based test of an RDoC domain across bipolar disorder and schizophrenia. Neuropsychopharmacology, 43(3), 598. February.

2018 Savill M, Skymba HV, Ragland JD, Niendam TA, Loewy RL, Lesh TA, Carter C,

Goldman HH. Acceptability of Psychosis Screening and Factors Affecting Its Implementation: Interviews With Community Health Care Providers. Psychiatric Services, 69(6), 689-695. April.

2018 Lesh TA, Careaga M, Rose DR, McAllister AK, Van de Water J, Carter CS, Ashwood

P. Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. Journal of neuroinflammation, 15(1), 165. May.

2018 Smucny J, Lesh TA, Iosif AM, Niendam TA, Tully LM, Carter CS. Longitudinal stability

of cognitive control in early psychosis: Nondegenerative deficits across diagnoses. Journal of abnormal psychology. May.

Presentations 2017 Cannabis Effects on the Brain in Young People with Recent Onset Schizophrenia.

Invited presentation for the Central California Chapter of the American Association of Child and Adolescent Psychiatry. Sacramento, CA. September.

2017 Maddock R, Amaral D, Bennett J, Wang H, Iosif AM, Van de Water J, Lesh TA,

Bauman M, Carter C. MRS Studies of Brain Glutathione and NAA in a Longitudinal Non-Human Primate Model of Maternal Immune Activation. Paper presented at the American College of Neuropsychopharmacology. Palm Desert, CA; November.

2017 Lesh T, Tanase C, Bennett J, Iosif AM, Van de Water J, Maddock R, Amaral D,

Bauman M, Carter C. Diffusion Measures of Extracellular Free Water in a Non-Human Primate Model of Maternal Immune Activation-Exploring Neuroimmune Mechanisms of Psychiatric Disorders. Paper presented at the American College of Neuropsychopharmacology. Palm Desert, CA; November.

51

2017 Cannabis Effects on the Brain in Young People with Recent Onset Schizophrenia. Invited presentation for the UC Davis CAARE Diagnostic and Treatment Center. Sacramento, CA. December.

2018 Niendam T, Loewy R, Savill M, Meyer M, Rosenthal A, Delucchi K, Lesh TA, Skymba

H, Ragland JD, Goldman H. A Technology-Enhanced Intervention To Reduce The Duration Of Untreated Psychosis Through Rapid Identification & Engagement. Paper presented at the Schizophrenia International Research Society. Florence, Italy. April.

2018 Lesh TA, Tanase C, Wang H, Steinbauer E, Bennett J, Iosif AM, Van de Water J,

Maddock RJ, Ragland JD, Niendam TA. Extracellular Free Water and Glutathione in First Episode Schizophrenia and a Non-Human Primate Model of Maternal Immune Activation–Exploring Neuroimmune Mechanisms of Psychiatric Disorders. Paper presented at the Society of Biological Psychiatry, 83(9), S97. New York, NY. May.

2018 Carter C, Lesh TA, Tanase C, Bennett J, Iosif AM, Van Der Water J, Maddock R,

Amaral D, Bauman M. Diffusion Measures Of Extracellular Free Water In A Non-human Primate Model Of Maternal Immune Activation: Exploring Neuroimmune Mechanisms Of Psychiatric Disorders. Paper presented at the Schizophrenia International Research Society. Florence, Italy. May.

2018 Ragland JD, Hsieh LT, Carter C, Hurtado M, Lam J, Lesh TA, Niendam TA, Solomon,

M, Ranganath C. Impact of Schizophrenia on Temporal Context Versus Item Memory. Paper presented at the Society of Biological Psychiatry, 83(9), S426. New York, NY. May.

Community Service Ad Hoc Reviewer, Journal of Psychiatric Research Ad Hoc Reviewer, Human Brain Mapping Ad Hoc Reviewer, Schizophrenia Bulletin Ad Hoc Reviewer, Biological Psychiatry Ad Hoc Reviewer, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Ad Hoc Reviewer, JAMA Psychiatry Ad Hoc Reviewer, American Journal of Psychiatry Ad Hoc Reviewer, Psychiatry Research Ad Hoc Reviewer, The British Journal of Psychiatry Ad Hoc Reviewer, Proceedings of the National Academy of Sciences

52

Russell F. Lim, MD, MEd Community Service Member, Editorial Board, Community Mental Health Journal Section Editor, International Journal of Mental Health and Culture

53

Richard Maddock, MD Journal Articles 2017 Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD,

Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, Potter WZ, Carlson M, Wall MM, Choo TH, Grinband J, Lieberman JA. Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial. JAMA Psychiatry, 10.1001/jamapsychiatry.3572.

Abstracts and Presentations 2017 Maddock RJ, Amaral DG, Bennett J, Wang H, Iosif AM, Van de Water J, Lesh TA,

Bauman MD, Carter CS. MRS Studies of Brain Glutathione and NAA in a Longitudinal Non-Human Primate Model of Maternal Immune Activation. American College of Neuropsychopharmacology. Palm Desert, December.

2017 Lesh TA, Tanase C, Bauman MD, Bennett J, Iosif AM, Maddock RJ, Amaral DG,

Carter CS. Diffusion Measures of Extracellular Free Water in a Non-Human Primate Model of Maternal Immune Activation – Exploring Neuroimmune Mechanisms of Psychiatric Disorders. American College of Neuropsychopharmacology. Palm Desert, December.

Research Funding Distinguishing vesicular from cytoplasmic glutamate in the brain with in vivo MRS, Behavioral Health Center of Excellence Pilot Grant Award. 11/1/2016 – 10/31/2018, (Maddock RJ: PI). NIH 1R01MH105411-01, Neural Mechanisms of Memory Dysfunction in Schizophrenia, 12/1/2014 – 11/30/2018 (Ragland JD: PI; Maddock RJ: Co-Invesitgator). NIH 1P50MH106438-01, UC Davis Conte Center Neuroimmune Mechanisms of Psychiatric Disorders, 04/01/2015 –03/31/2020 (Carter CS: PI; Maddock RJ: Co-Investigator, Project 4). Community Service Member, Editorial Board, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Reviewer, American Journal of Psychiatry Reviewer, Biological Psychiatry Reviewer, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Reviewer, Journal of Physiology Reviewer, NeuroImage Reviewer, Proceedings of the National Academy of Sciences Reviewer, Schizophrenia Bulletin

54

Anne McBride, MD Book Chapter 2018 Kelly M, McBride A, Daniels W. A Developmental Perspective on Risk Taking Among

College Students in Student Mental Health: A Guide for Psychiatrists, Psychologists, and Leaders Serving in Higher Education, LW Roberts ed., American Psychiatric Association Publishing.

Presentations 2017 McBride A, Scott C, McDermott B. Homicidal Juveniles: Can Bad Boys Be Good

Men? Presentation at: AAPL Annual Meeting, October. 2018 McBride A. Updates in Juvenile Justice. Presentation for Central California Regional

Organization Child and Adolescent Psychiatry meeting, May. 2018 McBride A, Kelly M. Addressing School Violence. Presentation at the American

Psychiatric Association Annual Meeting, May. 2018 McBride A. My Path to Child Psychiatry. Guest presentation at the Annual

Klingenstein Third Generation Foundation National Medical Student Conference. Community Service Chair, Child Psychiatry Recruitment Selection Committee, CAP Residency Training Program Department of Psychiatry and Behavioral Sciences, UC Davis Chair, Child Training and Education Committee, CAP Residency Training Program, Department of Psychiatry and Behavioral Sciences, UC Davis Member, Bioethics Committee, UC Davis Medical Center Member, Clinical Competency Committee, CAP Residency Training Program, Department of Psychiatry and Behavioral Sciences, UC Davis Member, Forensic Training in General Psychiatry Residency Programs Committee, American Academy of Psychiatry and the Law Member, Health Sciences Clinical Professor Selection Committee, Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, UC Davis Mentor, The Klingenstein Third Generation Foundation Fellowship Program in Child and Adolescent Psychiatry, UC Davis Health System Treasurer, California Central California Regional Organization of Child and Adolescent Psychiatry

55

Barbara E. McDermott, PhD Journal Articles 2017 McDermott BE, Newman WJ, Meyer J, Scott CL, Warburton K: The utility of an

admission screening procedure for patients committed to a state hospital as incompetent to stand trial. International Journal of Forensic Mental Health. 16: 281-292.

2017 Holoyda BJ, McDermott BE, Newman WJ: Insane sex offenders: Psychiatric and

legal characteristics of sexual offenders found Not Guilty by Reason of Insanity. Journal of Forensic Science. Epub, November.

2018 Preszler J, Marcus DK, Edens JF, McDermott BE: Network analysis of psychopathy

in forensic inpatients. Journal of Abnormal Psychology. 127: 171-182. Abstracts and Presentations 2017 Warburton K, McDermott BE: The new mental health crisis: Incompetent to stand trial

defendants overwhelm state hospitals. Proc Austr New Zeal Coll Psych, September. 2017 Ferranti J, McDermott BE, Scott CL: Assessments of Speech: From Trigger Warning

to True Threat. Proc. Am. Acad. Psych. Law. 2017 McDermott BE, Scott CL: Evaluating Malingered ADHD: Pay Attention! Proc. Am.

Acad. Psych. Law. 2017 McBride A, McDermott BE, Scott CL: Homicidal Juveniles: Can Bad Boys Be Good

Men? Proc. Am. Acad. Psych. Law. 2018 Schaufenbil R, McDermott BE, Warburton K, Packer I: Incompetent Defendants: A

National Problem. Proc. Am. Psych. Law Soc, March. Community Service Member, Napa State Hospital, Forensic Quality Review Panel Member, Napa State Hospital, Quality Council Member, Committee B, UC Davis Institutional Review Board Reviewer, Assessment Reviewer, International Journal of Forensic Mental Health Reviewer, Journal of the American Academy of Psychiatry and the Law Reviewer, Journal of Clinical Psychiatry Reviewer, Journal of Consulting and Clinical Psychology Reviewer, Law and Human Behavior Reviewer, Psychological Assessment Reviewer, Schizophrenia Research Senior Fellow, UC Justice and Health Consortium

56

Meghan Miller, PhD

Journal Articles

2018 Ozonoff S, Gangi D, Hanzel EP, Hill A, Hill MM, Miller M, Schwichtenberg AJ, Steinfeld MB, Parikh C, Iosif A. Onset patterns in autism: Variation across informants, methods, and timing. Autism Research, 11, 788-797. April.

Book Chapters

2018 Miller M, Schetter P, Ozonoff S. Executive dysfunction in autism spectrum disorder: From research to practice. In Meltzer, L. (Ed.), Executive Function in Education: From Theory to Practice, 2nd Edition (pp. 168-196). New York: Guilford Press. February.

Abstracts and Presentations

2018 Miller M. Siblings of children with autism and other select research topics from the UC Davis MIND Institute. University of California, San Francisco Developmental Disabilities Symposium, San Francisco, CA. March.

2018 Miller M. ADHD in autism spectrum disorder. University of California, Davis MIND Institute, Sacramento, CA. March.

2018 Schwichtenberg AJ, Kellerman AM, Abu-Zhaya R, Miller M, Young GS, Ozonoff S. Can the Social Responsiveness Scale index maternal responsiveness during play? International Meeting for Autism Research, Rotterdam, Netherlands. May.

2018 Schwichtenberg AJ, Abel E, Kellerman A, Chong P, Miller M, Ozonoff S. Does autism risk confer a greater risk for sleep problems? International Meeting for Autism Research, Rotterdam, Netherlands. May.

Research Funding

K99/R00 MH106642, 2015-2020, (Miller M: PI). Shared and Distinct Developmental Pathways to ADHD and Autism Spectrum Disorder. National Institute of Mental Health.

Community Service

Co-Chair, APA Society for Clinical Child & Adolescent Psychology Convention Programming Juror, 32nd Annual California State University Student Research Competition Member, Editorial Advisory Board, CHADD Attention Magazine Reviewer, Action Medical Research (UK) Reviewer, Autism Reviewer, Child Development Reviewer, Child Development Perspectives Reviewer, Journal of Abnormal Child Psychology Reviewer, Journal of Autism & Developmental Disorders Reviewer, Journal of Child Psychology & Psychiatry

57

Karl D. Murray, PhD

Journal Articles 2017 Palacio S, Chevaleyre V, Brann DH, Murray KD, Piskorowski RA, Trimmer JS.

Heterogeneity in Kv2 Channel Expression Shapes Action Potential Characteristics and Firing Patterns in CA1 versus CA2 Hippocampal Pyramidal Neurons. eNeuro 4 (4), DOI: https://doi.org/10.1523/ENEURO.0267-17.

2017 Song L, Yu A, Murray KD, Cortopassi G. Bipolar cell reduction precedes retinal

ganglion neuron loss in a complex 1 knockout mouse model. Brain Res. 1657:232-244. PMID: 28027875.

2018 Bishop H, Cobb MM, Kirmiz M, Parajuli LK, Mandikian D, Philp AM, Shigemoto R,

Murray KD, Trimmer JS. Kv2 channels determine the expression and localization of the associated AMIGO-1 cell adhesion molecule in brain neurons. Front. Mol. Neurosci. 19 January, doi:10.3389/fnmol.2018.00001.

Abstracts and Presentations 2017 Cheng HJ, Luu JD, Murray KD. Environmental enrichment impacts proliferation but

not integration following neurogenesis in aged mice., Society for Neuroscience Annual Meeting, Abstract 31.11.

2018 Murray KD. Development of Adult-Born mossy fiber projections in senescence.

Institute for Pediatric Regenerative Medicine, Shriners Hospital for children, Northern California.

Community Service Reviewing Editor, Frontiers in Neuroanatomy Reviewer, Journal of Human Molecular Genetics Reviewer, Journal of Neuroscience Reviewer, Journal of Proceedings of the National Academy of Science (PNAS) Reviewer, Journal of Thalamus and Related Disorders

58

Tara A. Niendam, PhD

Journal Articles 2017 Weisman O, Guri Y, Gur RE, McDonald-McGinn DM, Calkins ME, Tang SX, Emanuel

B, Zackai EH, Eliez S, Schneider M, Schaer M, Kates WR, Antshel KM, Fremont W, Shashi V, Hooper SR, Armando M, Vicari S, Pontillo M, Kushan L, Jalbrzikowski M, Bearden CE, Cubells JF, Ousley OY, Walker EF, Simon TJ, Stoddard J, Niendam TA, van den Bree MB, Gothelf D; International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study. Schizophr Bull. 43 (5): 1079-1089. September.

2017 Greenland-White SE, Ragland JD, Niendam TA, Ferrer E, Carter CS. Episodic

memory functions in first episode psychosis and clinical high risk individuals. Schizophr Res, 188: 151-157.October.

2017 Ramsay IS, Ma S, Fisher M, Loewy RL, Ragland JD, Niendam TA, Carter CS,

Vinogradov S. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr Res Cogn. 8;11:1-5. November.

2017 Hardy KV, Niendam TA, Loewy R. Measuring the Duration of Untreated Psychosis within First Episode Psychosis Coordinated Specialty Care. Technical Assistance Material Developed for SAMHSA/CMHS. Available online at https://www.nasmhpd.org/sites/default/files/DH-Measuring_UntreatedPsychosis_v3_0.pdf

2018 Niendam TA, Tully LM, Iosif AM, Kumar D, Nye KE, Denton JC, Zakskorn LN,

Fedechko TL, Pierce KM. Enhancing Early Psychosis Treatment Using Smartphone Technology: A Longitudinal Feasibility and Validity Study. J Psychiatr Res. 96: 239-246. January.

2018 Carrión RE, Walder DJ, Auther AM, McLaughlin D, Zyla HO, Adelsheim S, Calkins R,

Carter CS, McFarland B, Melton R, Niendam TA, Ragland JD, Sale TG, Taylor SF, McFarlane WR, Cornblatt BA. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline. J Psychiatr Res. 96:231-238. January.

2018 Kumar D, Tully LM, Iosif AM, Zakskorn LN, Nye KE, Zia A, Niendam TA.

Implementing a Mobile Health Platform for Clinical Monitoring in Community-Based Outpatient Early Psychosis Care. JMIR Ment Health. 5(1):e15. February.

2018 Smucny J, Lesh TA, Newton K, Niendam TA, Ragland JD, Carter CS. Levels of

Cognitive Control. A Functional Magnetic Resonance Imaging-Based Test of an RDoC Domain Across Bipolar Disorder and Schizophrenia. Neuropsychopharmacology 43(3):598-606. February.

59

2018 Savill M, Skymba HV, Ragland JD, Niendam TA, Loewy RL, Lesh TA, Carter C, Goldman HH. Acceptability of Psychosis Screening and Factors Affecting Its Implementation: Interviews With Community Health Care Providers. Psychiatr Serv. 69(6):689-695. doi: 10.1176/appi.ps.201700392. June.

Abstracts and Presentations 2017 Smucny J, Lesh T, Niendam TA, Ragland J, Carter C. Stability of Behavioral and

fMRI Measures of Cognitive Control Deficits in Early Psychosis: Evidence for Abnormal Neurodevelopment Rather Than Neurodegeneration. Poster presented at the annual meeting of the American College of Neuropsychopharmacology (ACNP) in Palm Springs, CA. December.

2018 Niendam TA, Loewy R, Savill M, Meyer M, Rosenthal A, Delucchi K, Lesh TA,

Skymba H, Ragland JD, Goldman H, Cress R, Kravitz RL, Carter CS. A technology-enhanced intervention to reduce the Duration of Untreated Psychosis through rapid identification and engagement. Symposium presentation at the Schizophrenia International Research Society in Florence, Italy. March.

2018 Tully L, Iosif AM, Zakskorn L, Kumar D, Nye K, Zia A, Denton J, Pierce K, Fedechko

T, Niendam TA. Enhancing Early Psychosis Treatment Using Smartphone Technology: Integration Of A Mobile Health Platform In Four Early Psychosis Programs. Oral Symposium presentation at the Schizophrenia International Research Society in Florence, Italy. March.

2018 Lesh TA, Tanase C, Wang H, Steinbauer E, Bennett J, Iosif AM, Van de Water J,

Maddock RJ, Ragland JD, Niendam TA, Styner M, Amaral D, Bauman M, Carter CS. Diffusion Measures of Extracellular Free Water in First Episode Schizophrenia and a Non-Human Primate Model of Maternal Immune Activation – Exploring Neuroimmune Mechanisms of Psychiatric Disorders. Symposium presentation at the Society of Biological Psychiatry in New York, NY. May.

2018 Solomon M, Krug M, Coleman C, Elliott M, Hogeveen J, Niendam TA, Ragland JD,

Carter CS. Adolescents and Young Adults With Autism Spectrum Disorder Show Differences in Dynamics and Recruitment of Cognitive Control Networks. Poster presented at the International Society for Autism Research in Rotterdam, Netherlands. May.

2018 Liles B, Blacker D, Tully L, Niendam TA. Trauma & Psychosis: Integrating Cognitive

Behavioral Interventions to assess and treat dual diagnosis. Workshop presentation at the American Professional Society on the Abuse of Children (APSAC) in New Orleans, LA. June.

Research Funding NIMH R01 MH105411, 12/1/14 – 11/30/18, .60 calendar months. Neural Mechanisms of Memory Dysfunction in Schizophrenia, $350,903 annual direct costs. The proposed research

60

will use EEG, fMRI and MRS to establish disrupted (GABAergic) neural inhibition in the dorsolateral prefrontal cortex (DLPFC) as a candidate mechanism for the reduced theta oscillations, reduced fMRI activation in DLPFC and hippocampal circuits, and disproportionate relational memory impairments in people with schizophrenia observed in our previous research. As a Co-Investigator, Dr. Neindam supports the acquisition of clinical and psychosocial functioning data as well as data analyses, interpretation and manuscript preparation. Ragland JD (PI); Niendam TA (Co-Investigator). NIMH R01 MH104235-01, 9/1/14 – 8/31/19, 2.1 calendar months. Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement, $457,828 annual direct costs. Through the use of technology-enhanced screening and engagement, the proposed project seeks to reduce the duration of untreated psychosis at a community level by addressing two bottlenecks: 1) delays in accurate identification and 2) delays in engagement in FEP care. The results of this project will provide new evidence-based practices for reducing DUP and improving outcomes in recent onset psychosis. As a Co-Investigator, Dr. Niendam assists in overseeing the project managing staff in day-to-day activities, recruiting participants, managing data collection and analysis. She participates in interpretation of the results as well as in presenting the results of the research and preparing manuscripts for publication. Carter C (PI); Niendam TA (Co-Investigator). NIH R01MH107108, 8/1/15 – 7/31/20, 1.2 calendar months. Cognitive-Affective Psychosis Proneness Risk and protective factors in 22q11.2DS, $ 485,236 annual direct costs. The proposed research seeks to explore the cognitive and neural correlates of psychosis risk in youth with 22qDS. 22q youth will be characterized clinically across a novel dimension of psychosis proneness, which will be examined in relationship to measures of cognitive function using ERP and fMRI. As a Co-Investigator, Dr. Niendam supervises the clinical assessments, as well as provides guidance on the analyses related to the psychosis risk data and development of the psychosis-proneness dimensional scale. Dr. Niendam is also involved in data analysis, interpretation and manuscript writing. Simon T (PI), Niendam T (Co-Investigator). NIMH 1R01MH106518, 1/01/16 – 12/31/21, 1.2 calendar months. Neurodevelopment of cognitive control in autism: adolescence to young adulthood, $410,533 annual direct costs. This study examines the development of cognitive control across adolescence into young adulthood and its relationship to functional outcomes in individuals with Autism Spectrum Disorders using fMRI and behavioral measures. Solomon M (PI), Niendam TA (Co-Investigator). Community Service Co-Chair, Society for Women in Academic Psychiatry (SWAP) Ad Hoc Reviewer, JAMA Psychiatry Ad Hoc Reviewer, Biological Psychiatry Ad Hoc Reviewer, Journal of Mental Health Ad Hoc Reviewer, Molecular Psychiatry Ad Hoc Reviewer, Schizophrenia Bulletin Ad Hoc Reviewer, Schizophrenia Research

61

Consulting Editor, Journal of Abnormal Psychology Member, Status of Women at Davis Administrative Advisory Committee (SWADAC)

62

Stephen Noctor, PhD

Journal Articles 2017 Jardim-Messeder D, Lambert K, Noctor SC, Pestana FM, de Castro Leal ME,

Bertelsen MF, Alagaili AN, Mohammad OB, Manger PR, Herculano-Houzel S. Dogs have the most neurons, though not the largest brain: Trade-off between body mass and number of neurons in the cerebral cortex of large carnivoran species. Frontiers in Neuroanatomy, 11:118, doi: 10.3389/fnana.2017.00118. eCollection.

2018 Hashemi E, Ariza J, Rogers H, Noctor SC, Martínez-Cerdeño V. The Number of

Parvalbumin-Expressing Interneurons Is Decreased in the Prefrontal Cortex in Autism. Cerebral Cortex, 27(3): 1931-1943.

Book Chapters 2017 Martínez-Cerdeño V, Noctor SC. Comparative aspects of mammalian cortical

development. In: Evolution of Nervous Systems (Elsevier) 2 edition, Edited by Kaas JH.

Abstracts and Presentations 2017 Neuroimmune interactions regulate development of the cerebral cortex. RGJ-PhD

Congress 18, Bangkok Thailand. 2017 Development of the cerebral cortex. Mahidol University, Salaya, Thailand. 2017 Neural precursor cell function under gestational immune challenge. The

neurobiological and genetic basis of brain evolution. Nice, France. 2017 Noctor SC, Tarantal AF, Barger N. Microglial cells intimately interact with multiple cell

types in the proliferative zones of the fetal primate cerebral cortex. Society for Neuroscience.

2017 Herculano-Houzel S, Dos Santos S, Alverenga D, Neves K, Kaz R, Noctor SC,

Lambert KG, Sherwood C, Manger PR, Kaas JH, Mota B. Cortical folding determines white matter volume and white/gray matter ratio across mammalian species. Society for Neuroscience.

2018 Microglial cells interface with neural precursor cells in the developing cerebral cortex.

Cortical Evolution 2018: Las Palmas de Gran Canaria, Spain. 2018 Barger N, Keiter J, Kreutz A, Martínez-Cerdeño V, Tarantal AF, Noctor SC. Microglia

interface with multiple cell types in the proliferative zones of the fetal primate cerebral cortex. Cortical Evolution 2018, Las Palmas de Gran Canaria, Spain.

Research Funding

63

R21 OD023716, (Tarantal: PI; Noctor SC: MPI), 08/01/2016 – 07/31/2018. Leveraging Established Fetal Primate Models to Expedite ZIKV Investigations. The goal of this project is to address the relationship between Zika virus infection and the developing brain. R21 NS103658, (Tarantal: PI; Noctor SC: MPI), 09/01/2017 – 08/31/2018. Congenital Zika Syndrome and Postnatal Outcomes in Nonhuman Primates. The goal of this project is to address the impact of Zika virus infection on postnatal outcomes for organ development including the developing brain. R01 MH101188A, (Noctor SC: PI), 08/01/2013 – 06/30/2019. Microglia Regulate Development of the Cerebral Cortex. The goals of this project are to identify factors that regulate microglial function in the prenatal cerebral cortex, including the signaling pathways that regulate phagocytosis of neural precursor cells. Community Service Ad Hoc Member, DBD Study Section, NIH Ad Hoc Member, Special Emphasis Panels, NIH Member, Executive Committee, MIND Institute, UC Davis Member, Executive Committee, Neuroscience Graduate Group, UC Davis Member, IACUC, UC Davis Member, Research Activities Committee, Department of Psychiatry and Behavioral Sciences, UC Davis Reviewer, Cerebral Cortex Reviewer, International Journal of Developmental Neuroscience Reviewer, Journal of Neuroscience Reviewer, K99-R00 Applications, NIH

64

Alex S Nord, PhD

Journal Articles 2017 Gompers AL, Su-Feher L, Ellegood J, Copping NA, Riyadh MA, Stradleigh TW, Pride

MC, Schaffler MD, Wade AA, Catta-Preta R, Zdilar I, Louis S, Kaushik G, Mannion BJ, Plajzer-Frick I, Afzal V, Visel A, Pennacchio LA, Dickel DE, Lerch JP, Crawley JN, Zarbalis KS, Silverman JL, Nord AS. Germline Chd8 haploinsufficiency alters brain development in mouse. Nat Neurosci. Aug;20(8):1062-1073. doi: 10.1038/nn.4592. Epub 2017 Jun 26. PMID: 28671691.

2018 Pla R, Stanco A, Howard MA, Rubin AN, Vogt D, Mortimer N, Cobos I, Potter GB,

Lindtner S, Price JD, Nord AS, Visel A, Schreiner CE, Baraban SC, Rowitch DH, Rubenstein JLR. Dlx1 and Dlx2 Promote Interneuron GABA Synthesis, Synaptogenesis, and Dendritogenesis. Cereb Cortex. Nov 1;28(11):3797-3815. Epub 2017 Sep 28. PMID: 29028947.

Abstracts and Presentations 2017 Linking acute and chronic genomic changes in the brain after TBI, UC Neurotrauma

Symposium, Santa Barbara, CA, September 24. 2017 Mouse models of Chd8 mutation, Simons Foundation Autism Research Initiative

Annual Meeting, New York, NY, October 2. 2017 Su-Feher L, Rubin AN, Silberberg SN, Lim K, Rubenstein JLR, Nord AS.

Transcriptional programming of interneuron specification in mouse basal ganglia. Molecular Psychiatry, San Francisco, CA, October 6.

2017 Wade AA, Lim K, Catta-Preta R, Nord AS. Reanalysis of Sequencing Data from

CHD8 Experimental Models to Examine the Role of CHD8 in Neurodevelopment. Molecular Psychiatry, San Francisco, CA, October 6.

2017 van der List DA, Estes M, Zdilar I, Su-Feher L, Catta-Preta R, John D, Shaffer I,

McAllister AK, Nord AS. Genomic changes in fetal cortex following maternal immune activation. Molecular Psychiatry, San Francisco, CA, October 6.

2017 Lim K, Su-Feher L, Nord AS. SCIFI, a flexible interactive platform for single cell

RNA-sequencing. Molecular Psychiatry, San Francisco, CA, October 6. 2017 Catta-Preta R, Sandberg M, Lindtner S, Su-Feher L, Silberberg SN, Rubenstein JLR,

Nord AS. Towards a systems-level understanding of the gene regulatory wiring of interneuron specification. Molecular Psychiatry, San Francisco, CA, October 6.

65

2017 Genetics of Psychiatric Disorders, UC Davis Psychotic Disorders, November 6. 2017 Gompers AL, Wade AA, Su-Feher L, Zdilar I, Catta-Preta R, Lim KJ, Stradleigh TW,

Nord AS.Transcriptional regulation mediated via dosage-sensitive Chd8 genomic interaction in mouse forebrain. Society for Neuroscience, San Diego, CA, November 14.

2017 Stradleigh TW, Zdilar I, Gopmers A, Sramek M, Nguyen, A, Adhikar A, Copping N,

Silverman JL, Nord AS. SCN1A-associated non-coding DNA regulatory elements in expression of Nav1.1: Biochemical, anatomical, and behavioral characterization of a novel mouse model for Dravet Syndrome. American Epilepsy Society, Washington, DC, December 1.

2018 Catta-Preta R, Lindtner S, Rubenstein JL, Nord AS. Integrative functional genomics

defining regulatory wiring directed by Dlx transcription factors in cortical interneuron specification. Systems Biology: Global Regulation of Gene Expression, Cold Spring Harbor, NY, March 22.

2018 Su-Feher L, Haigh JL, Zdilar I, Lim JK, Quintero DM, Morais V, Stradleigh TW,

Byrne LC, Nord AS. Parallel enhancer analysis in mouse brain to characterize regulatory variants. Systems Biology: Global Regulation of Gene Expression, Cold Spring Harbor, NY, March 22.

2018 Susceptibility and resilience in a mouse model of maternal infection. American Society

for Neurochemistry Annual Meeting, Riverside, CA, March 25. 2018 Wade AA, Lim K, Catta-Preta R, Nord AS. Disruptions to RNA processing and gene

regulation as convergent mechanisms associated with mutation to CHD8. Biology of Genomes. Cold Spring Harbor, New York, May 8.

2018 Lambert JT, Haigh JL, Zdilar I, Stradleigh TW, Nord AS. In vivo deployment of a

massively parallel reporter assay for the validation of enhancers active in postnatal brain development. Biology of Genomes. Cold Spring Harbor, New York, May 8.

Research Funding R35 1R35GM119831, NIH NIGMS, 09/01/2016-06/30/2021 (Nord AS: PI). $1,858,545 total, $250,000direct/year. Functional Elucidation of the Sequence-Encoded Regulatory Activity of Enhancers in Vivo in the Brain. R21 MH116681-01, NIH NIMH, 04/01/2018-03/30/2020 (Nord AS: PI – Multi-PI award, corresponding PI: McAllister). $431,750 total, $150,000direct/year. Prenatal brain development following maternal immune activation.

66

Nancy Lurie Marks Foundation, 09/01/2018-08/30/2020 (PI: Van De Water J: PI; Nord AS: Co-I). $400,000 total, $50,000direct/year (Nord lab). The Behavioral, Neuroanatomic, Cellular, and Molecular Impact of Maternal Autoantibodies in a Rat Model of Autism Spectrum Disorder. Community Service Ad Hoc Grant Review, NIH MMG Study Section Member, Admissions Committee, Neuroscience Graduate Group, UC Davis Member, Executive Committee, Integrated Genetics and Genomics Graduate Group, UC Davis Member, Steering Committee, Center for Neuroscience, UC Davis Member, Steering Committee, Genome Center, UC Davis Member, Membership Committee, Neuroscience Graduate Group, UC Davis Reviewer, Action Medical Research Grant Review (UK) Reviewer, Genome Biology Reviewer, Genome Research Reviewer, Journal of Neurodevelopmental Disorders Reviewer, Nature Reviewer, Nature Neuroscience Reviewer, Neuron

67

Christine Wu Nordahl, PhD

Journal Articles 2017 Shen MD, Kim SH, McKinstry RC, Gu H, Hazlett HC, Nordahl CW, Emerson RW,

Shaw D, Elison JT, Swanson MR, Fonov VS, Gerig G, Dager SR, Botteron KN, Paterson S, Schultz RT, Evans AC, Estes AM, Zwaigenbaum L, Styner MA, Amaral DG, Piven J. Increased extra-axial cerebrospinal fluid in high-risk infants who later develop autism. Biol Psychiatry, August, 82(3):186-193.

2017 Solomon M, Hogeveen J, Libero L, Nordahl CW. An altered scaffold for information

processing: Cognitive control development in adolescents with autism. Biol Psychiatry Cogn Neurosci Neuroimaging, September, 2(6):464-475.

2018 Solomon M, Iosif AM, Reinhardt VP, Libero LE, Nordahl CW, Ozonoff S, Rogers SJ,

Amaral DG. What will my child's future hold? Phenotypes of intellectual development in 2-8-year-olds with autism spectrum disorder. Autism Research, January, 11(1):121-132.

2018 Prabhakar J, Johnson EG, Nordahl CW, Ghetti S. Memory-related hippocampal

activation in the sleeping toddler. Proceedings of the National Academy of Sciences, June 19;115 (25):6500-6505.

Abstracts and Presentations 2018 Kuschner ES, Nordahl CW, Shen MD, Stephenson KG. Clinical strategies for

increasing Inclusion in neuroscience research across the ASD spectrum. Special Interest Group, International Society for Autism Research Meeting, Rotterdam, Netherlands. May.

2018 Hosseini SMH, Annapureddy A, Libero L, Lee J, Sharma N, Coleman C, Amaral DG,

Hoeft F, Nordahl CW. Multi-class pattern classification discriminates young males and females with autism spectrum disorder based on cortical morphology, International Society for Autism Research Meeting, Slide Presentation, Rotterdam, Netherlands. May.

2018 Nordahl CW, Iosif AM, Young GS, Hechtman A, Heath B, Winder-Patel B, Reinhardt

V, Amaral DG, Ozonoff S, Solomon M. Increased rates of co-morbid psychopathology in preschool-aged females with autism spectrum disorder, International Society for Autism Research Meeting, Rotterdam, Netherlands. May.

2018 Lee JK, Heath B, Hechtman A, Gohring C, Huynh K, Amaral DG, Ozonoff S, Nordahl

CW. Sex differences in Inter-Hemispheric Resting State Functional Connectivity in Autism Spectrum Disorder in Early Childhood, International Society for Autism Research Meeting, Rotterdam, Netherlands. May.

68

Research Funding NICHD R21HD088928, Hippocampal Contribution to Episodic Memory Development and Loss in Toddlers, 2016-2018, $135,000 (annual direct costs), (Nordahl CW: Co-Investigator). NIMH R01MH104438, Neural Phenotypes of Females with Autism Spectrum Disorder, 2014-2019, $446,894 (annual direct costs), (Nordahl CW: PI). NIMH R01MH103284, Predictors of Cognitive Development in Autism Spectrum Disorder, 2014-2019, $358,179 (annual direct costs), (Nordahl CW: Co-Investigator). NIMH R01MH103371, Neurophenotypic Trajectories and Behavioral Outcomes in Autism Spectrum Disorder, 2015-2020, $444,958 (annual direct costs), (Nordahl CW: Co-Investigator). NICHD P50HD093079 8480, Center for the Development of Phenotype-Based Treatments for ASD: Project 2 - Behavioral and Neurobiological Phenotyping of ASD with Megalencephaly, 2017-2022, $377,400 (annual direct costs), (Nordahl CW: PI). NICHD P50HD093079 8483 Center for the Development of Phenotype-Based Treatments for ASD: Recruitment and Retention Core, 2017-2022, $115,003 (annual direct costs), (Nordahl CW: Core Lead). NICHD P50HD093079 8479 Center for the Development of Phenotype-Based Treatments for ASD: Project 1 - Specifying and Treating the Anxiety Phenotype in ASD, 2017-2022, $443,496, (annual direct costs), (Nordahl CW: Co-Investigator). Community Service Chair, Academic Federation Committee on Research, UC Davis Member, Academic Federation Executive Council, UC Davis Member, Joint Task Force on Research Units, UC Davis Member, Neuroscience Graduate Group, UC Davis Reviewer, Autism Research Reviewer, Biological Psychiatry Reviewer, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Reviewer, Cerebral Cortex Reviewer, Developmental Psychology Reviewer, Human Brain Mapping Reviewer, Molecular Autism Reviewer, Journal of Child Psychology and Psychiatry

69

Sally Ozonoff, PhD

Journal Articles 2018 Solomon M, Iosif A, Reinhardt VP, Libero L, Nordahl C, Ozonoff S, Rogers SJ,

Amaral DG. What will my child’s future hold? Cognitive phenotypes of autism between ages 2 and 8. Autism Research, 11, 121-132.

2018 Ozonoff S, Gangi D, Hanzel EP, Hill A, Hill MM, Miller M, Schwichtenberg AJ,

Steinfeld MB, Parikh C, Iosif A. Onset patterns in autism: Variation across informants, methods, and timing. Autism Research, 11, 788-797.

2018 Philippat C, Barkoski J, Tancredi DJ, Elms B, Barr D, Ozonoff S, et al. Prenatal

exposure to organophosphate pesticides and risk of autism spectrum disorder and other non-typical development at 3 years in a high-risk cohort. International Journal of Hygiene and Environmental Health, 221, 548-555.

2018 Gangi DN, Schwichtenberg AJ, Iosif A, Young GS, Baguio F, Ozonoff S. Gaze to

faces across interactive contexts in infants at heightened risk for autism. Autism, 22, 763-768.

2018 Miller M, Iosif A, Young GS, Hill MM, Ozonoff S. Early detection of ADHD: Insights

from infant siblings of children with autism. Journal of Clinical Child & Adolescent Psychology, 47, 737-744.

2018 Ozonoff S, Li D, Deprey L, Hanzel EP, Iosif A. Reliability of parent recall of ASD

symptom onset and timing. Autism, 22, 891-896. 2018 Ozonoff S, Young GS, Brian J, Charman T, Shephard E, Solish A, Zwaigenbaum.

Diagnosis of autism spectrum disorder after age 5 in children evaluated longitudinally since infancy. Journal of the American Academy of Child and Adolescent Psychiatry, 57, 849-857.

Books 2018 Goldstein S, Ozonoff S. (Eds.) Assessment of autism spectrum disorders (2nd

edition). New York: Guilford.

Book Chapters 2018 Miller M, Schetter PL, Ozonoff S. Executive dysfunction in autism spectrum disorder:

From research to practice. In L. Meltzer (Ed.), Executive function in education: From theory to practice, 2nd edition (pp. 168-196). New York: Guilford Press.

2018 Deprey L, Ozonoff S. Assessment of comorbid psychiatric conditions in autism

spectrum disorder. In S. Goldstein & S. Ozonoff (Eds.), Assessment of autism spectrum disorder, 2nd edition (pp. 308-337). New York: Guilford Press.

70

Abstracts and Presentations 2017 Ozonoff S. Early diagnosis of ASD and ADHD. Grand Rounds, Department of

Psychiatry, Stony Brook University, July. 2018 Ozonoff S. Innovative approaches to screening for autism in the first year of life. ASD

Early Screening Planning Meeting, National Institutes of Health, February. 2018 Goin-Kochel RP, Mire SS, McKee SL, Ozonoff S. First concerns and skill loss:

Revisiting parent report of ASD onset via the ADI-R. Gatlinburg Conference, San Diego CA, April.

2018 Parikh C, Iosif A, Ozonoff S. A longitudinal examination of developmental trajectories

among infant siblings of children with ASD: Implications for screening. Gatlinburg Conference, San Diego CA, April.

2018 Walker CK, Kim K, Ozonoff S, Hertz-Picciotto I. Placental trophoblast inclusions do

not predict adverse neurodevelopment in the MARBLES cohort. International Meeting for Autism Research, Rotterdam, May.

2018 Nordahl CW, Iosif A, Young GS, Hechtman AL, Heath B, Reinhardt VP, Amaral DG,

Ozonoff S, Solomon M. Increased comorbid psychopathology and lower adaptive functioning in preschool-aged females with autism spectrum disorder. International Meeting for Autism Research, Rotterdam, May.

2018 Palomo R, Ozonoff S, Young GS, Belinchon M. Social orienting and joint attention in

9 to 12 month old children with ASD with and without intellectual disability: A study with family home movies. International Meeting for Autism Research, Rotterdam, May.

2018 Krakowiak P, Tancredi DJ, Hansen R, Ozonoff S, Hertz-Picciotto I, Walker CK.

Maternal metabolic conditions and ASD: Comparing associations from high- and low-risk populations. International Meeting for Autism Research, Rotterdam, May.

2018 McDonald NM, Carver LJ, Charman T, Chawarska K, Curtin S, … Ozonoff S, et al.

A comparison of high-risk siblings with multiplex and simplex familial risk status: A baby siblings research consortium study. International Meeting for Autism Research, Rotterdam, May.

Research Funding R01 MH099046, 2013-2019, Development of a prospective video-based measure to identify ASD risk in infancy, National Institute of Mental Health, Ozonoff S (PI). U54 HD079125, 2013-2019, MIND Institute Intellectual and Developmental Disabilities Research Center, National Institute of Child Health and Human Development, Ozonoff S (Core Director).

71

R01 MH104438, 2014-2019, Neural Phenotypes of Females with Autism Spectrum Disorder, National Institute of Mental Health, Ozonoff S (Co-investigator). R01 MH109541, 2016-2021, Longitudinal investigation of social-communication and attention processes in school-aged children at genetic risk for autism, National Institute of Mental Health, Ozonoff S (PI). R01 ES028089, 2016-2021. Environmental influence on infant microbiome development and ASD symptoms, National Institute of Environmental Health Sciences, Ozonoff S (Co-investigator). R24 ES928533, 2017-2022. BUILDS MARBLES: Biorepository upkeep and infrastructure for longitudinal data sharing for MARBLES, National Institute of Environmental Health Sciences, Ozonoff S (Co-investigator). UG3 OD023342, 2016-2023. An ASD-enriched ECHO cohort, National Institute of Environmental Health Sciences, Ozonoff S (Subcontract PI). Community Service Member, American Psychiatric Association DSM Review Committee Member, Autism Spectrum Disorders Advisory Board, UC Davis Extension Member, Autism Advisory Board, Guilford Press Member, BIRCWH Advisory Board and Review Committee, UC Davis Member, Editorial Board, Autism Research Member, Editorial Board, Autism Spectrum Quarterly Member, Editorial Board, Journal of Autism and Developmental Disorders Member, Graduate Group in Clinical Research, UC Davis Member, International Society for Autism Research Scientific Standards Committee Member, Special Project Option (MS-4) Review Committee, UC Davis School of Medicine Member, TEACCH Advisory Board, University of North Carolina Reviewer, Autism Research Reviewer, Autism: The International Journal of Research and Practice Reviewer, Journal of the American Academy of Child and Adolescent Psychiatry Reviewer, Journal of Autism and Developmental Disorders Reviewer, Journal of Child Psychology and Psychiatry Reviewer, Journal of Neurodevelopmental Disorders Reviewer, Pediatrics

72

Murat Pakyurek, MD Publications 2017 Pakyurek M. ADHD as a Possible Cause for Sexual Dysfunction in Adult Females.

Clinical Psychiatry, Vol.3 No 3:16. 2017 Pakyurek M, Luminare AA, Iosif AM, Azarang A, Nordahl TE. Comorbidity of Asthma

and Attention Deficit Hyperactivity Disorder: A Population-Based Cohort Study. Mental Health in Family Medicine, 13:600-607.

2018 Benzodiazepines in Children and Adolescents: A Review Article. The Carlat Report,

Child Psychiatry, Mar/Apr. 2018 Pakyurek M, Azarang A, Iosif AM, Nordahl TE. Assessment of Biometal Profile in

Children with ASD, ADHD, or with Other Psychiatric Diagnoses: A Comparative Outpatient Study. Acta Psychopathologica, Vol. 4 No 1:6.

Presentation 2017 Asthma and Attention-Deficit/Hyperactivity Disorder (ADHD): A Comorbidity Study Based on Medication Treatment. October AACAP Annual Conference in Washington, DC. Research Funding A Phase 3, Multicenter, Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar 1 Disorder (Current or Most Recent Episode Manic). Pfizer. Role: PI, Period: 2015-2018. Developmental Changes in Neural Processes Underlying Inattention, Impulsivity and Regulation, $3,714, 527. NIMH/NIH. Role: Co-Investigator. Budget Period: 07/10/2017-05/31/2018 Project Period: 08/15/2012-05/31/2022. Center for the Development of Phenotype-Based Treatments of Autism Spectrum Disorder. Specifying and Treating the Anxiety Phenotype in ASD (PI: Solomon M). NICHD. Role: Co-Investigator. 1P50HD093079-01 Project Period: 09/07/2017 – 07/31/2022 Average Annual Direct Cost: 1,600,000. Community Service

Member, Ambulatory Care Work Group, UCDMC Member, Bylaws Committee, AACAP Member, Hospital Quality and Safety Committee, UCDMC Member, MIND Institute Leadership Committee Member, Telemedicine Behavioral Health Committee, UC Health

73

J. Daniel Ragland, PhD Journal Articles 2017 Carrion RE, Walder DJ, Auther AM, McLaughlin D, Zyla HO, Adelsheim S,

Calkins R, Carter CS, McFarland B, Melton R, Niendam T, Ragland JD, Sale TG, Taylor SF, McFarland WR, Cornblatt BA: From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline. J. Psychiatric Research, 96:231-238.

2017 Ermel J, Carter CS, Gold JM, MacDonald AW, Ragland JD, Silverstein SM,

Strauss ME, Barch DM: Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder. Schizophrenia Research: Cognition, 9:1-7.

2017 Ramsay IS, Ma S, Fisher M, Loewy RL, Ragland JD, Niendam T, Carter CS, Vinogradov S: Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophr Res Cogn, 11:1-5.

2017 Greenland-White S, Niendam TA, Ferrer E, Carter CS, Ragland JD: Episodic Memory

Functions in First Episode Psychosis and Clinical High Risk Individuals. Schizophrenia Research, 188:151-157.

2018 Smucny J, Lesh TA, Newton K, Niendam T, Ragland JD, Carter CS: Levels of

Cognitive Control: A Functional Magnetic Resonance Imaging-Based Test of an RDoC Domain Across Bipolar Disorder and Schizophrenia. Neuropsychopharmacology, 43:598-606.

2018 Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD,

Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, Potter WZ, Carlson M, Wall MM, Choo TH, Grinband J, Lieberman JA: Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial. JAMA Psychiatry, 75:11-19.

2018 Savill M, Skymba HV, Niendam TA, Loewy RL, Lesh TA, Ragland JD, Carter CS,

Goldman HH: Acceptability, Barriers, and Facilitators to Implementing a Psychosis Screening Procedure in Different Healthcare Settings – A Qualitative Interview Study of Healthcare Providers. Psychiatric Services, 69:689-695.

Abstracts and Presentations 2018 Solomon M, Krug MK, Coleman C, Elliott M, Hogeveen J, Niendam TA, Ragland JD,

Carter CS. Functional Connectivity Underlying Cognitive Control Deficits in Adolescents and Young Adults with Autism Spectrum Disorder. Annual Meeting of the International Society for Autism, Rotterdam, Netherlands.

74

2018 Solomon M, Krug MK, Coleman C, Elliott M, Hogeveen J, Niendam TA, Ragland JD, Carter CS. Adolescents and Young Adults with Autism Spectrum Disorder Show Differences in Dynamics and Recruitment of Cognitive Control Networks. Annual Meeting of the International Society for Autism, Rotterdam, Netherlands.

2018 Dager AD, Marjanska M, Mason GF, Tice MR, Ragland JD, Silveri MM, Book GA,

Meagher C, Assaf M, Stevens MC, Pearlson GD. Nonverbal Memory and fMRI Response in Young Adult Marijuana Users. 73rd Annual Meeting of the Society of Biological Psychiatry, New York, NY.

2018 Dager AD, Marjanska M, Mason GF, Tice MR, Ragland JD, Silveri MM, Book GA, Meagher C, Assaf M, Stevens MC, Pearlson GD. Investigation of Neurochemistry and fMRI Response During Nonverbal Memory in Emerging Adult Marijuana Users. 73rd Annual Meeting of the Society of Biological Psychiatry, New York, NY.

2018 Ragland JD, Hsieh LT, Carter CS, Hurtado M, Lam J, Lesh TA, Niendam TA,

Solomon M, Ranganath C. Impact of Schizophrenia on Temporal Context versus Item Memory. 73rd Annual Meeting of the Society of Biological Psychiatry, New York, NY.

2018 Lesh TA, Tanase C, Wang H, Steinbauer E, Bennet J, Iosif A, Van de Water J,

Maddock RJ, Ragland JD, Niendam TA, Styner M, Amaral D, Bauman M, Carter CS Diffusion Measures of Extracellular Free Water in First Episode Schizophrenia and a Non-Human Primate Model of Maternal Immune Activation – Exploring Neuroimmune Mechanisms of Psychiatric Disorders. 73rd Annual Meeting of the Society of Biological Psychiatry, New York, NY.

Research Funding 5R01MH059883-11 (PI: Carter), NIMH, 6/1/13-6/1/18. Pathophysiology of Cognitive Disability in Schizophrenia: Using fMRI and two cognitive tasks evaluating unique aspects of cognitive control and approach motivation we will test the hypothesis that during a first episode of psychosis both schizophrenia that bipolar disorder patients will show cognitive control deficits that in schizophrenia will remain as stable trait deficits during the first year of illness, but that in Bipolar disorder will show substantial improvement with clinical remission. In contrast Bipolar Disorder patients will show an enhanced sensitivity to repeated rewards that will be stable across clinical states, while schizophrenia patients will show intact or reduced responses to incentives across the course of the first year of illness. 5R01MH084826-05 (PI: Carter), NIMH, 10/12/13-10/1/18. Cognitive Neuroscience Task Reliability and Clinical Application Consortium. Behavioral tasks measuring the RDoC constructs of reward sensitivity and working memory capacity will be validated, optimized, and characterized psychometrically. Optimized measures and their psychometric characteristics will then be publically available for use in treatment development studies. 1R01MH105411-01 (PI: Ragland) NIMH, 1/01/14-12/30/18. Neural Mechanisms of Impaired Episodic Memory in Schizophrenia. This grant uses a multimodal functional imaging approach (EEG, fMRI and MRS) to examine the relationship between the function of

75

prefrontal and hippocampal circuitry supporting item-specific and relational memory in the brain to schizophrenia diagnosis, daily function and symptoms in schizophrenia. 1R01 MH104235-01 (PI: Carter) NIMH, 9/1/14-8/30/18. Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement. This grant will consecutively test the impact of two interventions to reduce duration of untreated psychosis (DUP). First, we will test the ability of standard targeted provider education plus novel technology-enhanced screening to improve early identification. Secondly, we will test the ability of a mobile community-based, telepsychiatry-enhanced engagement method to promote early and stable treatment engagement and, thereby, reduce DUP. 1R01MH106518 (PI: Solomon), NIMH, 1/01/16-12/31/21. Neurodevelopment of Cognitive Control in Autism: Adolescence to Young Adulthood. This study examines the adolescent to young adulthood development of cognitive control and its relationship to functional outcomes using fMRI and behavioral measures. Community Service Chair, Compensation Advisory Committee, UC Davis School of Medicine Chair, Public Information Committee, American College of Neuropsychopharmacology (ACNP) Member, Committee on Student Promotions, UC Davis School of Medicine Member, Faculty Executive Committee, UC Davis School of Medicine Member, Faculty Personnel Committee, UC Davis School of Medicine Member, Research Affairs Committee, Department of Psychiatry and Behavioral Sciences, UC Davis School of Medicine Member, Search Committee for Associate Vice Chancellor for Academic Personnel, UC Davis School of Medicine Member, Study Section, NIMH Adult Psychopathology and Disorders of Aging Study Section (APDA). National Institutes of Health, Bethesda, MD. Editorial Board Member, Biological Psychiatry Editorial Board Member, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Editorial Board Member, Psychiatry Research: Neuroimaging Editorial Board Member, Schizophrenia Research: Cognition Faculty Member, Faculty of 1000 Medicine (Schizophrenia & Other Psychosis)

76

Swati Rao, MD

Journal Articles 2018 Rao S, How PC, Ton H. Education, Training, and Recruitment of a Diverse Workforce

in Psychiatry. Psychiatric Annals. March; 48(3), 143-148. Abstracts and Presentations 2017 The Value of Integrated Care: A Unique Grassroots Approach to Transgender Health

Services. Panel presentation at Annual Philadelphia Transgender Health Conference, September.

2017 Gender Affirming Care for Transgender Patients. Presentation at Association of Medicine and Psychiatry Annual Conference, September.

2017 Psychiatric Care of Transgender Patients. Presentation at California Psychiatric

Association Annual Conference, October. 2017 How a Mental Health-Centered, Trans-Led Organization Embraced Informed Consent.

Panel presentation at UCSF National Biannual Transgender Health Summit, November.

2018 No Time to Lose: Educational Disparities among LGBTQ Youth. Keynote Speaker at

Sacramento City Unified School District Biannual Conference on LGBTQ Youth, April. 2018 Psychiatric Care of Transgender Patients. Presentation at Sutter Center for Psychiatry

Grand Rounds, June. Research Funding Solano County Mental Health Interdisciplinary Collaboration and Cultural Transformation Model, 2016-present. A joint project between Solano County and the UC Davis Center for Reducing Health Disparities to improve mental health services utilization among three underserved populations – Filipino, Latino and LGBTQ communities – through community engagement, education and training in the Culturally and Linguistic Appropriate Services Standards. 15% FTE. The TRIUMPH Collaborative: Trans Research-Informed Communities United in Mobilization for the Prevention of HIV, 2016-present. Prescribing clinician and local project contributor in a partnership between Sacramento’s Gender Health Center and UC San Francisco’s Transgender Center of Excellence to study the Culturally Relevant Demonstration of HIV Pre-Exposure Prophylaxis (PREP) for Trans* Communities. 5% FTE

77

Creation of a Transgender Health Curriculum for UC Davis School of Medicine, 2017-present. Recipient of UC Davis Psychiatry Department’s Junior Faculty Development Award to conduct qualitative interviews with key stakeholders in the school of medicine (faculty and students) and the transgender community to create a culturally responsive curriculum on transgender health. 10% FTE. Community Chair, Transgender Care Group Committee, UC Davis Health Member, Diversity Advisory Committee, Department of Psychiatry and Behavioral Sciences, UC Davis Health Member, Vice Chancellor’s Advisory Council on LGBTQI Affairs, UC Davis Health Medical Co-Director and Volunteer Physician, Gender Health Center's Hormone Clinic, UC Davis Student-Run Free Clinic

78

Rachel Robitz, MD

Journal Articles 2018 Robitz R, Gajaria A, Stoklosa H, Jones E, Baldwin SB. A Young Transgender Woman

with Fatigue, Malnutrition, and a Previous Suicide Attempt. Psychiatric Annals. 48(3): 131-133.

Abstracts and Presentations 2018 Presenter: Why (and How) Combined Training? Insights for People Who’ve Been

There to Help People Who Might Like to Go There, AADPRT Annual Meeting, New Orleans, LA, February.

2018 Presenter: Building a Network of Future Leaders in Organized Psychiatry

#mentorshipgoals, APA Annual Meeting, New York, NY, May. 2018 Integrated Care, PsychSIGN National Conference, New York, NY, May. Community Service Chair, Medical Student Affairs Committee, Association of Medicine and Psychiatry Co-Chair, Direct Service Provider Committee, HEAL Trafficking Member, Early Career Psychiatrist Advisory Board, Psychiatric Services Journal Member, Mentorship Program Steering Committee, American Psychiatric Association

79

Sally Rogers, PhD

Journal Articles 2017 Zhou V, Munson J, Greenson J, Hou Y, Rogers SJ, Estes A. An exploratory

longitudinal study of social and language outcomes in children with autism in bilingual homes. Autism, DOI: 10.1177/136236131774351.

2017 Xiu X, Rogers SJ. Effects of parent-implemented Early Start Denver Model

Intervention on Chinese toddlers with Autism Spectrum Disorder: A non-randomized controlled trial. Autism Research: DOI:10.1002/aur.1917.

2017 Solomon M, Iosif A, Reinhardt V, Libero L, Nordahl C, Ozonoff S, Rogers SJ, Amaral

DG. What will my child’s future hold? Cognitive phenotypes of autism between ages 2 and 8. Autism Research, DOI?10.1002/aur.1884.

Abstracts and Presentations 2017 Rogers SJ. Keynote Address: Autism Symptoms in infants; what should we

professionals do? Australasian Society for Autism Research, La Trobe University, Melbourne Campus, Bundoora Victoria, Australia, November 10.

2017 Rogers SJ. Invited address: Does my baby have autism? What should we

professionals do? Zero to Three Annual Conference, San Diego, CA, November 29. 2017 Rogers SJ, Lord C, Skuse D. Roundtable: Debating diagnostic criteria for autism.

Webinar for Simons Foundation on Spectrum. April 17. 2018 Aranbarri A, Stahmer AC, Acha J, Arranz E, Miller ME, Talbott MR, Rogers, SJ. A

New Tool to Assess Family Context Features That Promote the Early Development of Young Children at-Risk for ASD. Poster presentation at the International Society for Autism Research (INSAR) Annual Meeting: Family Issues and Stakeholder Experiences Category, Rotterdam, The Netherlands, May.

Research Funding U54HD079125, National Institute of Child Health and Human Development, 2013-2017, MIND institute Intellectual and Developmental Research Center, $1,300,000 (Abbeduto L: PI; Rogers SJ: Core Director). This grant develops a new Intellectual and Developmental Disabilities Research Center at the MIND Institute. It includes six cores and a multi-modal treatment project, all focused on themes of biobehavioral characterization of intellectual and developmental disabilities (IDD), environmental contributions to IDD, and treatments for IDD. 1R01MH100030-01, NIH, 2013-2018, Intervention effects of intensity and delivery style for toddlers with ASD, $13,000,000, (Rogers SJ: PI). A multi-site randomized study of intensive treatment for toddlers with autism. This project proposes a three-site collaborative network plus a data coordinating center to evaluate the effects of intervention intensity and

80

intervention style delivered for 12 months, on the development of very young children with ASD ages 15-30 months old and their families, and the effect of children’s initial vocal skills, developmental rates and autism severity on their response to intervention. It will also examine whether the effects of intensive play-based intervention are sustained over a three year period for 6-7 year old children who previously were enrolled in a two-year study and compared to children receiving community interventions. R324A150211, Department of Education, 2015-2018, Adapting an Evidence-Based Program for Children at Risk for Autism for Diverse Early Intervention Service Systems, $1,497,049 (Rogers SJ, Stahmer A: Co-PIs). This project will work with community members across six states to adapt a parent-implemented Early Start Denver Model for use with children of low income parents who have or are at-risk for autism served by Part C in low resource areas. A pilot test of child outcomes will be conducted. T32 MH073124-11, National Institutes of Mental Health, 2014-2019, Interdisciplinary training for autism researchers, $1,730,310 TDC (Rogers SJ, Amaral D: Co-PIs). The purpose of this proposal is to develop and conduct a two-year training program for a cadre of six young scientists who will develop expertise in clinically relevant areas of neuroscience at the same time that they are learning the principles and protocols of sensitively conducting research with children. They will develop Core Competencies in areas relevant to autism research. The trainees will enter the program with backgrounds in either behavioral or biological research, but will interact with primary and secondary mentors to ensure the integration of these two disciplinary areas in the conduct of their research. 1R01MH103284, National Institute of Mental Health, 2014-2019, Predictors of Cognitive Development in Autism Spectrum Disorder, $326,826 (Solomon M: PI; Rogers SJ: Investigator). The goal of this study is to evaluate early neural predictors for middle childhood cognitive outcomes in a longitudinal study of children with ASD. La Trobe University, 2017-2019, How does parent coaching add value to evidence-based autism intervention?, $1,007,755 (Hudrey K: PI; Rogers SJ: Consultant). This project – a pragmatic randomized controlled trial, will be used to determine whether parent coaching adds value to traditional therapist-delivered intervention, and whether is brings benefits for caregivers, families, and children with autism, over a short, medium and long-term period of time. 15-091, Health Resources Services Administration, 2015-2020, Autism Intervention Research Network on Behavioral Health-III, $242,745 (Kasari C, Stahmer A: Co-PIs; Rogers SJ: Consultant). This project will use a community-based approach to reduce disparities in ASD access, diagnosis and services. Goals include increasing family engagement in under-resourced settings, development of treatment guidelines and educating young scholars.

The University of British Columbia, Vancouver, BC, Canada, 2017-2020, PACE (Parent and Community Early) Coaching Project, $2,850,000 (Mirenda P: PI; Rogers SJ: Consultant). The purpose of this implementation science study is to test the acceptability, usability, and effectiveness of a parent coaching intervention model for young children with ASD across the province of British Columbia.

81

T73MC30113-01-00, Health Resources Services Administration, 2016-2021, Leadership Education in Neurodevelopmental and Related Disorders Training Program, $2,459,826 (Rogers SJ, Stahmer A: Co-PIs). The purpose of this graduate-level training program is to improve the health of infants, children, and adolescents who have, or are at risk for developing autism spectrum disorder or other neurodevelopmental disabilities, to expand interdisciplinary leadership training opportunities for graduate level and other trainees from a wide variety of professional disciplines, including family members and individuals with disabilities, and to increase the number of providers able to diagnose or rule out autism spectrum disorder or other developmental disabilities. HHS-2016-ACL-AOD-DD-0121, DHHS Administration on Community Living, 2016-2021, University Center for Excellence in Developmental Disabilities. Education, Research, and Service (UCEDD), $547,000 (Hansen, R, Rogers SJ: Co-PIs). The UC Davis UCEDD is a DD Network Partner in California funded to increase capacity for interdisciplinary training, community services, translation of research into practice and advocacy in California for individuals with developmental disabilities and their families. University of Sydney, Sydney, Australia, 2017-2021, Oxytocin enhancement of social learning for toddlers with autism, (Guastella A: PI; Rogers SJ: Consultant). This project is designed to test the hypothesis that, for young children with autism, oxytocin increases and accelerates learning from a social intervention by improving social engagement and responsiveness. Using a randomized, double-blind placebo-controlled design, the study will test the effects of a 12 -week treatment of oxytocin or placebo in combination with parent coaching in 132 preschoolers with ASD. 1R01HD093457-01, National Institute of Mental Health, Autism Center for Excellence, 2017-2022, Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes, $627,945 (Stahmer A: PI; Rogers SJ: Investigator). This RCT study aims to demonstrate that standardized high-fidelity, universal early screening lowers the age of diagnosis and treatment onset, leading to improved short- and long-term outcomes. Community Service Chairperson, Fellows Nomination Committee, International Society for Autism Research (INSAR) Consult Volunteer, Wellspring Women’s Center, Sacramento Grant Reviewer, A Better Start National Science Challenge & Cure Kids, Wellington, New Zealand Member, Editorial Board, Journal of Autism and Developmental Disorders Member, Global Autism Public Health Initiative Advisory Committee, Autism Speaks Member, Toddler Treatment Network, Autism Speaks Member, Executive Committee, MIND Institute, UC Davis Member, Graduate Group in Developmental Psychology, UC Davis Member, Graduate Group in Human Development, UC Davis Member, Michelangelo Project Scientific Advisory Board, International Consortium; European Commission

82

Reviewer, Child Development Reviewer, Developmental and Psychopathology Reviewer, Journal of Child Psychology and Psychiatry Reviewer, Psychological Bulletin Reviewer, Giroux Faculty Development Proposal Reviewer, Rao Faculty Research Proposal

83

Jason Glen Roof, MD

Abstracts and Presentations 2017 Delirium, American Correctional Health Services Association, September. Community Service Leader and Member, Technology Committee, American Academy of Psychiatry and the Law Member, Membership Committee, American Academy of Psychiatry and the Law

84

Lorin M. Scher, MD

Book Chapters 2018 Scher LM, Shwarts E. Somatic Symptom and Related Disorders, in Textbook of

Psychiatry, 7th edition. Edited by Roberts L. American Psychiatric Publishing, Inc. Abstracts and Presentations 2017 Scher LM. Plenary Session on Behavioral Health Integration: Building a Stepped-

Integrated Model within Primary Care. A PRIME Learning Collaborative: PRIMED Annual Conference, Sacramento, CA.

2018 Scher LM. Special presentation on Integration of Behavioral Health within Primary

Care – Building a Stepped Intervention. UCSF Department of Psychiatry, San Francisco CA.

2018 Scher LM, Robitz R. Lecture and Small Group Case Discussions on the Management

of Patients with Substance Misuse. Essentials of Primary Care Psychiatry CME Conference, Las Vegas.

2018 Scher LM. Behavioral Health Integration in Primary Care. Quality and Safety

Operations Committee (QSOC), UC Davis Medical Center, Sacramento CA. 2018 Kern J, Scher LM. Applying the Integrated Care Approach: Collaborative Care Skills

for the Consulting Psychiatrist. 4-hour course at the American Psychiatric Association (APA) Annual Meeting, New York, NY.

2018 Scher LM, Mabanglo M. Lecture and Webinar on Shared Care Planning – Excellence

in Integration Complex Care Series. Behavioral Health Integration and Complex Care Initiative (BHICCI), Inland Empire Health Plan (IEHP).

2018 Gershengoren L, Scher LM. Emerging Roles of C-L Psychiatrists – Addressing

Interdisciplinary Care Transitions for the Medically Complex Patient. American Psychiatric Association.

Research Funding 2014-17 Integrated Medicine and Psychiatry Ambulatory Residency Training (IMPART3)

Preventive Public Psychiatry. California Office of Statewide Planning and Development, Mental Health Services Act – Workforce, Education and Training. Education Capacity – Psychiatrists RFP # 14-5017. $1,350,000, Scher LM (Psychiatric Educator), (PI McCarron).

2015-17 Implementation of Asynchronous Telepsychiatry (ATP) in the UC Davis Primary

Care Network (PCN) Practice Management Board Innovation Grant, UC Davis Health System. $345,000. Scher LM (PI), Yellowlees P.

85

2013-18 RCT of Store and Forward Telepsychiatry in Primary Care. U.S. Department of Health and Human Services; Agency for Healthcare Research and Quality (AHRQ). $2,500,000. Yellowlees, P. (PI), Scher LM (Co-Investigator).

2016-19 Tailored Activation in Primary Care to Reduce Suicide Behaviors in Middle-Aged

Men. National Center for Injury Prevention and Control (Centers for Disease Control and Prevention) U01CE002664. $1,320,000, Jerant (PI), Scher LM (Co-investigator).

2016-19 American Psychiatric Association (APA) Support and Alignment Network (SAN) to

train psychiatrists to use the Collaborative Care Model (CoCM) and population health principles. Centers for Medicare and Medicaid Services (CMS), Transforming Clinical Practice Innovative (TCPI). $2,900,000, Scher LM (Master Trainer), (PI – Ratzliff, A. University of Washington).

Community Service Chair, ED Psychiatry Workgroup, UC Davis Medical Center Chair, 4th Year Oversight Committee, UC Davis School of Medicine Chair, Mental Health External Relations Advisory Group, UC Davis Health Chair, PCN Psychiatry and Behavioral Health Taskforce, UC Davis Health

Member, Block Council, UC Davis School of Medicine Member, Committee on Educational Policy, UC Davis School of Medicine Member, Education Committee, Academy of Psychosomatic Medicine Member, Public Hospital Redesign and Incentives in Medi-Cal (PRIME) Oversight Committee, UC Davis Health Member, Sierra Sacramento Valley Medical Society, Emergency Psychiatry Mental Health Taskforce Member, UCDMC / SCMHTC Committee, UC Davis Health

86

Cynthia Schumann, PhD

Journal Articles 2018 Avino TA, Barger N, Vargas MV, Carlson EL, Amaral DG, Bauman MD, Schumann

CM. Neuron numbers increase in the human amygdala from birth to adulthood but not in autism. Proceedings of the National Academy of Sciences (PNAS). April 3; 115(14):3710-3715.

2018 Amaral DG, Anderson MP, Ansorge O, Chance S, Hare C, Hof PR, Miller M,

Nagakura I, Pickett J, Schumann CM, Tamminga C. Autism BrainNet: A Network of postmortem brain banks established to facilitate autism research. Handbook of Clinical Neurology. 150:31-39.

2018 Weir RK, Bauman MD, Jacobs B, Schumann CM. Protracted dendritic growth in the

typically developing human amygdala and increased spine density in young ASD brains. Journal of Comparative Neurology. 1;526(2):262-274.

2018 Zhan L, Jenkins L, Zhang A, Aifeng C, Giorgio F, Forbes A, Harvey D, Angkustsiri K,

Hunsaker T, Durdle C, Lee A, Schumann CM, Carmichael O, Kalish K, Leow A, Simon TJ. Baseline connectome modular abnormalities in the childhood phase of a longitudinal study on individuals with chromosome 22q11.2 deletion syndrome. Human Brain Mapping.

2018 Lew CH, Groeniger K, Bellugi U, Stefanacci L, Schumann CM, Semendeferi K. A

postmortem stereological study of the amygdala in Williams syndrome. Brain Structure and Function.233(4):1897-1907.

2018 Bauman MD, Schumann CM. Advances in nonhuman primate models of autism:

Integrating neuroscience and behavior. Experimental Neurology. ;299(Pt A):252-265. Abstracts and Presentations 2017 Barger N, Vargas MV, Avino TA, Semendeferi K, Schumann CM. Postnatal neuron

increase in the adult human amygdala is more extensive than in other hominids and

associated with expression of genes annotated to neurogenesis. Society for

Neuroscience Meeting, San Diego, CA. November.

2017 Stamova B, Ander BP, Omanska A, Sharp FR, Schumann CM. Differential alternative

splicing in superior temporal gyrus of autism spectrum disorder brains. Society for

Neuroscience, San Diego, CA. November 12.

Research Funding R01 MH-097236-01 (PI: Schumann CM) $250,000 annual directs. 9/01/11-1/31/23, Typical and pathological cellular development of the human amygdala.

87

Joe P. Tupin Award, UC Davis Psychiatry (Co-PI: Schumann CM, Co-I Niendam T) $75,000 annual direct. 7/1/17-12/31/18, Brain Endowment for Mental Health (Schizophrenia and Bipolar disorder brain tissue collection program). R21 MH108909 01 (PI: Schumann CM), $135,000 annual directs. 10/1/15-9/30/18 Cell-specific molecular mechanisms underlying brain pathology in ASD. Autism BrainNet, Simons Foundation (PI: Schumann CM), $230,000 annual directs. 5/01/14-4/30/20. UC Davis MIND Institute Brain Endowment for Autism Research Sciences (BEARS) tissue program. P50MH096859 (PI: Carter C) 4/01/15 – 3/31/20, Neuroimmune Mechanisms of Psychiatric Disorders Conte Center. Community Service Associate Editor, Molecular Autism Interviewer, UC Davis School of Medicine Multiple Mini Interview (MMI) Admissions Member, Editorial Board, Acta Neuropathologica Communications Member, Graduate Student Dissertation Committee – Caroline Lew Member, International Society for Autism Research (INSAR) Special Interest Group Review Committee Member, NIH Special Emphasis Panel study section – Cellular and Molecular Neuroscience and Neurodevelopmental Disorders Member, NIH Special Emphasis Panel Study Section – Developmental Brain Disorders and Alzheimer’s Disease Member, NIH Special Emphasis Panel Study Section – Early Independence Awards Member, UC Davis Committee on Research Member, UC Davis Status of Women Administrative Advisory Committee Member, UC Davis Human and Anatomical Specimen and Tissue Oversight Committee (HASTOC) Reviewer, Acta Neuropathologica Journal Reviewer, Archives General Psychiatry Journal Reviewer, Journal of Autism Research Reviewer, Journal of Biological Psychiatry Reviewer, Brain Journal Reviewer, Journal of Molecular Autism Reviewer, Journal of Cerebral Cortex Reviewer, Journal of Comparative Neurology Reviewer, Journal of Neuroscience

88

Julie Schweitzer, PhD Journal Articles 2017 Lyall K, Schweitzer JB, Schmidt RJ, Hertz-Picciotto I, Solomon M. Inattention and

hyperactivity in association with autism spectrum disorders in the CHARGE study. Research in Autism Spectrum Disorders. 35, 1-12.

2017 Schweitzer JB, Solomon M, Miller M, Hertz-Picciotto I. Comorbid Attention Deficit

Hyperactivity Disorder and Autism Spectrum Disorders. ADHD Report, 25 (7), 1-12. Guilford Press. November.

2018 Lewis Cohen SC, Harvey DJ, Shields RH, Shields GS, Rashedi RN, Tancredi DJ,

Angkustsiri K, Hansen RL, Schweitzer JB. The Effects of Yoga on Attention, Impulsivity and Hyperactivity in Pre-school Age Children with ADHD Symptoms. J Dev Behav Pediatr 0:1–10.

2018 Benyakorn S, Calub C, Riley SJ, Schneider A, Iosif-AM, Solomon M, Hessl DR,

Schweitzer JB. A Feasibility and Satisfaction Study of Computerized Cognitive Training in Children with Autism and Intellectual Disabilities. JMIR Ment Health 5(2):e40) doi:10.2196/mental.9564.

Presentations 2017 Schweitzer JB, Dixon JF. ADHD: 101. Davis High School, Davis, CA. September. 2017 Hessl D, Schweitzer JB, Nguyen D, McLennan B, Johnston C, Shickman R.

Cognitive Training for Fragile X Syndrome: Results of a Double Blind Controlled Trial of Cogmed. 18th International Fragile X and Related Neurodevelopmental Disorders Workshop. Quebec, Canada. October.

2017 Schweitzer JB. Annual Update on Research in ADHD. CHADD, Sacramento, CA.

December. 2018 Schweitzer JB. Using Virtual Reality to Reduce Distractibility in Children with

Attentional Impairments. UCD 3D Research Symposium. Center for Mind and Brain. Davis, CA. January.

Research Funding Joe P. Tupin Research Award – Department of Psychiatry and Behavioral Sciences, UC Davis, 5/1/16-4/30/18, $67,617 (Total cost). Building Resistance to Distraction via Virtual Reality Therapy. Schweitzer JB: PI. NICHD/NIH, 9/1/16-6/30/18, $50,000 (ADC) – no cost extension. Feasibility of Shaping Tolerance for Delayed Rewards in Impulsive 3-5 year olds. Schweitzer JB: PI.

89

NICHD/NIH, 10/01/13-9/30/18 – no cost extension. MIND Institute Intellectual and Developmental Disabilities Research Center. Schweitzer JB: Co-Director, Assessment and Recruitment Core; Abbeduto L: PI. NIH, 09/22/16-9/30/18, $999,635 (ADC). Pre-adolescent and Late-adolescent Follow-up of the CHARGE Study Children. Schweitzer JB, Hertz-Picciotto, Bennett: MPI. NIMH/NIH, 02/01/17-01/31/19, $368,631 (ADC). R33 component for 2019-2022 contingent upon R61 findings. Virtual Reality Attention Management Program for Improving Attention in Children. Schweitzer JB: PI. NIH/NCATS, 07/01/16-06/30/21. $2,709,457 (ADC). UC Davis Clinical and Translational Science Center. Schweitzer JB: Co-Investigator, Co-director Team Science, Berglund L: PI. NIH/NCATS, 07/01/16-06/30/21. $504,022. UC Davis Clinical and Translational Science Center – NRSA Training Core. Schweitzer JB: Associate Director; Kenyon N: Workforce Development: Director Postdoc Program PI. HRSA, 07/01/16-6/30/21, $2,500,000.00 (TDC). Leadership Education in Neurodevelopmental And Related Disorders Training Program. Rogers S: PI; Schweitzer JB: Course Leader. NIH/NIMH, 7/01/17-6/30/22, $519,097 (ADC). Developmental Changes in Neural Processes Underlying Inattention, Impulsivity and Regulation. Schweitzer JB: PI. NIH/NIMH, 04/20/2018-01/31/2023, $265,322 (ADC). Quantifying the attentional template. Geng J: PI; Schweitzer JB: Co-Investigator. NIEHS/NIH, 09/1/2013-08/31/2018, $750,000 (ADC). CHildhood Autism Risks from Genetics and Environment (CHARGE) Study, Schweitzer JB: Co-Investigator; Hertz-Picciotto: PI. DHHS Administration for Children and Families, 90DD0596/01, 07/01/2012-06/30/2016, $500,000 (ADC) per year. UC Davis Center of Excellence in Development Disabilities, Schweitzer JB: Co-Investigator; Hansen R: PI. John Merck Fund, 1/1/2013-12/31/2017, $250,000 (ADC). Cognitive Training for Fragile X Syndrome, Hessl D: PI; Schweitzer JB: Co-PI Community Service Chair, Curriculum Committee, Mentor Academy Developer, Parenting resources Facebook Page Group for UCDH Grant Reviewer: UC Davis Department of Psychiatry Junior Faculty Development Award Grant Reviewer: NIH – CPDD Grant Reviewer: NIH ZMH1; ERB-D 08 S, Fellowships and Dissertation Grants Grant Reviewer: United States – Israel Binational Science Foundation Member, CTSC Education and Research Training Oversight Committee

90

Member, CTSC Executive Committee, UC Davis Member, Editorial Board, ADHD Report Member, Endowed Chair Review Committee, UCDH Member, Executive Committee, Graduate Group in Clinical Research, UC Davis Member, Faculty Executive Committee, MIND Institute Member, Graduate Group in Education, UC Davis Member, Graduate Group in Human Development, UC Davis Member, Graduate Group in Neurosciences, UC Davis Member, Graduate Group in Psychology-Perception, Cognition, and Cognitive Neuroscience, UC Davis Member, IDDRC Executive Committee, UC Davis Member, Infrastructure Committee, MIND Institute Member, Recruitment Advisory Committee, Dean, School of Education, UC Davis Member, Schools of Health Sciences Mentor Academy, UC Davis Member, Search Committee, Child Psychiatry Faculty Member, Society for Neurosciences Committee for Media Distribution of Scientific Presentations Member, Steering Committee, Women in Medicine and Health Sciences Member, Strategic Affairs Planning Committee, UC Davis School of Medicine Member, TL1 Predoctoral Clinical Research Training Program, Selection Committee, UC Davis Member and Lead Mentoring/Sponsorship Workgroup, Under-represented Groups in Medicine and Biomedical Sciences (UGMBS) Faculty Affairs Committee, Reviewer, Journal of Clinical and Translational Science Reviewer, Neurodevelopmental Abstracts

91

Andrés F. Sciolla, MD Journal Articles 2017 Hinton L, Sciolla AF, Unützer J, Elizarraras E, Kravitz RL, Apesoa-Varano EC.

Family-centered depression treatment for older men in primary care: a qualitative study of stakeholder perspectives. BMC Fam Pract. Sep 29;18(1):88.

2018 Goldstein E, Murray-García J, Sciolla AF, Topitzes J. Medical Students’ Perspectives

on Trauma-Informed Care Training. Perm J. 22:17-126. E-pub: January 18. 2018 Sciolla AF. Screening for Childhood Adversities in Prenatal Care: What Works and

Why. J Women’s Health (Larchmt). March 19. doi: 10.1089/jwh.2018.6995. [Epub ahead of print].

2018 Yellowlees P, Parish MB, González Á, Chan S, Hilty D, Iosif A-M, McCarron R,

Odor A, Scher L, Sciolla AF, Shore, J, Xiong G. Asynchronous Telepsychiatry: A Component of Stepped Integrated Care. Telemedicine and e-Health. May;24(5):1-4.

Abstracts and Presentations 2017 Sciolla AF. Multicultural Town Hall: Overcoming the Stigma Surrounding Mental

Illness, community panel member, National Alliance on Mental Illness (NAMI), Sacramento, California, July 22.

2017 Sciolla AF. From What’s Wrong with You to What Happened to You. The Science

of Adverse Childhood Experiences and a Trauma-Informed Correctional System, Sacramento Area Re-entry Collaborative, Sacramento County Public Defender, Sacramento, California, August 23.

2017 Sciolla AF. From What’s Wrong with You to What Happened to You. Building a

Trauma-Informed Criminal Justice System. Sacramento County Public Defender, Sacramento, California, September 27.

2017 Sciolla AF. Advances in Integrating Psychotherapeutic and Psychopharmacological

Treatment of PTSD: Providing Trauma-Informed Care, 5th Annual Update and Advances in Psychiatry Conference, University of Wisconsin Department of Psychiatry, Madison, Wisconsin, October 13.

2017 Sciolla AF. The Science of Adverse Childhood Experiences and Trauma-Informed

Health and Justice Systems, McGeorge University School of Law, Sacramento, California, February 9.

2018 Sciolla AF. Interrogating the Science of Resilience and Adversity: Strategies for

Individuals, Families, Communities and Providers to Cope, Grow and Thrive (keynote speaker), NAMI 5th Annual Multicultural Symposium: Diversity in the Face of Adversity, Monterey, California, May 31-June 2.

92

2018 Sciolla AF, Giroux C, Ahlers D, Contreras Arroyo L, Aurora M, Friedrich C, Liu B, Murray S. Challenging Conversations: Communicating Effectively with Clients and Coworkers Utilizing Self-Care, Resilience and Trauma-Informed Approaches, Sacramento Food Bank and Family Services, June 15.

Research Funding 1R01HS021477-01A1, Agency for Healthcare Research and Quality, (Yellowlees P: PI, Sciolla AF: Co-Investigator). 2013 – 2017. A controlled trial of patient centered telepsychiatry interventions. $2.5m Total Direct and Indirect Cost. Mendocino County Champion Project to Reduce Impact of Childhood Trauma (Van Sant M: Co-PI [county partner]; MPH, Choe DE, PhD [academic partner]; Sciolla AF: Co-Investigator), Mendocino County Health and Human Services Agency, 2017 – 2019.

1R01HS024949-01, Agency for Healthcare Research and Quality, (Yellowlees P: PI, Sciolla AF: Co-Investigator). 2016 – 2020. A clinical trial to validate an automated online language interpreting tool with Hispanic patients who have limited English proficiency. $1.92m Total Direct and Indirect Cost.

Community Service Member, Committee on Education Policy Member, Doctoring Steering Committee Member, Faculty Executive Committee Member, Physician Well-Being Committee Reviewer, Academic Medicine Reviewer, Academic Psychiatry Reviewer, Journal of Women’s Health

93

Charles L. Scott, MD Journal Articles 2017 Scott CL, Holoyda BJ: The development of a correctional model mental health

treatment program. Training today provides treaters for tomorrow. Correctional Mental Health Report, Vol. 19, no 2, July/August, 19-22.

2017 McDermott BE, Newman WK, Meyer J, Scott CL, Warburton K: The utility of an

admission screening procedure for patients committee to a state hospital as incompetent to stand trial. Int J Forensic Ment Health, 16:4

Book Chapters 2018 Scott CL: Evaluation of competencies in the criminal justice system. In the APA

Publishing Textbook of Forensic Psychiatry, Third Edition, edited by Liza Gold and Rick Frierson. American Psychiatric Association Publishing, Arlington, VA.

2018 Scott CL: Evaluation of criminal responsibility, In the APA Publishing Textbook of

Forensic Psychiatry, Third Edition, edited by Liza Gold and Rick Frierson. American Psychiatric Association Publishing, Arlington, VA.

2018 Scott CL, Resnick PJ: Risk Assessment: In Applied Criminal Psychology: A guide to

forensic behavioral sciences, Second Edition (Editor: Richard N. Koscis). Charles C. Thomas: Springfield.

Presentations 2017 Juvenile Psychopaths: Can Bad Boys Become Good Men?, Grand Rounds,

Department of Psychiatry and Behavioral Neuroscience, St. Louis University School of Medicine, St. Louis, MO, September.

2017 Psychic Harm and Workers Compensation, American Academy of Psychiatry and the

Law, Denver, CO. 2017 Death Penalty, American Academy of Psychiatry and the Law, Denver, CO. 2017 Correctional Psychiatry, American Academy of Psychiatry and the Law, Denver, CO. 2017 Child Abuse/Child Witness, American Academy of Psychiatry and the Law, Denver,

CO. 2017 Psychiatric Disability, American Academy of Psychiatry and the Law, Denver, CO. 2017 Child Custody, American Academy of Psychiatry and the Law, Denver, CO.

94

2017 Juvenile Court and Minor’s Rights, American Academy of Psychiatry and the Law, Denver, CO.

2017 Right to Treatment, American Academy of Psychiatry and the Law, Denver, CO. 2017 Assessment and Treatment of Problematic Sexual Interests, The American Academy

of Psychiatry and the Law, Denver, CO. 2017 Treatment of ASPD in Corrections: Hopeful or Hopeless?, The American Academy of

Psychiatry and the Law, Denver, CO. 2017 Evaluating Malingered ADHD: Pay Attention!, The American Academy of Psychiatry

and the Law, Denver, CO. 2017 White Collar Crime, The American Academy of Psychiatry and the Law, Denver, CO. 2017 Homicidal Juveniles: Can Bad Boys Be Good Men?, The American Academy of

Psychiatry and the Law, Denver, CO, October. 2017 Psychiatric Training Behind Bars: Challenges and Opportunities, The American

Academy of Psychiatry and the Law, Denver, CO, October. 2017 Taking the Wheel: Psychiatrists’ Duties for Patient Driving, The American Academy of

Psychiatry and the Law, Denver, CO, October. 2017 Assessment and Treatment of Problematic Sexual Interests, The American Academy

of Psychiatry and the Law, Denver, CO, October. 2018 Treatment of ASPD and Psychopathy: Hopeful or Hopeless?, National

Psychopharmacology Update, Las Vegas Psychiatric Association. 2018 Juvenile Sex Offenders, Kerville State Hospital Texas State Conference. 2018 Homicidal and Violent Juveniles, Kerville State Hospital Texas State Conference. 2018 Medication Assisted Treatment, University of California, Davis and The California

Department of State Hospitals Public Forensic Mental Health Forum: Together, Leading the Way, Sacramento, CA.

2018 Sanchez: Implications and Treatment, University of California, Davis and The

California Department of State Hospitals Public Forensic Mental Health Forum: Together, Leading the Way, Sacramento, CA.

Community Service Vice Chair, Institute for Education, American Academy of Psychiatry and the Law Member, Association of Directors of Forensic Psychiatry Fellowships (ADFPF)

95

Member, Government Relations Committee, American Academy of Psychiatry and the Law Member, Institute for Research and Education, American Academy of Psychiatry and the Law Member, Maintenance of Certification Committee, American Academy of Psychiatry and the Law Member, National Awards Committee, American Academy of Psychiatry and the Law Member, National Committee for Evaluation of Sex Offenders, American Academy of Psychiatry and the Law Member, National Education Committee, American Academy of Psychiatry and the Law Member, National Program Committee, American Academy of Psychiatry and the Law Member, Public Relations Committee, American Academy of Psychiatry and the Law Member, Editorial Board, Behavioral Sciences and the Law Member, Editorial Board, Correctional Mental Health Law Reporter Reviewer, Academic Psychiatry Reviewer, American Journal of Psychiatry Reviewer, Behavioral Sciences and the Law Reviewer, Criminal Behavior and Mental Health Reviewer, Journal of the American Academy of Psychiatry and the Law Reviewer, Psychiatric Services Reviewer, The Journal of Forensic Psychiatry

96

Mark Servis, MD Book Editor 2017 McCarron RM, Xiong GL, Keenan CR, Han J, Scher L, Servis M. Psychiatric Aspects

of Preventive Care Study Guide: A Practical Guide for Healthcare Providers. Washington DC: American Psychiatric Press Inc.

Abstracts and Presentations 2017 Servis M. Interprofessional Education: Challenges and Solutions. Webinar. Global

Institute for Simulation Training. 2018 Chandraiah C, Spollen J, Kerlek A, Servis M, Kovach J. Evidence-based recruitment

and advising of future psychiatrists in a changing landscape. Annual Meeting Association for Academic Psychiatry, Milwaukee, WI, 2018.

Community Service Chair, Anatomical Materials Review Committee, UC Davis School of Medicine Chair, Education Council, UC Davis School of Medicine Chair, Learning Climate Committee, UC Davis School of Medicine Chair, Combined Training Task Force, American Association of Directors of Psychiatry Residency Training Member, Alternative Pathway Oversight Committee, American Board of Psychiatry and Neurology Member, American Psychiatric Association Practice Guideline Writing Group on Schizophrenia Member, Block Council, UC Davis School of Medicine Member, Committee on Educational Policy, UC Davis School of Medicine Member, Committee on Student Promotions, UC Davis School of Medicine Member, Curriculum Review Subcommittee, UC Davis School of Medicine Member, Dean’s Council, UC Davis Health Member, Doctoring Steering Committee, UC Davis School of Medicine Member, Executive Leadership Team, UC Davis School of Medicine Member, Fourth Year Oversight Committee, UC Davis School of Medicine Member, Interprofessional Teaching Scholars Advisory Council Member, Office of Continuing Medical Education Advisory Committee, UC Davis Health Member, PRITE Editorial Board, American College of Psychiatrists Member, Recruitment Committee, American Association of Directors of Psychiatry Residency Training Member, Steering Committee, Mentoring Academy, UC Davis Health Member, Third Year Clerkship IOR Committee, UC Davis School of Medicine Member, USMLE Step 2 Interdisciplinary Review Committee, National Board of Medical Examiners (NBME) Responsible Executive Officer and Chair, Human Anatomical Specimen and Tissue Oversight Committee, UC Davis

97

Reviewer, Academic Psychiatry Reviewer, American Journal of Psychiatry

98

Hong Shen, MD Community Service Co-chair, AACAP Adolescent Psychiatry Committee Fellow and Member, American Psychiatric Association Liaison AACAP Representative to The Partnership for Male Youth Member, Advisory Council, The Partnership for Male Youth Member, American Academy of Child and Adolescent Psychiatry Member, Central California Psychiatric Society Member, Central California Regional Organization of Child and Adolescent Psychiatry Member, Chinese Medical Association of California (CAMAC) Member, Sierra Sacramento Valley Medical Society Member, Society of Chinese American Physician Entrepreneurs (SCAPE) Mentor, Klingenstein Fellowship Program Reviewer, Adolescent Psychiatry

99

Ruth S. Shim, MD, MPH Journal Articles 2017 Shim RS and Compton MT. Measuring Up On Mental Health? Lessons Learned from

the Healthy People 2020 Midcourse Review. Psychiatric Times, 34(12). 2018 Shim RS, Compton MT. Addressing the Social Determinants of Mental Health: If Not

Now, When? If Not Us, Who? Psychiatric Services, 69(8):844-846. 2018 Pauselli L, Galletti C, Verdolini N, Paolini E, Gallucci D, Balducci PM, Bernardini F,

Kogan JH, Shim RS, Moretti P, Compton MT. Predictors of Client Satisfaction with Outpatient Mental Health Clinic Services in Italy and New York. Community Mental Health Journal, 54(5):562-570.

2018 Shim RS. The Evolution of Cultural Psychiatry. Psychiatric Annals, 48(3):134-136. 2018 Shim RS, Kho CE, Murray-García J. Inequities in Mental Health and Mental Health

Care: A Review and Future Directions. Psychiatric Annals, 48(3):138-142. Book Chapters 2018 Primm AB, Norris DM, Shim RS. Black Women and Mental Health: Psychosocial

Realities and Clinical Considerations, in Black Mental Health: Patients, Providers, and Systems. Griffith EE, Jones BE, Stewart AJ, Eds. American Psychiatric Publishing.

2018 Shim RS, Compton MT. The Social Determinants of Mental Health, in Textbook of

Psychiatry, 7th Edition. Roberts LW, Ed. American Psychiatric Publishing. Abstracts and Presentations 2017 Population Health Symposium: Integrating the Roles of Behavioral Health and Public

Health, Invited Reaction Panelist, Carter Center, Atlanta, GA.

2017 Big Goals, Small Steps: The Psychiatrist’s Journey to Advocate, Workshop Presenter, American Psychiatric Association IPS: The Mental Health Services Meeting Conference, New Orleans, LA.

2017 Mental Health in All Policies: How to Partner with Lawmakers to Improve Mental

Health Outcomes in Our Communities, Symposium Chair and Presenter, American Psychiatric Association IPS: The Mental Health Services Meeting Conference, New Orleans, LA.

2017 How Many Lawyers Does it Take to Change a Mental Health System? Reflections on

Medical-Legal Partnerships, Workshop Chair, American Psychiatric Association IPS: The Mental Health Services Meeting Conference, New Orleans, LA.

100

2017 Medical Director’s Boot Camp – Special Populations, Invited Course Presenter, American Psychiatric Association IPS: The Mental Health Services Meeting Conference, New Orleans, LA.

2017 Discrimination and the Social Determinants of Mental Health, Invited Presenter, Finger

Lakes Performing Provider System Annual Cultural Competency Conference, Rochester, NY.

2017 The Science of Discrimination: Implications for Mental Health, Grand Rounds, UC

Davis Department of Psychiatry and Behavioral Sciences, Sacramento, CA.

2017 Development of the Community Mental Health System, Invited Presenter, UC Davis Mental Health Symposium, Sacramento, CA.

2017 Career Development Dialogue, Invited Presenter, UC Davis Center Health Justice

Scholars, Sacramento, CA. 2018 Bending the Arc: Striving for Mental Health Equity in Trying Times, Invited Community

Lecture, UC Davis Behavioral Health Center of Excellence, Sacramento, CA.

2018 Social Determinants of Mental Health in Women, Invited Presenter, Women’s Health Conference, University of California, Davis, Napa, CA.

2018 I Am Not Your Negro: Deconstructing Racial Politics (and Implications for Psychiatry)

Through the Psyche of James Baldwin, Media Workshop Co-Chair and Presenter, American Psychiatric Association Annual Meeting, New York, NY.

2018 Warehousing – How Did We Get Here? Cutting Mass Incarceration in the United

States – the Physician’s Responsibility, Media Workshop Presenter, American Psychiatric Association Annual Meeting, New York, NY.

2018 Social Determinants of Mental Health Impact Lab, Presenter, American Psychiatric

Association Annual Meeting, New York, NY.

2018 Mental Health in All Policies: How to Partner with Lawmakers to Improve Mental Health Outcomes, Symposium Chair and Presenter, American Psychiatric Association Annual Meeting, New York, NY.

2018 How Many Lawyers Does It Take to Change a Mental Health System? Reflections on

Medical-Legal Partnerships in Behavioral Health Settings, Workshop Chair and Presenter, American Psychiatric Association Annual Meeting, New York, NY.

2018 Conversations on Diversity, Session Chair, American Psychiatric Association Annual

Meeting, New York, NY.

2018 Discrimination as a Social Determinant of Mental Health, Grand Rounds, Sutter Psychiatric Hospital, Sacramento, CA.

101

2018 Teaching Adults in the Changing Culture of Medicine and Society, Workshop

Presenter, Society for the Study of Psychiatry and Culture, San Diego, CA.

2018 Exploring the Complexity of Cultural Identity and Cultural Stressors/Supports Through the Film The Music of Strangers: Yo-Yo Ma and the Silk Road Ensemble, Workshop Presenter, Society for the Study of Psychiatry and Culture, San Diego, CA.

2018 Preventing Mental Illness: A Public Health Approach, Invited Presenter, Central

California Psychiatric Society 2018 Annual Meeting, Yosemite, CA.

2018 The Social Determinants of Mental Health, Invited Keynote Speaker, National Coalition of 100 Black Women, Inc., Sacramento, CA.

2018 Keynote Presentation: Embracing Our Diversity, Invited Keynote Speaker, Student

National Medical Association 11th Annual Candlelight Dinner, UC Davis, Sacramento, CA.

2018 Discrimination as a Social Determinant of Mental Health, Grand Rounds, UC Davis

Department of Family Medicine, Sacramento, CA.

2018 Addressing the Social Determinants of Mental Health Through Policy and Partnerships, Invited Presenter, Healthcare Policy and Research Series, UC Davis Center for Healthcare Policy and Research, Sacramento, CA.

Research Funding San Joaquin County Behavioral Health Services; San Joaquin County Homeward Bound Evaluation Plan (Shim RS: PI). 3R01MH104235 – 04; National Institute of Mental Health (NIMH), Reducing Duration of Untreated Psychosis through Rapid Identification and Engagement; (Carter C: PI; Shim RS: Co-Investigator). Community Service Chair, Diversity Advisory Committee, UC Davis Department of Psychiatry Chair, Fellowship Committee, Group for the Advancement of Psychiatry Chair, Vice Chancellor’s Advisory Committee on Faculty Excellence in Diversity, UC Davis Vice Chair, IPS: The Mental Health Services Meeting of the APA Scientific Program Committee Distinguished Fellow, American Psychiatric Association Member, American Public Health Association Member, Board of Trustees, American Association of Community Psychiatrists Member, Central California Psychiatric Society Member, Compensation Advisory Committee, UC Davis Health Member, Group for the Advancement of Psychiatry

102

Member, Leaders in Medical Student Education Committee, UC Davis Department of Psychiatry Member, Psychiatric Chair Recruitment Search Committee, UC Davis Member, Residency Education Policy Committee, UC Davis Department of Psychiatry Member, Student Professionalism Improvement Committee, UC Davis Column Co-Editor: “Social Determinants of Mental Health,” Psychiatric Services Member, Editorial Board, Community Mental Health Journal Member, Editorial Board, Psychiatric Services Reviewer, American Journal of Psychiatry Reviewer, Ethnicity and Disease Reviewer, 2017 Deans’ Award for Excellence in Mentoring, UC Davis Health Reviewer, NIH Loan Repayment Program Health Disparities Study Section

103

Jill L. Silverman, PhD Journal Articles 2017 Gompers AL, Su-Feher L, Ellegood J, Copping NA, Stradleigh TW, Zdilar I, Copping

NA, Pride MC, Schaffler MD, Asrafuzzaman M, Gaurav Kaushik R, Mannion B, Plajzer-Frick I, Afzal V, Visel A, Pennacchio LA, Dickel D, Lerch JP, Crawley JN, Zarbalis KS, Silverman JL, Nord AS. Germline Chd8 haploinsufficiency alters brain development in mouse. Nat Neurosci. Aug;20(8):1062-1073. doi: 10.1038/nn.4592. Epub 2017 Jun 26.

2017 Copping NA, Christen SB, Buscher N, Black S, Ellegood J, LaSalle JM, Lerch, J,

Dindot SV, Silverman JL. Selective Neuronal Forebrain Overexpression of Ube3a isoform 2 Causes Cognitive Impairments and Hippocampal Pathology. Human Molecular Genetics. October 15; 26(20):3995-4010.

2018 Keil K, Sethi S, Wilson M, Silverman JL, Pessah I, Lein PJ. Genetic mutations in

Ca2+ signaling alter dendrite morphology and social approach in juvenile mice. Genes, Brain and Behavior. doi: 10.1111/gbb.12526.

2018 Laman-Maharg A, Williams AV, Zufelt MD, Minie VA, Ramos-Maciel S, Hao R,

Ordoñes Sanchez E, Copeland T, Silverman JL, Leigh A, Snyder R, Carroll FI, Fennell TR, Trainor BC. Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test. Frontiers in Pharmacology. Feb 14;9:93.

2018 Matt L, Kirk LM, Chenaux G, Speca DJ, Puhger KR, Pride MC, Qneibi M, Haham T,

Plambeck KE, Stern-Bach Y, Silverman JL, Crawley JN, Hell JW, Díaz E. SynDIG4/Prrt1 Is Required for Excitatory Synapse Development and Plasticity Underlying Cognitive Function. Cell Reports. Feb 27;22(9):2246-2253.

2018 Berg EL, Pride MC, Rivera JK, Careaga M, Lein PJ, Harony-Nicolas H, Buxbaum JD,

Ellegood J, Lerch, JP, Wohr M, Silverman JL. Developmental Social Communication Deficits in the Shank3 deficient Rat Model of Phelan-McDermid Syndrome and Autism Spectrum Disorder. Autism Res. 2018 Apr;11(4):587-601. doi: 10.1002/aur.1925.

2018 Silverman JL, Ellegood J. Behavioral and Neuroanatomical Approaches in Models of

Neurodevelopmental Disorders: Opportunities for Translation. Current Opinion in Neurology. Apr;31(2):126-133.

2018 Adhikari A, Copping NA, Onaga B, Pride MC, Coulson R, Yasui D, LaSalle JM, Yang M, Silverman JL. Cognitive Deficits in the Snord116 Deletion Mouse Model for Prader-Willi Syndrome. Neurobiol Learn Mem. 2018 May 23. (18)30119-9. doi: 10.1016/j.nlm.2018.05.011.

104

2018 Jones KL, Pride MC, Edmiston E, Yang M, Silverman JL, Crawley JN, Van de Water J. Autism-specific maternal autoantibodies produce behavioral abnormalities in an endogenous antigen-driven mouse model of autism. Mol Psychiatry. 2018 Jun 28. doi: 10.1038/s41380-018-0126-1. PMID: 29955164.

2018 Velíšková J, Silverman JL, Benson M, Lenck-Santini PP. Autistic traits in epilepsy

models: Why, when and how? Epilepsy Res. Aug;144:62-70. doi: 10.1016/j.eplepsyres.2018.05.009. Epub 2018 May 18. Review.

2018 Kelly E, Schaeffer SM, Dhamne SC, Lipton JO, Lindemann L, Honer M, Jaeschke G,

Super CE, Lammers SH, Modi ME, Silverman JL, Dreier JR, Kwiatkowski DJ, Rotenberg A, Sahin M. mGluR5 Modulation of Behavioral and Epileptic Phenotypes in a Mouse Model of Tuberous Sclerosis Complex. Neuropsychopharmacology. 2018 May;43(6):1457-1465. doi: 10.1038/npp.2017.295.

Abstracts and Presentations 2017 Invited Speaker, Duplication 15q Syndrome Alliance’s Scientific Meeting, Los Angeles,

CA. July. 2017 Invited Speaker, Angelman Syndrome Biomarker and Outcome Measure Alliance’s

(A-BOM) Scientific Meeting, Chicago, IL. December. 2018 Foundation for Angelman Syndrome Therapeutics (FAST) Annual Scientific Meeting,

Invited Speaker, Innovative Outcome Measures Using Preclinical Models of Genetic Neurodevelopmental Disorders, College Station, TX. March.

2018 Pride MC, Silverman JL. Automated Motor Outcomes in Genetic Mouse Models of

Neurodevelopmental Disorders. International Behavioral Neuroscience Society (IBNS), Boca Raton, FL.

2018 Speaker, Touchscreen Learning in Genetic Mouse Models of Neurodevelopmental

Disorders, International Behavioral Neuroscience Society (IBNS), Boca Raton, FL. June.

2018 Symposium Co-Chair, Speaker, Social communication deficits in genetic models of

neurodevelopmental disorders, International Behavioral Neuroscience Society (IBNS), Boca Raton, FL. June.

Research Support 1R01NS097808-01A1, NIH/NINDS, Phenotypic Characterization of Novel Models of Dup15q Syndrome. (Silverman JL: PI). Foundation for Angelman Syndrome for Therapeutics (FAST) Evaluation of IGF2 efficacy in Models of Angelman Syndrome. (Silverman JL: PI).

105

Foundation for Angelman Syndrome for Therapeutics (FAST), Expression of UBE3A via lentivector delivery in blood cells to treat Angelman Syndrome. (Anderson, Segal, Silverman JL: Multi-PIs). California Institute for Regenerative Medicine (CIRM), MSC delivery of an artificial transcription factor to the brain as a treatment for Angelman Syndrome. (Segal: PI; Silverman JL: Co-Investigator). MIND Institute Intellectual and Developmental Disabilities Research Center Pilot, Development of a rat model for fragile X-associated disorders. (Silverman JL: PI; Hagerman P, Lein P: Co-Investigators). National Institute of Child Health and Human Development, MIND Institute Center for Excellence for Intellectual Disabilities, IDDRC, (Abbeduto L: PI; Silverman JL: Co-Investigator). NINDS 1U54NS079202-07, CounterAct Center, Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication, (Lein: PI; Silverman JL: Co-Investigator). Community Service Chair, Training and Education, International Behavioral Neuroscience Society Council Member, International Behavioral Neuroscience Society Grant Reviewer, Dup15q Alliance, 2017 Pre- and Postdoctoral Training Fellowships Grant Reviewer, RFA Research Grants, Autism Science Foundation Member, NJ Governor’s Council on Autism Research Member, Scientific Advisory Board, Foundation for Angelman Syndrome Therapeutics Member, Editorial Board, Neurotoxicology Peer Reviewer: Autism Research Peer Reviewer: Behavioural Brain Research Peer Reviewer: Biological Psychology Peer Reviewer: Biological Psychiatry Peer Reviewer: Brain and Behavior Peer Reviewer: eNeuro Peer Reviewer: Genes, Brain and Behavior Peer Reviewer: Journal of Autism and Neurodevelopmental Disorders Peer Reviewer: Journal of Pharmacology and Experimental Therapeutics Peer Reviewer: Molecular Autism Peer Reviewer: Molecular Psychiatry Peer Reviewer: Nature Peer Reviewer: Nature Neuroscience Peer Reviewer: Neuropsychopharmacology Peer Reviewer: Neuropharmacology Peer Reviewer: Neurotoxicology Peer Reviewer: Pharmacology Biochemistry and Behavior Peer Reviewer: Physiology and Behavior Peer Reviewer: Scientific Reports

106

Peer Reviewer: Toxicology Peer Reviewer: Toxicology and Applied Pharmacology Peer Reviewer: Translational Psychiatry

107

Tony J. Simon, PhD Journal Articles 2017 Guo, T. et al. Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the

22q11.2 Deletion Syndrome Identifies Variants in the GPR98 Locus on 5q14.3. Circ Cardiovasc Genet 10, e001690.

Abstracts and Presentations 2017 A Potential Digital Therapy for Brain Injury Induced Spatial and Temporal Cognitive

Impairments. 18th Annual University of California, Davis, Office of Research Expo. September.

Research Funding 1R43AG058287, NIH/NIA, 9/15/17-8/31/18, $99,967. Developing and testing a neurotherapeutic treatment to improve spatiotemporal cognition in seniors. Subcontract to Cognivive, Inc. (Simon TJ: CEO), Aronson T. Community Service Member, Autism Summit Infrastructure Working Group, University of California Member, Leadership Team of MIND International Training Program in Neurodevelopmental Disorders (ITPND) Working Group Member, Mentoring Academy, University of California Davis Schools of Health Member, MIND Institute Executive Committee Member, MRI Safety Committee, Imaging Research Center, University of California, Davis Member, Research Advisory Committee, Department of Psychiatry and Behavioral Sciences, University of California, Davis Review Editor, Journal of Neurodevelopmental Disorders Review Editor, Frontiers in Child and Neurodevelopmental Psychiatry Member, Editorial Board, Frontiers in Genetic Disorders

108

Elizabeth Solomon, PsyD

Community Service 5150 Designee, Sacramento County Children’s Behavioral Health Program Member, American Psychological Association (Div. 53 Society of Clinical Child and Adolescent Psychology) Member, California Psychological Association Member, Sacramento Valley Psychological Association Member, Society of Women in Academic Psychiatry (SWAP), UC Davis Medical Center Member, Training and Program Development, UC Davis Medical Center Clinical Psychology Training Programs

109

Marjorie Solomon, PhD, MBA Journal Articles 2017 McCauley JB, Harris MA, Zajic MC, Swain-Lerro LE, Oswald T, McIntyre, N.

Trzesniewski K, Mundy P, Solomon M. Self-esteem, internalizing symptoms, and theory of mind in youth with autism spectrum disorder. Journal of Clinical Child Psychology, October 19:1-12. PMID: 29048245.

2018 Benyakorn S, Calub CA, Riley SJ, Schneider A, Iosif AM, Solomon M, Hessl D,

Schweitzer JB. Computerized Cognitive Training in children with Autism and Intellectual Disabilities: Feasibility and Satisfaction Study. JMIR Mental Health, 5(2). PMID: 29802090.

2018 Hogeveen J, Krug MK, Elliott MV, Carter CS, Solomon M. Proactive Control as a

Double-Edged Sword in Autism Spectrum Disorder. Journal of Abnormal Psychology. 84(4),

287-294. PMID: 29523413.

2018 Hogeveen J, Krug MK, Elliott MV, Solomon M. Insula-Retrosplenial Cortex Overconnectivity Increases Internalizing Via Reduced Insight in Autism. Biological Psychiatry, 84(4), 287-294. PMID: 29745707.

2018 Oswald TM, Winder-Patel B, Ruder S, Xing G, Stahmer A, Solomon M. A Pilot

Randomized Controlled Trial of the ACCESS Program: A Group Intervention to Improve Social, Adaptive Functioning, Stress Coping, and Self-Determination Outcomes in Young Adults with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders, 48(5), 1742-1760. PMID: 29234931.

2018 Guoynes CD, Simmons TC2, Downing GM, Jacob S, Solomon M. Bales KL. Chronic

Intranasal Oxytocin has Dose-dependent Effects on Central Oxytocin and Vasopressin Systems in Prairie Voles (Microtus ochrogaster). Neuroscience, 369, 292-302, PMID: 29183825.

2018 McCauley JB, Zajic MC, Oswald TM, Swain-Lerro LE, McIntyre NC, Harris MA,

Trzesniewski K, Mundy PC, Solomon M. Investigating Relations Between Self-Concept and Performance in Reading and Math for School-Aged Children and Adolescents with Autism Spectrum Disorder. Journal of Autism Developmental Disorders, 48(5). 1825-1832. PMID: 29168089.

2018 Solomon M, Iosif AM, Reinhardt VP, Libero LE, Nordahl CW, Ozonoff S, Rogers,

SJ, Amaral DG. What will my child’s future hold? Phenotypes of intellectual development in 2-8 year olds with autism spectrum disorder. Autism Research, 11(1):121-132. PMID: 29076255.

110

Book Chapters 2018 McCauley JB, Mundy PC, Solomon M. Parenting and Autism Spectrum Disorder. In

Bornstein, MH. (ed.) Handbook of Parenting 3rd Ed, Volume 1: Children and Parenting.

2018 Timmer S, Hawk B, Tudor ME, Solomon, M. Reflections on the First Efficacy Study of

Parent-Child Interaction Therapy with Children Diagnosed with Autism Spectrum Disorder. In CB McNeil, LB Quetsch, C Anderson (Eds.), Handbook on Parent-Child Interaction Therapy for Children on the Autism Spectrum. New York, NY: Springer.

Abstracts and Presentations 2017 Solomon M, Ruder S. ACCESS Design and Results. Invited address to the UCEDD

Community Advisory Committee. Sacramento, California. September. 2017 Solomon M. Helping adults with ASD to achieve their life goals: the ACCESS

program. Invited address to the 12th Annual Psychotic Disorders Conference. Sacramento, California. November.

2017 Solomon M, Elliott M, Krug MK, Coleman CC, Farren J, Ragland JD, Niendam TA,

Carter CS. Adolescents and Young Adults with Autism Spectrum Disorder Show Differences in Dynamics and Recruitment of Cognitive Control Networks. Poster presented at the American College of Neuropsychopharmacology, Palm Desert, California. December.

2018 Solomon M. Beyond social deficits: How understanding cognitive development in

autism spectrum disorders can provide clinically-relevant insights. Invited address to Child and Adolescent Psychiatry Department, NYU. New York, New York. March.

2018 Solomon M, Krug MK, Coleman C, Elliott MV, Hogeveen J, Niendam TA, Ragland

JD, Carter CS. Adolescents and Young Adults with Autism Spectrum Disorder Show Differences in Dynamics and Recruitment of Cognitive Control Networks. Poster presented at INSAR. Rotterdam, Netherlands. May.

2018 Reinhardt VP, McCauley JB, Nordahl CW, Amaral DG, Solomon M. Examining

Reciprocal and Predictive Relations Among Social, Language and Emotion Regulation Skills across Early Childhood in a Longitudinal Sample of Children with ASD. Poster presented at INSAR. Rotterdam, Netherlands. May.

2018 Nordahl CW, Iosif AM, Young GS, Hechtman AL, Heath B, Reinhardt VP,

Amaral DG, Ozonoff SJ, Solomon M. Poster presented at INSAR. Rotterdam, Netherlands. May.

2018 Libero L, Winder-Patel B, Solomon M, Nordahl CW, Amaral DG. Differences in the

Anxiety Profiles of Middle Childhood Boys and Girls with ASD. Poster presented at INSAR. Rotterdam, Netherlands. May.

111

2018 Solomon M, Ring M. Memory in ASD: Spared or Impaired? Insights from Behavioral

and Neuroimaging Studies. Special Interest Group panel accepted to International Meeting for Autism Research. Rotterdam, Netherlands. May 2018.

2018 Solomon M. The Specifying and Treating Anxiety in Autism Research (STAAR)

Clinical Trial. Anxiety Pre-Meeting. International Meeting for Autism Research. Rotterdam, Netherlands. May 2018.

2018 Solomon, M. The Specifying and Treating Anxiety in Autism Research (STAAR) Clinical Trial. NIH ACE Centers Annual Meeting. Bethesda, Maryland. June.

Research Funding NIMH, 1R01MH103284, 9/2014-8/31/19. Predictors of Cognitive Development in Autism Spectrum Disorder. The goal of this study is to evaluate early neural predictors for middle childhood cognitive outcomes in a longitudinal study of children with ASD. (Solomon M: PI). NIH, 1R01MH103371, 4/01/15–03/31/20. Neurophenotypic Trajectories and Behavioral Outcomes in Autism Spectrum Disorder. The goal of the research is to determine whether identified neural phenotypes persist into middle childhood and are associated with the quality and severity of core and co-morbid behavioral impairments related to ASD. (Amaral DG: PI; Solomon M: Co-Investigator). NIMH, 1R01MH106518, 1/01/16-12/31/21. Neurodevelopment of cognitive control in autism: adolescence to young adulthood. This study would examine the adolescent to young adulthood development of cognitive control and its relationship to functional outcomes using fMRI and behavioral measures. (Solomon M: PI) NICHD 1 P50 HD093079-01, 10/01/17-09/30/22. Center for the Development of Phenotype-Based Treatments of ASD. Project #1: (Solomon M: PI) Specifying and Treating the Anxiety Phenotype in ASD. The Aims of this project are to: Aim #1: To use enhanced clinical evaluations of children with ASD, particularly those with intellectual disability, to better characterize the sub-group that exhibits clinically significant anxiety. Aim #2: To conduct a 16-week randomized comparative treatment trial of Behavioral Intervention for Anxiety in Children with Autism (BIACA), sertraline, and pill placebo in youth with ASD. Aim #3: To use fMRI to investigate neural predictors of treatment efficacy, markers of treatment-induced change, and signatures of anxiety sub-types defined in Aim 1. 1UG3OD023365-01, 9/1/18-8/31/23. Pre-adolescent and late-adolescent follow-up of the CHARGE study children. The UC Davis ECHO ReCHARGE Study will follow a cohort of children last seen at ages 2-5 years (‘baseline’) to determine environmental chemical and non-chemical stressors and resiliency factors that are associated with neurodevelopmental outcomes at ages 8-12 years (pre-adolescent) and 15-19 years (mid-to-late adolescence). (Hertz-Picciotto: PI; Solomon M: Co-Investigator).

112

Community Service Member, Clinic Advisory Committee, MIND Institute Member, Executive Committee, MIND Institute Member, Selection Committee, UC Davis Medical School Admissions Member, Space Committee, MIND Institute Representative, Department of Psychiatry, UC Davis Academic Senate Member, Editorial Board, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Reviewer, American Journal of Psychiatry Reviewer, Archives of General Psychiatry Reviewer, Autism Research Reviewer, Biological Psychiatry Reviewer, Journal of Autism and Developmental Disorders Reviewer, Neuropsychologia

113

Aubyn C. Stahmer, PhD, BCBA-D Journal Articles 2017 May L, Shigyo K, Stahmer AC, Yadav K. Pre-implementation assessment of an

antimicrobial stewardship program for acute respiratory infections within emergency and urgent care settings. Open Forum Infectious Diseases, 4 (1), S261 https://doi.org/10.1093/ofid/ofx163.572.

2017 Oswald TM, Winder-Patel B, Ruder S, Xing G, Stahmer AC, Solomon M. A pilot

randomized controlled trial of the ACCESS Program: A group intervention to improve social, adaptive functioning, stress coping, and self-determination outcomes in young adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, online first, http://link.springer.com/article/10.1007/s10803-017-3421-9.

2017 Dickson KS, Suhrheinrich J, Rieth SR, Stahmer AC. Parent and Teacher

Concordance of Child Outcomes for Youth with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders, online first, http://link.springer.com/article/10.1007/s10803-017-3382-z.

2017 Stahmer AC, Brookman-Frazee L, Rieth SR, Stoner JT, Feder JD, Searcy K, Wang T. Parent perceptions of an adapted evidence-based practice for toddlers with autism in a community setting. Autism: International Journal of Research and Practice, 21(2), 217-230. PMCID:PMC5083231 ERIC: ED566966.

2018 Nuske H, Hassrick EM, Bronstein B, Hauptman L, Aponte C, Levanto L, Stahmer AC,

Mandell DM, Mundy P, Kasari C, Smith T. Broken bridges: New school transitions for students with Autism Spectrum Disorder: A systematic review on difficulties and strategies for success. Autism: International Journal of Research and Practice. Online First, February, doi/full/10.1177/1362361318754529.

2018 Pellicano L, Bölte S, Stahmer AC. [Editorial] A new era for autism research, and for

our journal. Autism: International Journal of Research and Practice. Online First, March 30.

2018 Pellecchia M, Nuske HJ, Straiton D, Hassrick EM, Gulsrud A, Iadarola S, Vejnoska

SF, Bullen B, Haine-Schlagel R, Kasari C, Mandell DS, Smith T, Stahmer AC. Strategies to engage underrepresented parents in child intervention services: A review of effectiveness and co-occurring use. Journal of Child and Family Studies. Online First June, 19. https://doi.org/10.1007/s10826-018-1144-y.

2018 Brookman-Frazee L, Stahmer AC. Effectiveness of a Multi-Level Implementation

Strategy for ASD Interventions: Study Protocol for Two Linked Cluster Randomized Trials, Implementation Science, 13:66. https://doi.org/10.1186/s13012-018-0757-2.

114

2018 Rieth SR, Haine-Schlagel R, Burgeson M, Searcy K, Dickson KS, Stahmer AC. Integrating a parent-implemented blend of developmental and behavioral intervention strategies into speech-language treatment for toddlers at risk for autism spectrum disorders. Seminars in Speech and Language (39), 1-11.

2018 Stahmer AC, Suhrheinrich J, Schetter P, McGhee Hassrick E. Exploring Multi-level

System Factors Facilitating Educator Training and Implementation of Evidence-Based Practices (EBP): A Study Protocol. Implementation Science. https://doi.org/10.1186/s13012-017-0698-1.

2018 Gomez E, Drahota A, Stahmer AC. Developing community-academic partnerships-

Choosing strategies that work right from the start: A mixed methods study. Action Research Journal. Online First, DOI: 10.1177/1476750318775796.

2018 Pellicano L, Mandy W, Bölte S, Stahmer AC, Lounds Taylor J, Mandell D. [Editorial] A

new era for autism research, and for our journal. Autism: International Journal of Research and Practice, 22, 82-83.

Book Chapters 2018 Rieth SR, Stahmer AC, Brookman-Frazee LI. A Community Collaborative Approach

to Scaling-Up Evidence-Based Practices: Moving Parent-Implemented Interventions from Research to Practice. In M. Siller, L. Morgan (Eds.), Handbook of Family-Centered Practice for Very Young Children with Autism. New York: Springer.

2018 Lee LC, Stahmer AC, Wu CC, Tsai PC, Chiang CH. Home-based, parent-

implemented intervention for underserved families in Taiwan. In M. Siller, L. Morgan (Eds.), Handbook of Family-Centered Practice for Very Young Children with Autism. (pp. 385-391). New York: Springer

Abstracts and Presentations 2017 Understanding Autism Through a Cultural Lens Access to ASD Services in

Underserved Communities. International Society for Autism Research Summer Institute, Webinar, July.

2017 Navigating a New Autism Diagnosis. Minds Behind the MIND, October. 2018. Autism Updates: Understanding Advances in Psychosocial Treatment of ASD, Clinical

and Bridging the Gap: Molecular and Interventional Advances in Autism, Manila, Philippines, March.

2018 Stahmer AC. Reaching Children Where they Are: The Promise and Challenge of

School-Based Interventions for Autism (Chair: Kenworthy L.). Panel discussant at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

115

2018 Rieth SR, Stahmer AC, Dickson KS, Searcy KL, Feder J, Brookman-Frazee L. Building Community Capacity for Evidence-based, Parent-Mediated Early Intervention: Effectiveness of a Train-the-Trainer Approach. Paper presented as part of a panel Developing ASD Interventions for End-Users: Examining the Process and Impacts of Training Providers in Multiple Community Service Systems (Chair: Brookman-Frazee L.) at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

2018 Stahmer AC, Suhrheinrich J, Rieth S, Roesch S. Examining Effectiveness of

Classroom Pivotal Response Teaching in Public Schools. Paper presented as part of a panel Developing ASD Interventions for End-Users: Examining the Process and Impacts of Training Providers in Multiple Community Service Systems (Chair: Brookman-Frazee L.) at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

2018 Vejnoska SF, Dickson KS, Rieth S, Suhrheinrich J, Stahmer AC. Characterizing

Disparities in Special Education Classroom Quality for Students with Autism. Poster presented at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

2018 Aranbarri A, Stahmer AC, Acha J, Arranz E, Miller ME, Talbott MR, Rogers S J. A

New Tool to Assess Family Context Features that Promote the Early Development of Young Children at-risk for ASD. Poster presented at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

2018 Straiton D, Pellecchia M, Nuske HJ, McGhee Hassrick E, Gulsrud A, Iadarola S,

Vejnoska SF, Bullen B, Haine-Schlagel R, Kasari C, Mandell D, Smith T, Stahmer AC. Strategies to Engage Under Represented Parents in Child Intervention Services: A Review of Effectiveness and Use. Poster presented at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

2018 Sparapani N, Towers L, Traser J, Suhrheinrich J, Rieth SR, Stahmer AC. Analysis of

Teacher-Student Interactions Within Classroom Activities: Implications for Effective Instructional Practices. Poster presented at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

2018 Bronstein B, Nuske HJ, McGhee Hassrick E, Hauptman L, Aponte CA, Levato

L, Stahmer AC, Mandell DS, Mundy P, Smith T. Broken Bridges: New School Transitions for Students with Autism Spectrum Disorder: A Review on Difficulties and Strategies for Success. Poster presented at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

2018 McGhee Hassrick E, Iadarola S, Friedman C, Shamsi Z, Chow J, Hauptman L,

Bronstein B, Fitzgerald A, Carley K, Linares D, Stahmer AC, Mandell D, Mundy P, Smith T, Kasari C. Pilot Data Findings: Mapping Transition Network Dynamics for Low

116

Resource Parents of Children with ASD during School Transitions. Paper presented at the Annual Meeting of the International Society for Autism Research, Rotterdam, Netherlands. May.

Research Funding R324A140005, ended June 2018, ($2,545,268). U.S. Department of Education Grant: Examining the Efficacy of Classroom Pivotal Response Teaching in Classroom Environments, University of California, San Diego. (Stahmer AC: PI). Autism Speaks Grant: 8136 Training Community Providers to Implement an Evidence-Based Early Intervention Program. University of California, Davis. ($449,181). (Stahmer AC: PI). R324A140004, ended December 2017, U.S. Department of Education Grant: Adapting an Evidence-Based Program for Infants and Toddlers at High Risk for Autism. University of California, Davis. ($1,155,999). (Stahmer AC: PI). 4R33MH097033-03, ($861,835). NIMH Research Grant: U.S.P.H.S. Optimization of Fidelity Procedures for Pivotal Response Training in Autism. University of California, Davis. (Stahmer AC: Site PI). 200-2016-91951, ($544,013). CDC contract: A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Tract Infection for Adults and Children in Emergency Department and Urgent Care Settings. (May L: PI; Stahmer AC: Investigator). R324A150211, University of California, Davis, ($1,495,156).U.S. Department of Education Grant: Adapting an Evidence-based Practice for Children At-Risk for Autism for Diverse Early Intervention Service Systems. (Rogers S: PI; Stahmer AC: Co-Investigator). 2 UA3MC 11055-077-00, Human Resources Services Agency (HRSA): Autism Intervention Research Network for Behavioral Health 3, University of California, Davis ($1,751,020). (Stahmer AC: Site PI). 16-031, Human Resources Services Agency (HRSA): Leadership Education In Neurodevelopmental and Related Disorders.(Rogers S: PI; Stahmer AC: Co-Principal Investigator). 1R01MH111981, ($2,753,311). National Institute of Mental Health (NIMH): 2/2 Effectiveness of a Multi-Level Implementation Strategy for ASD Interventions. (Collaborative R01; Brookman-Frazee; UCSD), University of California, Davis. (Stahmer AC: PI). 1R01HD093457-01, National Institute of Mental Health (NIMH) Autism Center of Excellence Network Award. Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes, University of California, Davis / Drexel ($3,139,397). (Robins D: PI; Stahmer AC: Site PI).

117

R324A170063, U.S. Department of Education Grant: Exploring Mulit-level System Factors Facilitating Educator Training and Implementation of Evidence-Based Practices (EBP). ($1,397,241). (Stahmer, AC: PI) Community Service Editor, Autism: The International Journal of Research and Practice External Member, Interagency Autism Coordinating Committee (IACC) Services Working Group Member, Advisory Board, Hands in Autism Interdisciplinary Training and Resource Center, Indiana University Member, Child Care Administrative Advisory Committee (CCAAC) Member, ClinX Faculty Search Committee, Department of Psychiatry and Behavioral Sciences, UC Davis Member, Editorial Board, Journal of Early Intervention Member, Faculty Search Committee, Department of Psychiatry and Behavioral Sciences, UC Davis Member, Program Committee, International Meeting for Autism Research Member, Research Advisory Committee (RAC), Department of Psychiatry and Behavioral Sciences, UC Davis Member, Research Leadership Team, California Autism Professional Training and Information Network (CAPTAIN) Member, Research Space Allocation Committee, MIND Institute Member, Standing Study Section, Mental Health Service Research Committee Member, Executive Committee, MIND Institute Center for Excellence in Developmental Disabilities

118

Shannon Suo, MD Journal Articles 2017 Suo S, McCarron RM, Parish M. Fellowship Expands Behavioral Health Care Where

Needed the Most, Psychiatric News. Published online: December 08. Book Chapters 2018 Suo S, Chada P. Obsessive-Compulsive and Related Disorders in Older Age. In

Textbook of Geriatric Psychiatry (Eds. Hategan A, Bourgeois J, Hirsch C, Giroux C), Springer International Publishing.

Abstracts and Presentations 2017 Invited keynote speaker, Building Wellbeing through Innovation, California Psychiatric

Association Annual Meeting, Yosemite, CA, October. 2017 Panelist, The Why and How of Organized Psychiatry, California Psychiatric

Association Annual Meeting, Yosemite, CA, October. 2018 Presenter, Personality Disorders in Primary Care: Just What you Need to Know,

California Psychiatric Association, Essentials of Primary Care Psychiatry, Las Vegas, NV, January.

2018 Presenter, Prevention Implementation in Psychiatry, Central California Psychiatric

Society Annual Meeting, Yosemite, CA, April. 2018 Presenter, Of Sound Mind: Planning for Mental Health and Wellbeing, American

Planning Association California Conference, Sacramento, CA, September. 2018 Presenter, Why (and How) Combined Training? Insights from People Who’ve Been

There to Help People Who Might Like to Go There, American Association of Directors of Psychiatry Residency Training Annual Meeting, New Orleans, LA, March.

2018 Panelist, What does culture mean? Clinical, research, training, and policy

perspectives, Society for the Study of Psychiatry and Culture Annual Meeting, San Diego, April.

2018 Moderator, Teaching Adults in the Changing Culture of Medicine and Society, Society

for the Study of Psychiatry and Culture Annual Meeting, San Diego, April. 2018 Presenter, Exploring the Complexity of Cultural Identity and Cultural

Stressors/Supports through the film The Music of Strangers: Yo-Yo Ma and the Silk Road Ensemble, Society for the Study of Psychiatry and Culture Annual Meeting, San Diego, April.

119

2018 Presenter, Women and Money, American Psychiatric Association Annual Meeting, New York, NY, May.

Community Service Chair, Bylaws Committee, Central California Psychiatric Association Co-chair, Committee on Integrated Care, California Psychiatric Association Co-chair, Educational Committee, Essentials of Primary Care Psychiatry CME Conference Co-chair, Membership Committee, Association of Medicine and Psychiatry Deputy Representative to Assembly, Central California Psychiatric Society, American Psychiatric Association Representative to Assembly, Central California Psychiatric Society, American Psychiatric Association – as of 5/2018 Member, Communications Committee, Society for the Study of Psychiatry and Culture Member, Doctoring Steering Committee, UC Davis School of Medicine Member, Pharmacy and Therapeutics Committee, Sacramento County Mental Health Member, Third year Instructors of Record Committee, UC Davis School of Medicine Member, Vice Chancellor’s Advisory Committee for Women in Medicine and Health Sciences, UC Davis Health Newsletter editor, Society for the Study of Psychiatry and Culture Secretary, Board of Directors, Paul Hom Asian Clinic (UC Davis student-run clinic)

120

Laura Magdalen Tully, PhD Journal Articles 2018 Tully LM, Boudewyn MA. Creating a Novel Experimental Paradigm: A Practical

Guide, Sage Research Methods Cases. January. 2018 Niendam TA, Tully LM, Iosif AM, Kumar D, Nye KE, Denton JC, Zakskorn LN,

Fedechko TL, Pierce K. Enhancing early psychosis treatment using smartphone technology: A longitudinal feasibility and validity study Journal of Psychiatric Research, 96, 239-246. doi: 10.1016/j.jpsychires.2017.10.017. January.

2018 Mukerji CE, Lincoln SH, Tully LM, Hooker CI. Neural Simulation mechanisms and

their relations to socioemotional function in schizophrenia. Psychiatry Research: Neuroimaging, 271, 34-42. doi: 10.1016/j.pscychresns.2017.10.006. January.

2018 Kumar D, Tully LM, Iosif AM, Zakskorn L N, Nye KE, Zia A. Implementing a Mobile

Health Platform for Clinical Monitoring in Community-Based Outpatient Early Psychosis Care. JMIR Mental Health, 5(1), e15. doi: 10.2196/mental.8551 PMCID: PMC5849797. February.

2018 Tully LM. Testing Causal Relationships Between Emotion Processing Circuitry and

Behavior using Non-Invasive Brain Stimulation. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 3(4), 305-307. doi: 10.1016/j.bpsc.2018.03.001. April.

2018 Smucny J, Lesh TA, Iosif AM, Niendam TA, Tully LM, Carter CS. Longitudinal

Stability of Cognitive Control in Early Psychosis: Non-Degenerative Deficits Across Diagnoses. Journal of Abnormal Psychology. doi: 10.1037/abn0000356. [Epub ahead of print]. May.

Abstracts and Presentations 2017 Zakskorn LN, Kymba HV, Morrison MC, Sellers AM, Rahim R, Carter CSC, Tully LM.

Sex differences in reactivity to and regulation of negative social evaluation in healthy individuals and individuals with psychosis. Society for Research in Psychopathology ’17 Meeting [poster]. September.

2017 Tully LM, Zakskorn LN, Skymba HV, Morrison MC, Sellers AM, Rahim RA. The

SocialStim: A video database of positive and negative social evaluation stimuli for use in social cognitive neuroscience paradigms. Society for Research in Psychopathology ’17 Meeting [poster]. September.

2017 Saxena A, Haut K, Nook E, Dodell-Feder D, Tully LM, Germine LT, Hooker CI.

Relationship between emotional granularity and functioning in psychosis and health adults. Society for Research in Psychopathology ’17 Meeting [poster] September.

121

2017 Tully LM. Implementing Mobile Health Platforms in Early Psychosis Care. Technology in Psychiatry Summit, McLean Hospital, Harvard Medical School, Boston, MA [invited talk]. November.

2018 Tully LM, Niendam TA, Hidalgo-Mazzei D, Alvarez-Jimenez M. Innovative

approaches to early identification and treatment: using mobile health technology to improve outcomes in psychosis. Annual Schizophrenia International Research Society meeting. Florence, Italy. [Symposium Chair]. April.

2018 Tully LM, Iosif AM, Zakskorn LN, Kumar D, Nye K, Zia A, Denton JC, Pierce K,

Fedechko TL, Niendam TA. Enhancing Early Psychosis Treatment: Integration of a Mobile Health Platform into Four Early Psychosis Programs. Annual Schizophrenia International Research Society meeting. Florence, Italy [symposium]. April.

2018 Niendam TA, Bolden KA, Sardo AC, Botello R, Liles BD, Blacker DM, Tully LM.

An integrated cognitive behavioral approach to address comorbid trauma ad psychosis within coordinated specialty care. IEPA 11th Annual International Conference on Early Intervention and Prevention in Mental Health [poster]. October.

Research Funding Joe P. Tupin Research Award, 7/1/17 – 6/30/18; $73,455 total direct. [NCE through 6/30/19].

tDCS treatment of frontal-limbic dysfunction in cognitive control of emotion in schizophrenia. (Tully, LM: PI).

K12 HD051958, 8/1/17 – 7/31/20, $389,972 total direct. Building Interdisciplinary Research Careers in Women’s Health. Neural mechanisms underlying higher rates of psychotic and mood symptoms in women with schizophrenia. (Tully LM: BIRCWH K Awardee; Gold: PI) Community Service Member, Bioethics Consultation Committee, UC Davis Medical Center Member, Medical Staff Well-Being Committee, UC Davis Medical Center Reviewer, Biological Psychiatry Reviewer, Biological Psychiatry, Cognitive Neuroscience and Neuroimaging Reviewer, Brain and Cognition Reviewer, Cortex Reviewer, Early Intervention in Psychiatry Reviewer, Frontiers in Human Neuroscience Reviewer, Journal of Abnormal Psychology Reviewer, Journal of Medical Internet Research (JMIR) Reviewer, Psychiatry Research Reviewer, Psychiatry Research: Neuroimaging Reviewer, Schizophrenia Bulletin Reviewer, Schizophrenia Research Reviewer, The Lancet Psychiatry Reviewer, The Journal of Clinical Psychiatry

122

Paula Wadell, MD Journal Articles 2017 Mili FM, Allen T, Wadell P, Hooper WC, De Staercke C, Bean CJ, Austin H, Wenger

N. VKORC1-1639A allele influences warfarin maintenance dosage among Blacks receiving warfarin anticoagulation: a retrospective cohort study. Future Cardiology. 8 December.

Presentations 2017 Wadell P, Collins H. Case discussion: diagnostic dilemmas. 12th Annual UC Davis

Psychotic Disorders Conference; November 6; Sacramento, CA. 2017 Wadell P. Medications in Psychosis, Psychosis: Understanding Your Treatment

Options community education event, December 13. Community Service President-elect, Central California Regional Organization, Child and Adolescent Psychiatry Member, Child Psychiatry Clinical Competency Committee (CCC), Child and Adolescent Psychiatry Residency Training Program, Department of Psychiatry, UC Davis Member, Child Training and Education Committee (CTEC), Child and Adolescent Psychiatry Residency Training Program, Department of Psychiatry, UC Davis Treasurer, Central California Regional Organization, Child and Adolescent Psychiatry

123

Carlina Ramirez Wheeler, PhD

Presentations 2018 Diversity Training Seminar, Sacramento County Children’s Behavioral Health Program Research Funding American Psychological Association (APA) Internship Program Development Grant. 6/19/17-6/30/18. $16,000 Total Direct. (Wheeler CR: PI; Peerson S). Community Service 5150 Designee, Sacramento County Children’s Behavioral Health Program Assessment Program Supervisor and Mental Health Program Consultant, Children’s Receiving Home of Sacramento Member, ACES Connection, Sacramento County Member, American Psychological Association (Div. 53 Society of Clinical Child and Adolescent Psychology; Div. 41 American Psychology-Law Society; Div. 43 Society for Couple and Family Psychology) Member, Society of Women in Academic Psychiatry (SWAP), UC Davis Medical Center Member, Training and Program Development, Postdoctoral Psychology Program, UC Davis Medical Center

124

Guohua Xia, MD, PhD Journal Articles 2018 Maitan J, Xia G, Tayyib Z, Carrie B. Case report: dTMS and improvement of kidney

functions in a CKD patient. Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation, May-June; 11(3), e3.

Abstracts and Presentations 2017 Xia G. Invited Speaker: Deep TMS – New Progress in Brain Stimulation as a

Treatment of Major Psychiatric Disorders. The 15th Academic Mental Health Symposium of Chinese Medical Association and Chinese Society of Psychiatry. Hangzhou, China, August 8-9.

2017 Xia G. Invited Key Speaker, TMS – Progress in Non-pharmaceutical Treatment of

Mental Disorder. The Anhui Mental Health Institute Research Forum, Hefei, China, September 13.

2017 Xia G. Invited Key Speaker: TMS in Treatment of Mental Disorders. The International

Mental Health Conference at GuanJi. SuZhou, China, September 15. 2017 Xia, G. Invited CME Presentation: TMS – a New Technique in Treatment of Major

Psychiatric Disorders. The 1st International Summit of Mental Health, Hefei, China, October 11.

2017 Xia, G. Invited CME Presentation: Deep TMS Treatment of Major Psychiatric

Disorders. The International Conference of Psychiatry, Suzhou, China, October 14. 2017 Xia, G. Invited Lecture: Recent Advances in Brain Stimulation as a Treatment of Major

Psychiatric Disorders. November 17. 2018 Xia, G. TMS in Pain Management and Rehabilitation. Department of Rehabilitation,

UC Davis School of Medicine. Grand Round Presentation. February 13. 2018 Maitan J, Xia G, Tayyib Z, Carrie B. Case Report: Deep Transcranial Magnetic

Stimulation (dTMS) and Improvement of Kidney Functions in a CKD patient. Clinical TMS Society Annual Conference, Brooklyn, New York, May 11-13.

Research Funding Brainsway Co., A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-Coil deep Transcranial Magnetic Stimulation (TMS) in conjunction with mood stabilizers in Subjects with Bipolar Depression. This is a randomized, parallel group, sham-controlled phase III trial testing the safety and efficacy of an H-coil in treatment of medication-resistant Bipolar Depression (BD). This study is aimed at evaluating the efficacy and safety of deep rTMS and gathering needed data for a FDA approval for

125

future clinical use. Brainefit has been the hosting institute for enrollment and treatment of participants of this study. The result will be used to apply for FDA approval of the novel deep TMS device to be used in clinical practice for treatment of BD. The device has been approved now by FDA of USA for MDD, and also Israel, Chile, Canada and Europe for more indications. Xia G (PI). Brainsway Co., A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) (with the H-ADD Coil) Intended as an Aid to Smoking Cessation. This is a randomized, parallel group, sham-controlled phase III trial testing the safety and efficacy of an H-coil as an aid to Smoke Cessation (BR-SMOK-01). This study is aimed at evaluating the efficacy and safety of deep rTMS and gathering needed data for an FDA approval for future clinical use of deep TMS for smoke cessation. Brainefit serves as the research site for enrollment and treatment of participants. The result of this study will be used to apply for FDA approval of the novel deep TMS device to be used in clinical practice for smoke cessation. Xia G (PI). UC Davis Center for Mind, and Brain MRI Seed Grant, The neurobiology of empathy. This is a pilot study using TMS as research tool to search brain neurobiology mechanism related to the human social empathy. Hastings P, Xia G (Co-PIs). Community Service

Invited Reviewer, Schizophrenia Bulletin

Member, Steering Committee of Deans Office for Cooperation with Universities in China.

126

Glen L. Xiong, MD Journal Articles 2018 Xiong GL, Godwin H, Ziegahn L, Beckett LA, Filshtein T, Hinton L. The

communication gap between the medical system and communication resources for Dementia-Related Behavioral Symptoms Management. Primary Care Companion CNS Disorder, April, 20:e1-e4.

2018 Yellowlees P, Parish MB, Gonzalez A, Chan S, Hilty D, Iosif, AM, McCarron R, Odor

A, Scher L, Sciolla A, Shore J, Xiong G. Asynchronous Telepsychiatry: A component of Stepped Integrated Care. Telemedicine and e-Health. May, 24(5):1-4.

2018 Xiong GL, Iosif AM, Godwin HT, Khan M, Parish MB, Yellowlees P, Kahn D. A pilot

randomized trial of asynchronous and synthronous telepsychiatry skilled nursing facilities. Journal of American Medical Directors Association. May,19:461-462.

Book Chapters 2017 Schomer KJ, Firestone RL, Parker PL, Xiong GL. Hypoactive delirium in the critical

care setting. Delirium: Prevention, Symptoms and Treatment. Bourgeois JA (Editor) Nova Science Publisher. New York, p. 93-101.

2018 Hategan A, Xiong GL. Major or Mild Neurocognitive Disorders due to Alzheimer’s

Disease. Hategan A, Bourgeois J, Hirsch C, Giroux C (eds). Springer Nature. Abstracts and Presentations 2017 Cognitive Behavioral Therapy in Primary Care. Train New Trainers Fellowship

Conference. Sacramento, CA, August 27. 2017 Treatment Depression in the Post-Acute Long-term Care. California Association of

Long-term Care Meeting, Sacramento, CA, October 28. 2017 Mental Health Impacts of Methamphetamine Use. Methamphetamine Symposium.

Sacramento County Behavioral Health Services. Sacramento, CA, November 1. 2018 Pilot Study of Asynchronous Telepsychiatry Compared to Synthronous Telepsychiatry

(Poster). American Telemedicine Association, April 30. Research Funding R01HS021477 - 01A1, Yellowlees (PI), 10/01/13 – 08/31/18. Agency for Health Care Research and Quality Research. Title: A controlled trial of patient-centered telepsychiatry interventions. This proposal uses an innovative Health IT application solution (Asynchronous Telepsychiatry) to improve the efficiency and reach of mental health. To assess the impact of this novel approach, this randomized controlled trial of clinical outcomes seeks to evaluate

127

the superiority of asynchronous telepsychiatry consultation model on access, quality, cost and outcomes of care over the usual care for adults referred from primary care clinics for psychiatric evaluation and treatment. Role: Co-PI. R01HS025395-01, Xiong (PI), 8/2017-7/2022. Agency for Health Care Research and Quality Research. Title: Comparison of Asynchronous Telepsychiatry vs. Synchronous Telepsychiatry in Skilled Nursing Facilities (CATeleST). This study aims to evaluate the comparative clinical effectiveness of Asynchronous Telepsychiatry (ATP) vs. Synchronous Telepsychiatry (STP) in SNF population, in a 12-month randomized controlled trial. $2,000,000. Community Service Member, Journal Editorial Board, Primary Care Companion CNS Disorders Member, Society of Post-Acute/Long-term Care Medicine / American Medical Directors’ Association (AMDA) Core Curriculum Faculty Chief Editor, Medscape Drugs & Disease, Psychiatry Co-Chair, Research and Scholarship Committee, Association of Medicine and Psychiatry Reviewer, American Journal of Psychiatry Reviewer, Circulation Reviewer, JAMA Internal Medicine Reviewer, Journal of Clinical Psychopharmacology Reviewer, Medical Letter, The Reviewer, Primary Care Companion CNS Disorders

128

Peter Yellowlees, MBBS, MD Journal Articles 2017 Kocsis BJ, Yellowlees PM. Telepsychotherapy and the Therapeutic Relationship:

Principles, Advantages, and Case Examples. Telemed J E Health. August 24. 2017 Godwin HT, Khan M, Yellowlees PM. The Educational Potential of YouTube. Acad

Psychiatry. 2017 September 18. 2017 Yellowlees PM, Burke Parish M, González Á, Chan S, Hilty D, Iosif AM, McCarron R,

Odor A, Scher L, Sciolla A, Shore J, Xiong G. Asynchronous Telepsychiatry: A Component of Stepped Integrated Care. Telemed J E Health. October 12.

2017 Parish MB, Fazio S, Chan S, Yellowlees PM. Managing Psychiatrist-Patient

Relationships in the Digital Age: a Summary Review of the Impact of Technology-enabled Care on Clinical Processes and Rapport. Curr Psychiatry Rep. October 27;19(11):90.

2017 Chan S, Godwin H, Gonzalez A, Yellowlees PM, Hilty DM. Review of Use and

Integration of Mobile Apps Into Psychiatric Treatments. Curr Psychiatry Rep. October 30;19(12):96.

2018 Xiong GL, Iosif AM, Godwin HT, Khan M, Parish MB, Yellowlees PM, Kahn D. A Pilot

Randomized Trial of Asynchronous and Synchronous Telepsychiatry in Skilled Nursing Facilities. J Am Med Dir Assoc. May;19(5):461-462.

Electronic Publications 2017 Managing Opioid Withdrawal: How Does Buprenorphine Compare? Dr. Peter

Yellowlees talks about a new study that compares buprenorphine with other agents for management of opioid withdrawal. Experts And Viewpoints, August.

2017 Interventions to Prevent and Reduce Physician Burnout. Dr. Peter Yellowlees urges

immediate action to prevent and reduce physician burnout. Experts And Viewpoints, August.

2017 Supplementing Psychosis Therapy. Dr. Peter Yellowlees talks about psychological

and psychosocial interventions for negative symptoms in psychosis. Experts And Viewpoints, September.

2017 A Traditional Chinese Herbal Treatment Shows Promise. A Cochrane methodology

study revealed some positive effects of a classic Chinese herbal therapy when combined with antipsychotics. Experts And Viewpoints, October.

129

2017 Do Benzodiazepines Increase All-Cause Mortality? Benzodiazepines could increase mortality rates, especially in the elderly, but the latest research might suggest otherwise. Experts And Viewpoints, November.

2017 Prevent Schizophrenia Relapse With Regular Maintenance. Dr. Peter Yellowlees

discusses 1-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo. Experts And Viewpoints, December 2017

2018 Do Contraceptive Hormones Increase Suicide Risk? Dr. Peter Yellowlees talks about

the association between hormonal contraception and suicide. Experts And Viewpoints, March.

2018 Use It or Lose It to Prevent Alzheimer Disease. Exercise and cognition training could

alleviate symptoms of cognitive decline. Experts And Viewpoints, April. 2018 Non–English-Speaking Patients Have High Rates of Depression. Dr. Peter Yellowlees

discusses collaborative care for depression among patients with limited English proficiency. Experts And Viewpoints, April.

Book Edited 2018 Telepsychiatry and Health Technologies - A Guide for Mental Health Professionals.

Yellowlees P, Shore J. Pub Feb 18. American Psychiatric Publishing Inc. Book Authored 2018 Yellowlees P. Physician Suicide: Cases and Commentaries. Publisher: American

Psychiatric Publishing Inc., June. Book Chapters 2017 Waugh M, Yellowlees PM, Dixon R, Shore JH. Telepsychiatry. In Understanding

Telehealth. Eds Rheuban K, Krupinski E. McGraw Hill. 2017 Yellowlees PM, Waugh M, Shore JH. Child Telepsychiatry. In Understanding

Telehealth. Eds Rheuban K, Krupinski E. McGraw Hill. 2018 Yellowlees PM, Shore J. MPHCurrent psychiatric practice in the information age. In

Telepsychiatry and Health Technologies – a guide for mental health professionals. Ed Yellowlees PM, Shore J. Pub Feb 18. APA Inc.. Pages 1-30.

2018 Kaftarian E, Caudill RL, Malik T, Yellowlees PM. The Business: How to set up a

practice, or integrate technology into a current practice. In Telepsychiatry and Health Technologies – a guide for mental health professionals. Ed Yellowlees PM, Shore J. Pub Feb 18. APA Inc. Pages 59-96.

130

2018 Yellowlees PM, Roberts L, Shore P. Communication and media skills, and the ethical doctor patient relationship. In Telepsychiatry and Health Technologies – a guide for mental health professionals. Ed Yellowlees P, Shore J. Pub Feb 18. APA Inc. Pages 137-182.

2018 Yellowlees PM, Shafqat S, Myers K. Indirect Consultations and hybrid care. In

Telepsychiatry and Health Technologies – a guide for mental health professionals. Ed Yellowlees P, Shore J. Pub Feb 18. APA Inc. Pages 251-288.

2018 Luo J, Yellowlees PM. Managing Populations of Patients. In Telepsychiatry and

Health Technologies – a guide for mental health professionals. Ed Yellowlees P, Shore J. Pub Feb 18. APA Inc. Pages 289-312.

Abstracts and Presentations 2017 California Telemedicine Policy Initiatives. Keynote CA Telehealth Policy Coalition,

Sacramento. July 14. 2017 The evidence base for telespsychiatry. Senate Hearings, Capitol, Washington DC,

September 9. 2017 Practical Guide to Telepsychiatry. National Webinar by Zoom. Sacramento, CA,

September 19. 2017 Innovations in Telemedicine. TTRN Conference, Sacramento, CA, September 26. 2017 Hybrid telemedicine practice. The ATA Edge 2017. Washington, DC, October 2. 2017 Telemedicine history and evidence base. APA IPS Conference, New Orleans, LA,

October 19. 2017 Telemedicine Innovations. UCD Paediatric Telehealth Symposium, Davis, CA,

October 24. 2017 Telemedicine National Innovations. Successes and Failures in Telehealth Conference,

Brisbane, Australia, October 30. 2017 Advances in Telepsychiatry. Princess Alexandra Hosp Research Institute, Brisbane,

Australia, November 1. 2017 Telepsychiatry practice of the future. UCD Early Psychosis Conference, Sacramento,

CA, November 6. 2017 Telepsychiatry as a transformative tool. Uni Colorado Depression Center, Denver,

CO, November 9.

131

2017 Telepsychiatry and Precision Medicine. UCD Digital Health Conference, Sacramento, CA, November 15.

2018 Fedtel National Webinar. Asynchronous Telepsychiatry as a component of hybrid

psychiatric care, January 3. 2018 UC Davis Cardiology Grand Rounds, Physician Wellbeing, Sacramento, CA, January

18. 2018 UC Davis K30, Invited Presentation. Telemedicine, January 30. 2018 UC Davis Neurosurgery Grand Rounds. Physician Wellbeing, February 13. 2018 Adventist Health. Telepsychiatry and Hybrid Practice, Sacramento, CA, March 13. 2018 UC Davis Psychiatry. Global Mental Health – digital approaches, Sacramento, CA,

March 15. 2018 National Drug Rx Summit. Telemedicine and Opiate Addiction, Atlanta, GA, April 4. 2018 South Carolina Telehealth Summit. The hybrid practitioner, Columbia, SC, April 12. 2018 Central CA Psychiatric Society. Telepsychiatry, Yosemite, CA, April 14. 2018 ATA Plenary. Future directions for telemedicine, Chicago, IL, April 29. 2018 ATA Conference. ATA and APA Guidelines, Chicago, IL, April 30. 2018 ATA Conference. Asynchronous Telepsychiatry workshop, Chicago, IL, April 30. 2018 APA Conference. Digital Integrated Care, New York, NY, May 5. 2018 APA Conference. Presidential symposium on Telepsychiatry, New York, NY, May 5. 2018 APA Conference. APA-ATA guidelines, New York, NY, May 6. 2018 APA Conference. Innovations in Telepsychiatry, New York, NY, May 7. Research Funding Asynchronous Telepsychiatry Implementation for Depression, UCD Practice Management Board Amount: $330,000. Scher L (PI), Yellowlees PM (Co-PI 4%), 2015-2017. Asynchronous Telepsychiatry in Nursing Homes, UCD Behavioral Health Center of Excellence: $200,000. Xiong G (PI), Yellowlees PM (Co-PI 5%), 2015-2017.

132

Telepsychiatry Services Across Languages, UCD Behavioral Health Center of Excellence: $200,000. Yellowlees PM (PI 5%), 2015-2017. A controlled trial of patient-centered telepsychiatry interventions, AHRQ: $2.5 million. Yellowlees PM (PI 15%), 2013-2018. A clinical trial to validate an automated online language interpreting tool with Hispanic patients who have limited English proficiency, AHRQ: $2,000,000. Yellowlees PM (PI 20%), 2016 – 2021. Asynchronous Telepsychiatry in Nursing Homes, AHRQ, $2 million, Xiong G (PI), Yellowlees PM (Co-PI 10%). 2017-2022. Community Service President, Board of Directors of American Telemedicine Associations (ATA) Chair, UCDHS Wellbeing Committee Member, Board of Trustees Committee on Telepsychiatry, American Psychiatric Association Member, Institute of Medicine Committee reviewing VA mental health services Member, Editorial Board, Journal of Participatory Medicine Member, Editorial Board, Journal of Telemedicine and e-Health Member, Editorial Board, Journal of Telemedicine and Telecare Member, NCQA Telemedicine Expert Group Member, UC Davis Peer Review Committee Member, UCOP Telemedicine Committee Reviewer, BMC Medical Informatics Reviewer, General Hospital Psychiatry Reviewer, Annals of General Psychiatry Review Reviewer, Journal of Medical Internet Research Reviewer, BMC Psychiatry Reviewer, American Journal of Psychiatry Reviewer, Academic Psychiatry Reviewer, Medical Journal of Australia Reviewer, Psychiatric Services Reviewer, Psychosomatics

133

Erik Youngdale, MD Community Service Chair, Clinical Competency Committee, Child Psychiatry Residency Training Program, Department of Psychiatry and Behavioral Sciences, UC Davis Member, Child Training and Education Committee, Child Psychiatry Residency Training Program, Department of Psychiatry and Behavioral Sciences, UC Davis Member, Child Psychiatry Residency Training Program Selection Committee, Department of Psychiatry and Behavioral Sciences, UC Davis Mentor, Klingenstein Fellowship Program